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ABSTRACT 
This PhD thesis deals with the development of bioactive polysaccharide-based biomaterials for 
bone tissue and neural tissue engineering. Alginate was chosen for its gel forming properties; 
hyaluronic acid and chitlac (a lactose-modified chitosan) were chosen for their bioactive properties. 
The properties of these polysaccharides have been implemented by introducing gelatin, 
functionalized Carbon Nanotubes (f-CNTs) and silver nanoparticles (nAg). 
In the first part of the work, the dispersibility and aggregation tendency of f-CNTs have been 
characterized by means of Low Field Nuclear Magnetic Resonance (LF-NMR). It was also possible 
to correlate the f-CNTs concentration to the proton transversal relaxation rate of water. Alginate/f-
CNTs solutions and hydrogels have been analyzed by LF-NMR, rheology and uniaxial 
compression tests; these investigations showed that the f-CNTs are able to affect nanocomposite 
properties depending on their concentration and functionalization. 
In the second part of the work, the preparation of a bioactive (bridging) implant for the treatment 
of Spinal Cord Injury is described. Neuronal cells and mesoangioblasts (MABs) engineered for the 
production of neurotrophines have been cultured and co-cultured on polysaccharide-coated glass 
substrates in order to evaluate the biological effects of chitlac. Chitlac-coated surfaces where shown 
to possess higher surface energies if compared to chitosan-coated ones and enable the formation of 
wider neural networks with improved electrical activity. The co-cultures confirmed the higher 
bioactivity of chitlac/alginate substrates and the biological role of neurotrophines. Porous scaffolds 
of alginate/chitlac have been prepared; these scaffolds where shown to be stable in simulated body 
fluid for over a month. The mechanical properties of rehydrated scaffolds where proved to be 
similar to those of neural tissue. Biological properties of chitlac substrates enriched with f-CNTs 
are currently under investigation. 
In the third part of the work, tridimensional scaffolds and injectable fillers were developed for the 
treatment of non-critical bone defects. Porous scaffolds with different pore morphologies have been 
prepared by freeze casting of alginate/HAp hydrogels. Isotropic porosity was obtained by freezing 
the constructs in a cryostat, while anisotropic porosity was obtained by the Ice Segregation Induced 
Self Assembly process. Physical, mechanical and biological analyses revealed that the differences 
ABSTRACT 
 
xii 
in pore morphology determine differences in the mechanical properties of the scaffolds. 
Biocompatible f-CNTs have been used to implement the isotropic scaffolds; the biological analyses 
showed that the presence of f-CNTs does not affect scaffold properties. 
Osteoconductive/antimicrobial injectable bone fillers, based on alginate/HAp microbeads 
dispersed in polysaccharide mixtures, have been developed. Microbeads were enriched with nAg 
synthesized in chitlac. Antimicrobial assays proved the antibacterial properties of the microbeads 
towards bacteria in suspension and on pre-formed biofilms. Biological assays showed the 
biocompatibility of the microbeads and their ability to sustain osteoblast proliferation. The fillers 
prepared by dispersing microbeads in polysaccharide mixtures were shown to be easily injectable 
through surgical syringes. In vivo studies on a rabbit model of non-critical bone defect pointed out 
the biocompatibility and the osteoconductivity of the composite materials. Further studies are 
ongoing in order to evaluate the possibility to further implement the bioactive properties of the 
microbeads by addiction of gelatin. 
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RIASSUNTO 
Questa tesi di dottorato descrive lo sviluppo di biomateriali a base di polisaccaridi per applicazioni 
di ingegneria tissutale ossea e neuronale. L’alginato è stato scelto per la sua abilità di formare 
idrogeli, l’acido ialuronico e il chitlac (un chitosano modificato con gruppi lattosidici) sono stati 
scelti per la loro bioattività. Le proprietà di tali polisaccaridi sono state implementate introducendo 
gelatina, nanotubi di carbonio funzionalizzati (f-CNT) e nanoparticelle di argento (nAg). 
Nella prima parte del lavoro, la dispersibilità e la tendenza all’aggregazione dei f-CNT è stata 
caratterizzata grazie alla risonanza magnetica nucleare a basso campo (LF-NMR). Inoltre è stato 
possibile correlare la concentrazione dei f-CNT alla velocità di rilassamento trasversale dei protoni 
dell’acqua. Soluzioni e idrogeli di alginato e f-CNT sono stati analizzati tramite LF-NMR, studi 
reologici e test di compressione uniassiale; queste indagini hanno mostrato che i f-CNT sono in 
grado di influenzare le proprietà dei nanocompositi in base alla loro concentrazione e 
funzionalizzazione. 
Nella seconda parte del lavoro è descritta la preparazione di un impianto bioattivo per il trattamento 
delle lesioni spinali. Neuroni e mesangioblasti (MAB) ingegnerizzati per la produzione di 
neurotrofine sono stati coltivati e co-coltivati su substrati vetrosi ricoperti di polisaccaridi, in modo 
da valutarne gli effetti su tali cellule. Le superfici contenenti chitlac hanno mostrato di possedere 
energie di superficie più alte di quelli contenenti chitosano e di consentire la formazione di reti 
neuronali estese con un’attività sinaptica aumentata. Le co-culture hanno evidenziato la bioattività 
dei substrati contenenti chitlac e alginato e il ruolo biologico delle neurotrofine. Sono stati preparati 
scaffold porosi di alginato e chitlac; tali scaffold sono risultati stabili per più di un mese in un fluido 
mimante il plasma sanguigno. Le proprietà meccaniche degli scaffold reidratati si sono mostrate 
simili a quelle del tessuto neuronale. Sono in corso studi sulle proprietà biologiche di substrati di 
chitlac implementati con f-CNT. 
Nella terza parte del lavoro sono stati sviluppati scaffold tridimensionali e riempitivi iniettabili per 
il trattamenti di difetti ossei non critici. Scaffold con diversi tipi di porosità sono stati preparati 
grazie alla liofilizzazione di idrogeli di alginato/idrossiapatite (HAp). La porosità isotropica è stata 
ottenuta grazie al congelamento in criostato, mentre quella anisotropa grazie al metodo definito Ice 
RIASSUNTO 
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Segregation Induced Self Assembly. Le analisi fisiche, meccaniche e biologiche hanno rivelato che 
le differenze nella morfologia dei pori determinano differenze nelle proprietà meccaniche dei 
costrutti. f-CNT biocompatibili sono stati usati per implementare gli scaffold isotropici. Le analisi 
biologiche hanno mostrato che la presenza dei f-CNT non condiziona l’effetto degli scaffold sugli 
osteoblasti. 
Sono inoltre stati sviluppati riempitivi iniettabili osteoconduttivi e antimicrobici basati su 
microparticelle di alginato/HAp disperse in soluzioni polisaccaridiche. Le microparticelle sono 
state implementate con nAg sintetizzate in chitlac. Test antimicrobici hanno mostrato l’attività 
antibatterica delle microparticelle sia su batteri in sospensione che su biofilm preformato. Test 
biologici in vitro hanno mostrato la biocompatibilità delle microparticelle e la loro abilità di 
supportare la proliferazione di osteoblasti. I riempitivi preparati disperdendo le microparticelle in 
soluzioni polisaccaridiche sono risultati essere facilmente iniettabili attraverso siringhe per uso 
chirurgico. Studi in vivo su un modello di difetti ossei non critici hanno mostrato la biocompatibilità 
e l’osteoconduttività dei riempitivi. Studi preliminari sono stati effettuati al fine di implementare 
ulteriormente le proprietà bioattive delle microparticelle grazie all’introduzione di gelatina. 
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1 INTRODUCTION 
1.1 TISSUE REGENERATION AND TISSUE ENGINEERING 
1.1.1 BIOMATERIALS DESIGN 
Tissue regeneration and tissue engineering are highly multidisciplinary fields that combine 
different approaches for the restoring, the maintenance or the improvement of tissue functions or 
whole organs.1 These fields arise from the synergistic combination of materials engineering, 
biology and medicine, and exploit the use of biomaterials, cells, growth factors (GFs), 
nanomedicine, immunomodulation, gene therapy and other techniques. The design of biomaterials 
is aimed at the preparation of hydrogels, scaffolds, membranes, and injectable materials that have 
to allow, sustain and promote cell adhesion, migration, proliferation, differentiation and function. 
The most investigated approach for tissue engineering is the preparation of scaffolds, which can be 
implemented with bioactive compounds and loaded with cells harvested from the patients.2,3 
 
Figure 1. Schematic representation of the preparation of ideal cellularized/bioactive scaffolds for 
tissue engineering, by using cells harvested from the patients. 
Figure 1 shows a schematic representation of a typical tissue engineering approach: first of all, 
primary or stem cells (SCs) are harvested from the patients; the possibility to use autologous cells 
enables to avoid any immune reaction to a cellularized scaffolds. Scaffolds can be prepared by 
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using natural-derived or synthetic materials, and can be implemented with bioactive components, 
such as GFs. The harvested cells are expanded and differentiated in vitro for the specific application 
and loaded into the scaffolds; the processes can be performed in bioreactors, in order to mimic the 
in vivo environment. At the end of the process, the cellularized bioactive scaffolds are implanted 
into the patient.4-6 
1.1.1.1 Biomaterials implementation with growth factors 
The stimulation of cell differentiation and growth, and of tissue regeneration, can be achieved by 
the introduction of GFs in the scaffolds. The classical approaches are based on the covalent 
conjugation of GFs to the components of the biomaterials, or on the physical entrapment of GFs 
inside the polymer matrices. The GFs embedded in the biomaterials are, in this way, able to interact 
with cells, or to be released during the degradation of the biomaterials.7,8 These approaches have 
some drawbacks, principally related to the difficulty of obtaining a long-term controlled delivery; 
this issue is partially overcame by the preparation of biomaterials containing stimuli-responsive 
components that can be triggered to release the GFs upon pH or temperature variations, enzymatic 
cleavage, ionic interactions or external stimuli.7,9 
1.1.1.2 Cell loading in biomaterials 
Several research groups have implemented biomaterials by loading cells for a wide range of 
applications. The preparation of these materials follows specific protocols for the harvesting and 
the cultivation of cells and for their loading and encapsulation into materials, such as scaffolds and 
hydrogel microspheres. 
Scaffolds for tissue engineering can be loaded with primary cells or SCs that will differentiate, 
upon appropriate conditions, in the cells of the target tissue. This approach has been used for the 
preparation of tridimensional hydrogels and porous scaffolds loaded with MSCs (Mesenchymal 
Stem Cells), BMSCs (Bone Marrow Stromal Cells) or SCs derived from adipose tissue, for 
applications of tissue regeneration in bone,10 cartilage,11 heart valves,12 skin,13 nerve,14 alveolar 
cleft,15 tendon and muscles16 and wound healing.17 
The biomaterials can be also loaded with GFs-producing cells. This strategy helps to overcome the 
problems related to the loading and the release of GFs, guaranteeing a sustained and controlled 
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release of these bioactive molecules. Moreover, cells seeded into the scaffolds can synthesize 
extracellular matrix (ECM) and create a permissive environment for cell growth.18 The main 
applications of this approach are in the fields of neural and bone tissue regeneration. For example, 
scaffolds containing Bone Morphogenetic Protein (BMP-2)-producing cells were proved to 
improve the heterotopic bone formation,19 and scaffolds containing Vascular Endothelial Growth 
Factor (VEGF)-producing BMSCs enhanced vascularization, osteogenesis and resorption of the 
scaffold itself.20 
1.2 BIOPOLYMERS FOR BIOMATERIALS 
As discussed before, the main approach in the tissue engineering consists in the preparation of 
biocompatible biomaterials that can contain cells and bioactive molecules. The choice of the 
components that are used for the preparation of the biomaterials depends on their final properties 
and applications: for example, metallic implants or thermosets can be used for the restoring of large 
bone defects, biopolymers can be used for the preparation of membranes and tridimensional 
scaffolds, for the electrospinning and wet spinning of fibers or for injectable materials. 
The present thesis is focused on the combination of biopolymers, nanostructures and cells for the 
preparation of tridimensional, biopolymer-based scaffolds and injectable composites, to be 
employed in bone and neural tissue regeneration. After the description of biopolymers and tissue 
regeneration strategies, the introduction will focus on two main issues: the healing of non-critical 
bone defects and the neural tissue regeneration in Spinal Cord Injury (SCI). The strategies for the 
implementation of biomaterials for these applications will be presented. 
Biopolymers used for the preparation of biomaterials can be classified in two main categories: 
polysaccharides and proteins; the most commonly used are alginate, hyaluronic acid and chitosan, 
among polysaccharides, and collagen and gelatin among proteins.21 Other polysaccharides include 
cellulose, agarose and dextran and other proteins include elastin, fibrin, fibronectin laminin and 
silk. 
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1.2.1 PROPERTIES AND APPLICATIONS OF POLYSACCHARIDES 
 Alginate 
Alginate is a polyuronate, a polysaccharide that contains carboxylic groups in the C6, and is derived 
from algae and bacteria.22 Its structure consists of 14 linked α-L-guluronic acid and β-D-
mannuronic acid in different blocks and portions within the polysaccharide chain (Figure 2). The 
monomer blocks can be composed by a sequence of guluronic monomers (G blocks), mannuronic 
monomers (M blocks) or a mixing of the two monomers (MG blocks). 
 
Figure 2. Chemical structure of alginate. 
An important feature of alginate is the ability to form hydrogels upon interaction with divalent 
cations, such as Ca2+. These hydrogels are typically composed by the 95-99% of water and their 
properties depend on alginate concentration and composition, and on the concentration and 
typology of the cations. Several studies showed the different affinity of alginate for cations such as 
Pb2+, Cu2+, Cd2+, Zn2+, Ca2+, Mg2+, Ba2+, Sr2+. The affinity for the divalent cations is explained by 
considering the alginate chain structure that can bind the cations and form the so-called “egg-box” 
structure (Figure 3).23,24 
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Figure 3. Schematic representation of the egg-box model: the structure of 
the G blocks allows to the carboxylic groups of the guluronic monomers to 
interact and coordinate the calcium ions in a well-ordered structure. 
The affinity of alginate for the different divalent cations is highly selective, and for the alkaline 
earth metals is Mg2+ << Ca2+ < Sr2+ < Ba2+. Moreover, it has been shown that the cations affinity is 
not related to the composition of MM and MG blocks and that it increases with the increasing of 
the G blocks number and length.24,25 Lastly, the strength of the alginate hydrogels depends on the 
concentration of the divalent cations, as shown in the model reported in Figure 4. 
 
Figure 4. Schematic representation of the calcium concentration 
increasing effect: on the left, low calcium concentration results in low 
dense egg-boxes, on the right dense and compact egg-boxes are formed 
upon the addition of high calcium concentration. 
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Alginate is biocompatible and does not trigger immune or adverse tissue reactions; it possesses 
hemostatic properties26,27 and it has been used to enrich medications for skin grafts in order to 
accelerate the wound healing.28 It is a very versatile polysaccharide for the preparation of 
biomaterials in form of membranes, films, hydrogels, porous scaffolds, fibers and foams, for 
several applications in wound healing, bone, cartilage and neural tissue regeneration.29-31 
 Chitosan 
Chitosan is a polysaccharide obtained from crab-shell chitin deacetylation in alkaline environment; 
it is characterized by having different degrees of deacetylation (40-98%). It is widely used in the 
pharmaceutical industry and in biomedical application and as adjuvant in diets for its lipids binding 
properties.32-34 Its structure consists of β(1→4) linked D-glucosamine e N-acetyl-D-glucosamine, 
arranged in helix stabilized by hydrogen bonds (Figure 5). 
 
Figure 5. Chemical structure of chitosan. 
Due to the presence of amino groups, a consequence of the deacetylation process, chitosan is 
soluble in acid environment, in which it behaves as a polycation. The chemical reactivity of the 
amino groups can be exploited for the functionalization and modification of chitosan; moreover, 
cross-linking agents can react with amino groups allow obtaining biomaterials in form of fibers 
and hydrogels. The biomedical applications of chitosan are limited by its scarce solubility in water 
and physiological environment; however, these characteristics can be tailored by chemical 
modifications of chitosan.35 
Likewise to alginate, chitosan is a good candidate for the preparation of biomaterials. It is 
biocompatible and biodegradable and it possesses antibacterial and wound-healing properties. 
Moreover, chitosan possesses gel-forming properties (in the presence of polyanions and 
glicerophosphates) and can it be used to obtain porous structures. Chitosan and its derivatives have 
been widely used in several tissue engineering applications for the stimulation of the regeneration 
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and healing of skin, bone, cartilage, liver, nerve and blood vessels.35 
 Hyaluronic acid 
Hyaluronic acid is a high molecular weight glycosaminoglycan; it is not covalently bound to 
proteins and is the simplest among glycosaminoglycan; it is present in most of all tissues and 
biological fluids.36 Its structure consists in 1→4 and 1→3 linked D-glucuronic acid e N-acetyl-D-
glucosamin (Figure 6). 
 
Figure 6. Chemical structure of hyaluronic acid. 
Hyaluronic acid is highly hydrophilic and its aqueous solutions display peculiar viscoelastic 
properties. Owing to these properties, this polysaccharide plays a key role in the modulation of 
mechanical properties and water content of the ECM, and is responsible for the viscoelastic 
properties of the synovial fluid.36,37 Moreover, hyaluronic acid modulates and triggers several 
biological functions thanks to the presence of specific membrane receptors: the interactions with 
CD44 can modulate cell migration, proliferation, differentiation, and adhesion, and can also 
regulate tissue regeneration, angiogenesis and immune response.36-39 
Hyaluronic acid for biomedical application can be extracted from rooster comb or rabbit skin, or 
obtained through recombinant synthesis from Streptococci. Hyaluronic acid is widely used in 
biomedical applications (such as the treatment of articular pathologies, aesthetic surgery, wound 
healing) and cosmetics.39 It can be used as a bioactive component within the biomaterials or, thanks 
to chemical modifications and crosslinking agents, it can be used in the form of hydrogels or 
scaffolds for cell delivery.40 
 Cellulose 
Cellulose is a non-biodegradable, biocompatible, linear polysaccharide composed by β(1→4) 
linked D-glucose. In nature, it is one of the most widespread polymeric material. Cellulose 
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possesses hemostatic properties41 and can be employed in form of fibers for the preparation of 
reinforcement mashes for membranes. It can be also used for the preparation of hydrogels and 
scaffolds for vascular devices, bone tissue regeneration and other applications, and for the 
preparations of drug delivery systems.42 
 Agarose 
Agarose is a linear polysaccharide that consists of repeating agarobiose units. Agarobiose is a 
disaccharide made up of D-galactose and 3,6-anhydro-L-galactopyranose. It can be used for the 
preparation of hydrogels and scaffolds and it is commonly used in combination with proteins, such 
as gelatin or laminin, because of its poor biological properties. Agarose-based biomaterials have 
been used for neural growth, corneal organotypic substitutes and for cartilage repair.43-45 
 Dextran 
Dextran is a biocompatible, branched polysaccharide that consists of α1→6 and α 1→3 linked 
glucose, and possesses anti-thrombotic properties. Dextran can be used for the preparation of 
porous scaffolds and implant coatings, and can be modified in order to enhance its bioadhesive 
properties.46,47 
1.2.2 PROPERTIES AND APPLICATIONS OF PROTEINS 
 Collagen 
Collagen is the most abundant protein of the mammalian connective tissue, the main component 
of the ECM and it is present in all connective tissues of the body.48,49 Collagen is present in 29 
isoforms and it is structured in a right-handed triple helix, which is stabilized by hydrogen bonds 
and N-π* interactions formed by three left-handed α-helixes (Figure 7).50,51  
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Figure 7. A) Collagen triple helix stabilized by hydrogen bonds (blue dashed line) and n→π* interactions 
(red dashed line). B) Collagen fibers assembly (adapted from Chattopadhyay et al.52). 
Among the isoforms, collagen I is the most used for biomedical applications because of its highest 
abundance in the ECM.52 It can be extracted from animal tissues (horse and bovin tendon and skin, 
rat tail, porcine skin)53 or obtained through recombinant synthesis from E. coli.54 
Collagen possesses a rigid structure and a good mechanical resistance; these properties, together 
with its biocompatibility and biodegradability, make the collagen a good coice for the preparation 
of different types of biomaterials, such as hydrogels, foams, membranes, beads and scaffolds. It 
can be used for the preparation of scaffolds for cell loading, injectable materials for surgical 
applications, drug delivery systems and membranes for wound healing.52 Collagen drawbacks 
derive from its water insolubility: collagen has to be solubilized in acidic conditions and it is 
difficult to process, moreover it is difficult to control its degradation rate.48,55 
 Gelatin 
Gelatin is obtained through thermal denaturation of animal derived collagen; the process leads to 
the triple helix denaturation and the formation of uncoiled structures (Figure 8). 
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Figure 8. Schematic representation of collagen denaturation process for the obtaining of gelatin. 
Gelatin possesses biological properties similar to collagen (biocompatibility, biodegradability and 
cell adhesiveness) and in addition, thanks to the denaturation process, gelatin is water soluble and 
less immunogenic; moreover, the denaturation helps to expose the RGD (arginylglycylaspartic 
acid) peptides of collagen, which are recognized by cells and trigger biological responses such as 
adhesion and proliferation. For these reasons gelatin is a good material for biomedical 
applications.55,56 
Due to its lower mechanical properties, gelatin is often cross-linked or used in association with 
other polysaccharides, such as alginate and chitosan.57-59 For example, in situ forming hydrogels 
for wound-dressing or bone tissue engineering applications have been prepared combining gelatin 
with alginate.60,61 
 Elastin 
Elastin is a hydrophobic insoluble protein that constitutes the ECM. The content of elastin depends 
on the mechanical properties required from the tissues and it is abundant in skin, lungs, elastic 
ligaments and blood vessels.62-65 Soluble elastin protein, derived from elastin hydrolysis, can be 
used for the fabrication of biomaterials with different mechanical properties and in different forms 
like hydrogels, films, nanoparticles, sponges and nanoporous materials. Elastin can be used for the 
preparation of skin substitutes, vascular constructs and drug delivery systems.66 
 Fibrin 
Fibrin is a protein derived from fibrinogen and plays a key role in the coagulation cascade and thus 
in wound healing process. Fibrin contains peptides and domains that are recognized by cells and 
INTRODUCTION 
 
11 
can be used for the preparation of scaffolds with good cell adhesiveness. Fibrin scaffolds have been 
widely used as a support for the growth of stem or primary cells to be employed for the regeneration 
of several tissues.48,67,68 
 Fibronectin 
Fibronectin is a protein component of the ECM, where it can bind different proteins such as 
collagen and fibrin. It possesses self-assembly characteristics; the mats that are formed upon its 
aggregation can be used as scaffolds for neural tissue engineering applications.48,69 The main 
domain of its structure (the central cell binding domain) contains RGD peptides, which are essential 
for cell adhesion; moreover, fibronectin promotes cell proliferation, migration and 
differentiation.70,71 
 Laminin 
Laminin is a group of heterotrimeric glycoprotein; is one of the major component of basement 
membranes and plays an essential role in cell adhesion, migration, proliferation and angiogenesis, 
with a specific role in the neurite outgrowth.72 In the field of tissue regeneration it is mostly used 
for the functionalization (by adsorption or chemical crosslinking) of scaffolds in order to improve 
their regeneration capacity, with specific applications in neural tissue regeneration.73,74 
 Silk 
Silks are biocompatible proteins that are mostly obtained from the domesticated silkworm (Bombyx 
mori) and from some spiders (Nephila clavipes and Araneus diadematus).75 Due to its peculiar 
mechanical properties, flexibility and high tensile strength, silk is a good material for the 
preparation of suture and load-bearing scaffolds with higher mechanical properties than other 
biopolymer-based scaffolds. The main fields of applications are cartilage and bone tissue 
engineering.75,76 
1.3 SPINAL CORD TISSUE REGENERATION 
The spinal cord is an organ of the central nervous system (CNS) placed in the spinal column and 
possesses several functions; the main functions are the transmission of the neural signals between 
the periphery and the cortex, and the coordination of sensory, motor and autonomic functions.77 
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The organization of the spinal cord (reported in Figure 9) consists of segments composed by the 
dorsal root ganglia that contain the sensory neuron bodies, whose axons travel into the spinal cord. 
The grey matter of the spinal cord consists in interneurons that receive the information from 
neurons descending from the brain, and in primary afferent neurons; moreover, it contains 
neuroglia cells.77  
 
Figure 9. Schematic representation of the anatomic organization of the spinal cord 
(adapted from Bradbury et al.78). 
Within the human body, CNS is the organ with the most limited capability of repair or regeneration, 
posing a challenge that is difficult for clinicians to overcome.79 Apart from the low intrinsic 
regenerative ability of neurons, the CNS is also characterized by a specific glial reaction following 
injury and an inhibitory environment that prevent axon regrowth leading to severe and permanent 
deficits.78 
1.3.1 SPINAL CORD INJURY AND CURRENT THERAPIES 
Spinal cord injury (SCI) is a devastating clinical condition that significantly impacts the ability of 
affected individuals to produce functional movements and often results in paraplegia or 
quadriplegia.78 SCI can be caused by traumas or by other pathologies; the non-traumatic SCI can 
be induced, for example, by vertebral spondylosis, tumor compression, vascular ischemia, neuronal 
motor diseases, infectious abscess and transverse myelitis. Every year 12000 new cases of SCI in 
the USA are reported, with a total number of ~259000 patients living with SCI;80 the incidence in 
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Europe is slightly lower.81,82 Given the complications caused by the SCI, the costs related to the 
hospitalization and the assistance to the patients are very high.83 
Likewise to other CNS injuries, it can be divided in two phases: primary and secondary. The 
primary injury involves the immediate damage to neural tissue and surrounding soft tissues, 
generically caused by mechanical impact, ischemia or haemorrhage; the tissue damages worsen the 
injury over time and lead to the secondary injury.84 The second phase consists of several processes 
that comprise focal vascular changes, congestion, petechial haemorrhages, massive secondary cell 
death and degradation of distal axon ends; it is accompanied by edema and impairs the 
microcirculation, leading after several days to the formation of a cystic region and glial scar 
tissue.84,85 These events are also accompanied by oligodendrocyte apoptosis and inhibition of 
myelin regeneration, and by Wallerian degeneration (the degeneration of the distal part of a 
damaged axon).78 In the Figure 10 is reported a schematic representation of the events that take 
place in the SCI site. 
 
Figure 10. Schematic representation of the nerve injury site (adapted from 
 Yiu et al. 86). 
The injury environment is highly complex; it changes and evolves with the formation of the glial 
scar, which plays an initial protective role, but leads to the producton of molecules that inhibit the 
axonal regrowth. Moreover, the migration of oligodendrocytes, astrocytes and fibroblasts leads to 
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the formation of tissue that isolates the site of primary injury and to the production of other 
molecules that inhibit the axonal regrowth and trigger apoptotic pathways.86-88 
Given the complexity of the injury, which involves cell growth inhibition and apoptosis and the 
formation of a cystic cavity, it is necessary to design a multidisciplinary approach for the neural 
tissue regeneration and the recovery of the tissue functions. Currently there are no therapies able 
to repair the damage of the spinal cord; the common strategies involve a plethora of curative 
interventions towards prevention of cell death or towards stimulation of axonal regrowth, inhibition 
of immune and inflammatory reactions, enhancement of axonal transmission or amelioration of 
secondary damage, thanks to pharmacological approaches and multi-system neurorehabilitative 
interventions.78,89-92 
1.3.2 RESTORING THE NEURAL NETWORK: THE BRIDGING IMPLANT STRATEGY 
In this contest, the advantages offered by the use of tridimensional biomaterials (scaffolds and 
hydrogels) appear to be very promising for the development of a new strategy that could stimulate 
neural tissue and axonal regrowth, thus inducing the formation of new synapses for the restoring 
of the lost neural circuits.89,93 In order to act as a bridging implant, an ideal scaffold should possess 
specific characteristics: the ability to fit the cystic cavity, proper morphology, mechanical 
properties and degradation rate, the ability to deliver cells and growth factors and, preferably, 
electrical conductivity.6,94-97 In particular, regarding the morphology, an ideal scaffold should 
possess oriented/channel-like pores in order to guide the neuronal and axonal growth6,94,98 with 
pore dimension around 50-100 µm for scaffold colonization.94,99,100 The electrical conductivity can 
be achieved by the introduction of conductive polymers, such as polypirrole100 or carbon nanotubes 
(CNTs), as described in the following paragraphs. 
1.3.2.1 Scaffolds design for neural tissue engineering 
Among the wide range of possible materials that can be employed for the preparation of scaffolds 
for neural tissue engineering, biopolymer-based biomaterials are very promising candidates for 
their biocompatibility, gel forming properties, biodegradability and bioactivity.94 Several methods 
and processes can be used for the preparation of scaffolds and hydrogels with oriented pores, 
containing alginate or chitosan as structural components. In alginate hydrogels these structures can 
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be obtained thanks to an oriented gelation101 or through mechanical stretching of the materials.102 
Anisotropic porous structures can also be obtained by means of directional supercritical CO2 
foaming,103 after the freeze-casting of hydrogels that have been frozen in an oriented way on a 
cooled plate98,104,105 or by the Ice Segregation Induced Self Assembly (ISISA) process in a liquid 
nitrogen bath106-110 or in dry ice.111 
For example Francis et al. reported the preparation of a scaffold with aligned pores prepared with 
chitosan and alginate: the scaffold possesses mechanical properties similar to the neural tissue and 
was able to guide the neurite growth of the dorsal root ganglia.94 Alginate, chitosan and gelatin-
based scaffolds have been successfully used, in combination with GFs or RGD peptides, to promote 
neural differentiation and nerve regeneration.112-114  
Specific biologically relevant proteins and polysaccharides can be used as bioactive components 
within the scaffolds. For example, hyaluronic acid has proved to reduce astrocyte proliferation thus 
helping to attenuate the inflammatory response and gliosis in the surrounding tissue;115 moreover, 
it was demonstrated that the presence of hyaluronic acid supports angiogenesis and inhibits glial 
scar formation.116 Fibrin has been used for the preparation of scaffolds for the delivery of 
neurotrophin-3 (NT-3), resulting into enhanced neural fiber sprouting in rats;117 on the other hand, 
the aligned fibers of fibronectin mats can orient the axonal growth in rat damaged spinal cord.118 
1.3.2.2 Sustained neurotrophine synthesis: co-cultures with engineered mesoangioblasts 
An interesting approach for the implementation of neural scaffolds and the improvement of their 
bioactivity is represented by the incorporation of cells that are able to synthesize and locally release 
neurotrophines (NTs) such as NT-3, Nerve Growth Factor (NGF) and Brain Derived Neurotrophic 
Factor (BDNF). This approach guarantees a sustained, selective and controlled release for long 
periods. Sasaki et al. showed an improved locomotor recovery for rat after the transplantation of 
gene-modified human mesenchymal stem cell (hMSCs) that overexpressed BDNF.119 These cells 
were also used in combination with agarose scaffolds and showed an improved tissue 
regeneration.98 Genetically engineered neural stem cells that overexpressed NT-3, seeded in 
poly(ɛ-caprolactone) (PCL) scaffolds, proved to increase behavioural and electrophysiological 
recovery in rats with hemisection surgery in the spinal cord.120 
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A promising cell lineage that can be used in this approach is represented by the mesoangioblasts 
(MABs): these cells are self-renewal multipotent progenitors of mesodermal tissue that have 
already been utilized for tissue engineering121 and can be isolated from small biopsies of postnatal 
human skeletal muscle.122 Su et al. showed that it is possible to genetically engineer these cells to 
induce the production and release of NGF and BDNF.123 The positive effects of these cells were 
proved in terms of viability and electrophysiological activity of primary neuronal cells and adult 
organotypic hippocampal slices when cultured in the presence of MABs conditioned media. 
Moreover, the effect of BDNF produced by the engineered MABs is higher than that obtained with 
the administration of recombinant BDNF.123 
Altogether, these results show the great potential of the development of scaffolds enriched with 
bioactive components and genetically modified cells, to be employed in the design of bridging 
implant strategy, since the supplementation of NTs and of other bioactive compounds can sustain 
the survival and functional recovery of neurons by modulating the post-injury microenvironment. 
1.4 BONE TISSUE REGENERATION 
Bone tissue is a specialized form of connective tissue that plays key roles in several physiologic 
functions: to name a few, protection and support for organs, movement, blood production, storage 
and homeostasis of calcium and other minerals, blood pH regulation, mesenchymal and 
hemopoietic cell progenitors housing.5 It is mainly composed of inorganic mineral crystals, that 
accounts for the 60-70% of the dry mass; the principal mineral component is hydroxyapatite (HAp, 
Ca10(PO4)6(OH)2), but there are also small amounts of other inorganic salts.
124 The remaining part 
of the dry mass is composed for the 10–20% by collagen fibers, with a prevalence of collagen type 
I, proteoglycans and non-collagenous proteins such as osteocalcin, osteopontin, osteonectin, 
fibronectin and thrombospondin.125-127 According to the structure, bone can be categorized in two 
types: the cortical (compact) and the trabecular (cancellous or spongy) bone. The 80% of the 
skeletal bone is composed of cortical bone; it possesses a high elastic modulus (~20 GPa) and a 
low porosity (5-10%) and its average ultimate compression strength is 105-131 MPa.128,129 In 
contrast, the porosity of trabecular bone is higher (approximately 50–95%), but it presents lower 
mechanical properties: the elastic modulus ranges from 25 to 240 MPa, while the ultimate 
compressive strength ranges from 0.2 to 10.4 MPa.75,130 
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1.4.1 BONE TISSUE DAMAGES AND COMMON THERAPEUTIC APPROACHES 
Bone tissue damages can derive from diseases such as osteogenesis imperfecta, osteoarthritis, 
osteomyelitis, and osteoporosis, or from  traumatic injury, orthopedic surgeries (e.g. total joint 
arthroplasty, spine arthrodesis, implant ﬁxation, etc.) and primary tumor resection.5 The treatment 
of bone defects has a huge clinical and economic impact: osteoporotic fractures are at great risk of 
bone defects, especially in women over 60 years old, and according to recent reports there are more 
than one million patients who need bone grafts in Europe and United States each year.75 Moreover, 
the number of patients and the related costs are increasing; for example the number of total joint 
arthroplasties and revision surgeries in the US has increased from 700000 in 1998 to over 1.1 
million in 2005, while medical expenses relating to fracture, reattachment, and replacement of hip 
and knee joint was estimated to be over $20 billion in 2003 and was predicted to increase to over 
$74 billion by the year 2015.5 
Several factors can impair the self-repair of bone upon mechanical fixation, such as large bone 
defect size, infections and poor vascularization, thus resulting in non-unions. These issues are 
frequent in bone fractures related to injuries or in joint arthroplasties. Other cases can be tumor 
resection or massive traumatic bone loss.5 In all these cases, it is necessary to fill the bone defect 
with a substitutionary material. The gold standard for the treatments of bone defect is the use of 
autogenous bone grafts: bone is harvested from the pelvis or the iliac crest and is placed within the 
bone defect. Although the reliability and the efficacy of this treatment, there can be several 
complications: 30% of the cases are related to donor site morbidity, pain, paresthesia, prolonged 
hospitalization and rehabilitation, increased risk of deep infection, hematoma, inflammation, which 
can impair the outcomes of the healing process. Moreover, the restricted availability of autologous 
bone is a critical issue for this approach.5,131 
Other alternatives are the use of allografts from human donors or xenografts from non-human 
organisms, but these treatments are associated with a high risk of infection, disease transmission 
and host immune responses.132-137 Common medical procedures include also the use of metallic 
pins, screws, plates, and rods to stabilize and align the fractured bone, although the use of these 
devices is associated with extended surgery and healing time, stress shielding induction, and risks 
for infection and chronic pain.138 
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In many cases, bone defects can be small and non-critical defects: these defects can heal on their 
own in a certain time. Non-critical bone defects can derive from the removal of fracture fixation 
devices (pins, screws, screw-plate devices, and rod entry holes), from the excision of small tumors, 
areas of infection, voids (after revision joint replacement), traumatic injuries, cysts and pathologies 
characterized by an altered balance between bone tissue deposition and resorption.139-142 These 
defects and voids represent a hot spot for mechanical stresses that can cause fractures; thus it is 
necessary to accelerate their healing.140 
1.4.2 BIOMATERIALS FOR BONE TISSUE REGENERATION 
The drawbacks and the limitations associated with the use of auto-, allo- and xenografts have 
addressed and motivated the research toward the development of tissue engineering strategies and 
the optimization of bone substitutes. The use of synthetic bone substitutes enables to reduce the 
surgical procedures and the risk of infection or immunogenicity, and to eliminate the risk of disease 
transmission.5,75 Moreover, synthetic scaffolds can be loaded with bioactive molecules or cells 
before implantation. 
An ideal bone substitute should possess specific morphological, mechanical and biological 
characteristics in order to mimic properly the bone tissue, and to support and enhance bone healing. 
The materials employed should favor bone cell migration and adhesion into the scaffold 
(osteoconduction) and promote osteogenic differentiation (osteoinduction); moreover, the porosity 
of the scaffolds should be enough for the migration of cells, for the diffusion of nutrients and gases 
and for neoangiogenesis. The materials should be able to integrate and interact with the surrounding 
tissue without the growth of fibrous capsules on the bone-implant interface (osteointegration) and 
in some cases they have to be able to provide a mechanical support to the affected area. Lastly, the 
materials should be sterilizable without loss of properties and their degradation has to proceed in a 
controlled manner during the new bone tissue development.143,144 
Biopolymer based bone substitutes can be prepared in two main formulations: tridimensional 
structures and injectable composites. In both cases these biomaterials are implemented with an 
osteoconductive component, such as HAp or other calcium phosphate ceramics.145 HAp, whose 
crystalline structure is reported in Figure 11, is the major mineral component of bone and can be 
syntherized to obtain a bioceramic for bone scaffolds and fillers.146  
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Figure 11. Crystalline structure of HAp. 
HAp is characterized by excellent osteoconductivity, osteoinductivity, good biocompatibility and 
bioactivity in vivo; it can be used for the preparation of prosthesis coatings for the improvement of 
osteointegration, or for the implementation and reinforcement of polymeric scaffolds.147,148 In the 
following paragraphs the two main categories of bone fillers and their clinical use are described. 
1.4.2.1 Tridimensional scaffolds 
Biopolymer-based tridimensional scaffolds can be prepared by different techniques: thermally 
induced phase separation, solvent casting and particulate leaching, solid free form fabrication 
techniques, supercritical-fluid technology, chemical cross-linking and electrospinning.149,150 
Biopolymers, and in particular polysaccharides, offer the advantage to be water soluble and very 
easily exploitable for the preparation of biomaterials in physiological conditions, without using 
toxic reagents.149 In all cases, the porous structure has to satisfy certain requirements: the pores 
have to be highly interconnected, their size distribution has to favor cell colonization and 
proliferation and the formation of new blood vessels. In literature, the desired scaffold properties 
include a porosity in the range of 70 – 90% and a pore size in the range of 50 – 600 µm.147,151-153 
These characteristics can be easily tailorable by changing polymer concentration, polymerization 
conditions and by grafting of chemicals and functional groups;154 furthermore, the scaffolds 
bioactivity can be tuned by addition of functional groups, peptides, proteins and cells.154 The main 
disadvantages of biopolymers in the preparation of tridimensional structures are represented by 
their low mechanical properties;147,149 therefore, the implementation of these structures with 
calcium phosphate materials, such as HAp, is very useful to overcome this issue, besides giving 
more bioactive features to the biomaterials.147 
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Alginate is a good candidate for the preparation of tridimensional scaffolds thanks to its gel forming 
properties. It has been used for the preparation of porous scaffold enriched with antimicrobial 
properties155 and for mineral-coated scaffolds using biomimetic approaches.156 It has been also 
used in combination with peptides and growth factor such as RGD, VEGF and BMP-2157,158 leading 
to an increased bone formation and for the co-culturing of bone cells in order to increase the 
bioactivity.159 Chitosan scaffolds have been prepared in combination with collagen160 and with 
different methods of cross-linking161,162 in order to obtain scaffolds with good bioactivity and 
mechanical properties. Chitosan has been also added to silk/HAp scaffolds to increase their 
mechanical properties163 and used in combination with bioactive molecules such as insulin-like 
growth factor-1 (IGF-1), BMP-2 and RGD peptides to increase their bioactivity.164 In addition to 
polysaccharides, collagen has been widely used for the preparation of tridimensional bone 
scaffolds; in combination with PCL or bioactive glass it showed to has the ability to support 
osteoblasts growth and differentiation, with an increased alkaline phosphatase (ALP) activity and 
osteocalcin/osteopontin expression.165-167 
1.4.2.2 Injectable bone fillers 
Injectable bone fillers represent an attractive strategy for the treatment of bone defects caused by 
traumatic injuries, cysts and pathologies characterized by an altered balance between bone tissue 
deposition and resorption;139,141,142 they can also be employed to relieve the pain and to strengthen 
osteoporotic bones.142 These materials hold great promise in clinical applications thanks to their 
advantages that include minimal tissue injury, nearly no influence on blood supply, easy operation 
and negligible postoperative pain.4 The two main categories of injectable fillers are calcium 
phosphate cements (CPCs) and polymeric fillers. CPCs have the great advantage to be chemically 
and structurally similar to the mineral component of the bone tissue, but they are not easily 
injectable through syringes and cannulas168,169 and they lack of adequate porosity and degradation 
rate.170 The polymeric fillers offer the possibility to prepare materials whose injectability and 
degradation rate can be tailored.171 
Several works reported in literature are based on a synergistic combination of polysaccharides and 
mineral component such as β-tricalcium phosphate (β-TCP), HAp, CPCs and bioactive glass, for 
the preparation of injectable fillers. Such materials, at the same time, possess good osteoconductive 
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and osteoinductive properties, and present degradation rate and injectability that can be tailored. 
Suzuki et al. reported the enhanced osteoconductive properties, degradation rate and injectability 
of octacalcium phosphate dispersed with hyaluronic acid.172 Nejadnik et al. developed an injectable 
nanocomposite hydrogel based on calcium phosphate nanoparticles and bisphosphonate-
functionalized hyaluronic acid; these hydrogels possess good bioactive properties, together with a 
proper degradation rate and robustness.173 Sohrabi et al. developed and characterized bioactive 
glass dispersed in an alginate/hyaluronic acid mixture in order to prepare a filler with a good 
injectability.174  
1.4.2.3 Orthopedic clinical practice 
Commercially available materials are commonly based on HAp, β-TCP, bioactive glass, collagen 
and demineralized bone matrix (DBM); they can be formulated as granules, sponges and matrices, 
cements, putties, pastes, block and cylinders.175 
To report some examples, BIOMET EUROPE developed HAp based cylinders and blocks for the 
treatment of tibial and radial fractures and for bone tumor surgery (Endobone®) and several calcium 
phosphate-based and DBM-based pastes for the treatment of orthopedic trauma and as bone void 
fillers (Alpha-BSM®, EquivaBoneTM, CarriGen®); DEPUY developed a collagen/HAp-based 
matrix that can be mixed with bone marrow and is used in spinal surgery (Healos®); ORTHOVITA 
prepared a collagen/β-TCP foam for spinal and trauma surgery (Vitoss®) and a bioactive glass 
cement for vertebroplasty and as bone void filler (Cortoss®); STRYKER has developed a 
HAp/polyvinilpyrrolidone injectable cement for small defects and not load-bearing applications 
(HydroSetTM); SYNTHES prepared β-TCP blocks and granules as cancellous bone void filler in 
trauma, spinal and reconstruction surgery (ChronOSTM); BONALIVE LTD, using bioactive glass, 
developed granules, putty and plates for bone cavity filling and orbital floor reconstruction. 
Despite the huge availability of bone graft substitutes, scaffolds and injectable fillers, in the clinical 
practice the gold standard remains the use of autografts for their ability to provide the three essential 
features required for the bone regeneration: osteoconductivity, osteoinductivity, osteogenicity. 
Bone graft substitute used in the clinical practice are always osteoconductive, but only in some 
cases are also osteoinductive; moreover, limited data have been reported on their properties and 
their effect, with respect to the autografts, thus making difficult their informed selection and use. 
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The cost of these materials is another important issue, but, despite it is usually higher than 
autografts and allograft procedures, it is an affordable expense if it is considered that these materials 
are fully characterized, easily stored, sterile and available for an immediate use.175 
The main concern in the clinical practice is related to the possibility of microbial infection 
development, which, despite the surgical procedures and care, accounts for the 5% of biomaterial 
implantation interventions;139,176 this percentage increases up to 14% for dental implants due to 
particular exposure to bacteria.177 In general, peri-implants infections are more serious than 
infections of temporary implants, since the latter cause pain and discomfort and only in some cases 
the use of systemic antibiotics and re-application of the implant is needed; on the other hand, peri-
implants infections can result in bone damage, secondary surgical interventions, implant failure 
and in some cases, mortality.139,178 In order to overcome this issue, the research is investigating the 
incorporation of antibiotics in the biomaterials and their local delivery inside to target tissue; for 
example, poly(methyl methacrylate) (PMMA) cements for joint arthroplasty procedures can be 
loaded with small amounts of gentamicin and tobramycin.176 Even if the delivery of antibiotics 
incorporated in biomaterials can be a good strategy for the prevention of peri-implant infections, 
there is a great concern regarding the development of multi-resistant bacteria strains and the need 
of novel strategies based on novel antimicrobial compounds.139,176,179,179 
1.5 IMPLEMENTATION OF BIOPOLYMER-BASED BIOMATERIALS 
Despite all the advantages offered by the use of polysaccharide and protein-based biomaterials, 
they can be further implemented with respect to the specific requirement of the final application. 
Several strategies can be adopted in order to tailor and improve the mechanical, physical and 
biological properties of biopolymers-based biomaterials; one possibility is the chemical 
modification/grafting of polysaccharides with bioactive chemical groups, and molecules, in order 
to modify the physical-chemical and biological properties of the polysaccharides; another 
possibility is the implementation of the biomaterials with structures and compounds that can 
provide the required characteristics.29,150,180,181 The nanotechnologies can be used for the 
nanofabrication of materials, the micro- and nanopatterning of surfaces and the preparation of smart 
nanomaterials for the drug delivery;3,182 moreover, biomaterials can be implemented with 
nanostructures in order to tailor specific properties of the materials, such as electrical conductivity 
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or antimicrobial properties.183-186 In bone and neural tissue engineering the low mechanical 
properties of the polysaccharides, their lack of electrical conductivity and, in some cases, the low 
bioactivity emphasize the need of strategies for the tailoring and amelioration of these features.150 
1.5.1 ENGINEERED POLYSACCHARIDES 
Polysaccharides can be chemically modified in order to tailor their properties and to make them 
useful materials for the preparation of different types of biomaterials. For example, alginate can be 
conjugated with poly(N-isopropylacrylamide) (PNIPAAm) for the preparation of 
thermoresponsive and thermoreversible hydrogels, or it can be modified with RGD peptides to 
introduce cell ligands for bioadhesion. Alginate can be also functionalized with methacrylic groups 
to be used for free radical polymerizations, and it can be also functionalized with peptides and 
gelatin to enhance its bioactivity.29,56 
Regarding hyaluronic acid, one of the most used derivatives is its benzyl ester (HYAFF®). Thanks 
to its physical-chemical properties, HYAFF® can be easily processed to obtain several types of 
biocompatible devices such as tubes, membranes, non-woven fabrics, gauzes and sponges for 
application in vascular, skin, cartilage and neural tissue regeneration.187,188 
Functionalization of chitosan is aimed at the improvement of its water solubility and at the 
introduction of chemical groups and active functions.189,190 Chitosan can be modified by addiction 
of sugars group, dendrimers, cyclodextrins and crown ethers principally for drug delivery 
applications191 as well as for the improvement of its bioactivity.35 Moreover, chitosan can be 
grafted to synthetic or natural polymers in order to improve its mechanical or biological 
properties.35 
1.5.1.1 Chitlac: a lactose-modified chitosan 
Chitosan can be covalently modified by an N-alkylation between lactose molecules and the amino 
groups of chitosan: the reaction leads to the formation of a branched polysaccharide named 
“chitlac” (Figure 12).181,192 
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Figure 12. Chemical structure of chitlac. 
This modification makes chitosan soluble in water and at physiological pH, leading to an 
improvement in its processability; in this form chitosan is miscible with anionic polysaccharides 
such as alginate and hyaluronic acid,193 and it can be used for the preparation of tridimensional 
hydrogels and microspheres.184,194 Chitlac has also been used for the preparation of bioactive 
coatings for methacrylic thermosets195 and alginate scaffolds,155 showing bioactive properties such 
as increased osteoblasts proliferation and ALP activity, and increased bone-implant contact in the 
case of chitlac-coated thermosets.196 Chitlac has also proved to induce chondrocytes aggregation 
and synthesis of type II collagen and glycosaminoglycan by chondrocytes.181 A similar effect has 
been showed by encapsulating chondrocytes in alginate and alginate/chitlac microbeads: the 
presence of chitlac led to a notable increase of proliferation if compared with alginate 
microbeads.194 
It has been shown that the biological effects of chitlac are mediated by galectins.181,197,198 Galectins 
are a family of β-galactoside-binding lectins that have in common a structurally conserved domain, 
the carbohydrate recognition domain, which recognizes the β-galactoside-containing carbohydrate 
moieties of glycoconjugates.199 Galectins are able, in the ECM, to bind laminin, fibronectin, and 
elastin; they are also able to mediate biological activities such as adhesion, growth and functions 
of cells, thus regulating tissue homeostasis, composition, reorganization, and mechanical 
performance.200 Marcon et al. found that galectin-1 was highly expressed in the chondrocyte 
aggregates formed in the presence of chitlac, suggesting a possible biological role.198 Moreover 
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galectins expression has been associated to wound healing,201 regulation of epithelial cells202 and 
neural tissue regeneration.203 
1.5.2 NANOTECHNOLOGIES AND BIOMATERIALS 
Nanotechnologies offer several opportunities for the tailoring and the implementation of physical-
chemical, mechanical and biological properties of biomaterials. The strategies for biomaterials 
preparation, which involve the use of nanotechnologies, can be divided into two main categories: 
the production of nanostructured biomaterials and the implementation of biomaterials with organic 
or inorganic nanostructures. 
1.5.2.1 Nanostructured biomaterials 
Nanostructured biomaterials can be prepared by nanoscaled modification of the material surface 
and morphology by means of lithography, chemical etching, micro-contact printing, self-assembly 
or electrospinning of nanofibers. 
The nanopatterning of surfaces and the nanostructuration of the materials can have several positive 
effects on the biological interactions between cells and materials, by creating and mimicking the 
natural architecture of extracellular matrix.3,204  
The nanofibrous scaffolds combine in a synergistic way the high “surface area to volume” ratio of 
the nanofibers and the microporosity of the scaffolds, creating an environment that favors cell 
adhesion, proliferation, migration and differentiation, thus presenting all the desired properties for 
tissue engineering concepts.205,206 These structures represent a promising approach for muscle, 
bone and vascular tissue engineering.204 
1.5.2.2 Organic and inorganic nanostructures 
Organic and inorganic nanostructures can be added to polymer matrices for several purposes. For 
instance, drug-loaded polymer nanoparticles can be embedded in matrices for a controlled delivery; 
nanostructured ceramics, CNTs and polymer nanofibers can be mixed to the polymers in order to 
reinforce the structures, while metal nanoparticles can be used to provide antimicrobial properties. 
The advantages of these approaches are strictly related to the dimension of the nanostructures: their 
high surface area to volume ratio and the peculiar physical-chemical properties that arise from their 
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nano-dimensions enable unique interactions between these nanostructures, the polymer matrices 
and cells. These interactions lead for example to mechanical reinforcement of the structures and 
enhanced cell adhesion and functions.150,176,184,207,208 
1.5.2.3 Carbon nanotubes 
CNTs are, together with graphene and fullerenes, an allotropic form of carbon. They are used in 
several applications such as material engineering, industrial and energetic applications and tissue 
engineering.95,209,210 CNTs are organized in one or more cylindrical graphene-like sheets of sp2 
carbon atoms, which form tubes with fullerene-like extremities. Depending on the number of 
graphene-like sheets that compose their structure, CNTs they can be distinguished in single-walled 
(SW-), double-walled (DW-) or multi-walled carbon nanotubes (MWCNTs).211,212 Their diameter 
is comprised between 0.5 – 1.5 nm for the SWCNTs and over 100 nm for the MWCNTs, and they 
can be long up to some centimeters.185 Due to their peculiar dimension, CNTs are characterized by 
a high aspect ratio (length to diameter ratio) and high surface area; these characteristics together 
with the presence of dangling bonds on the side walls, allow modifying the CNTs for several 
biomedical applications, and make them able interact with polymer matrices, proteins and 
cells.185,213 
The structure of the CNTs is responsible for their unique physical properties: CNTs are the 
strongest material with a tensile strength up to 60 GPa214,215 and a Young modulus higher than 1 
TPa.216,217 CNTs are also electrically conductive and behave like semiconductor or metallic 
depending on their chiral vector (the vector perpendicular to the graphene sheet rolling direction) 
and can carry currents greater up to 104 times than those carried by normal metals.218-220 
Over the last two decades, CNTs have been receiving great attention for biomedical applications. 
Their unique morphological and chemical properties are very attractive to develop systems to be 
employed in drug delivery, phototermal and photodynamic therapy, gene therapy, cancer 
theranostic, diagnostic, biosensing and tissue engineering.221-223 In particular, in the field of tissue 
engineering, CNTs can play an essential role in the creation of a biomimic environment thanks to 
their dimensions, nanoroughness, surface reactivity, interactions with water molecules, cells and 
polymers.95,150,213,224-227 CNTs have been widely used and investigated for the culturing and the 
differentiation of several cell types for applications in bone, muscle, cardiac and neural tissue 
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regeneration.228 Several research groups have focused their efforts on the development of 
nanostructured hydrogels and scaffolds based on the combination of natural or synthetic polymers 
and CNTs, where the latter play different roles such as the reinforcement of the polymer 
matrix,176,222,229 the improvement of the electrical conductivity of the scaffolds,183 and the 
improvement of material surface roughness and wettability.230 
In particular, in the field of bone tissue engineering, CNTs proved to allow and sustain adhesion, 
proliferation and function of osteoblasts;209,231,232 moreover, they are able to trigger and enhance 
the deposition of ECM and the nucleation of HAp.233-235 Interestingly, it has also been reported that 
MWCNTs are able to regulate the bone cells, inhibiting the differentiation and the function of 
osteoclasts.236 
CNTs are widely investigated also for neural tissue engineering applications. The immobilization 
of CNTs on two dimensional substrates allowed culturing neural cells and spinal cord organotypic 
slices on CNTs layers; electrophysiology measurements showed that CNTs are biocompatible and 
able to sustain neural cells functions and nervous impulse transmission.95,237,238 CNTs have been 
also entrapped in polydimethylsiloxane (PDMS) in order to create tridimensional sponge-like 
scaffold in which neuron can be grown and analyzed: CNTs remarkably boosted synaptic activity 
also in this condition, and such scaffold can be also potentially used as an implant for the neural 
tissue engineering.99 
The use of CNTs in biomedical applications can be limited also by their low water solubility, and 
the possible presence of toxic metals and other impurities due to the production process.211,239 The 
in vivo toxicity of CNTs is strongly debated;240 this depend on the fact that the studies are not 
standardized and take into consideration several typologies of cells and CNTs; moreover, CNTs 
toxicity is related to their dimension, purity grade, number of layers, dispersibility and aggregation 
tendency.241,242 The toxicity of CNTs can be diminished by their functionalization with chemical 
groups and macromolecules that increase their water solubility,186 for example the 1,3-dipolar 
cycloaddition make the CNTs biocompatible and for B and T cells, whose viability and function 
wass not affected after CNTs endocytosis.243 CNTs dispersed in biopolymers or functionalized 
with polyethylene glycol (PEG) can be gradually eliminated by the organism.244,245 CNTs 
functionalized with amino groups or peptides do not negatively affect the viability and the electrical 
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function of neurons.246,247 Moreover, it has been observed that in certain conditions, functionalized 
carbon nanotubes (f-CNTs) can be degraded by oxidative enzymes.248 Another important positive 
aspect of the functionalization is that during the chemical processes of purification and washing, 
catalytic metal and other impurities are removed, reaching very low, irrelevant and biocompatible 
percentages.249 
CNTs can be functionalized by chemical processes and covalent modifications, or by non-covalent 
interactions with several types of molecules. Among chemical processes, the most important is the 
oxidation, performed at high temperatures in the presence of sulfuric or nitric acid, which introduce 
hydroxyl and carboxylic groups on CNTs surface.250,251 Regarding the non-covalent modifications, 
CNTs can be wrapped with polymer chains (polysaccharides, proteins, nucleic acids) or can 
interact, through hydrophobic and π-π stacking interactions, with drugs and molecules with non-
polar and aromatic groups.213 Lastly, CNTs can be covalently conjugated with macromolecules and 
chemical groups that can be electrically charged; the most important are the arylation reactions 
based on diazonium salts, developed by Tour and colleagues,252,253 and the 1,3-dipolar 
cycloaddiction developed by Prato and colleagues;186,254 both reactions allow an easy surface 
modification of CNTs with polar or electrically charged chemical groups. 
1.5.2.4 Silver nanoparticles 
The development of multi-resistant bacteria strains is a serious concern for the use of antibiotics in 
the design of biomaterials. Therefore, there is a strongly need of novel and highly effective 
strategies and compounds not susceptible to bacterial resistance development. There is a wide 
variety of new agents based on inorganic and organic/polymeric materials that have been proved 
to act as wide spectrum agents; some examples are represented by silver, antimicrobial peptides, 
materials able to generate reactive oxygen species and carbon-based materials.208 
Among those compounds, silver has been known for centuries for its bactericidal activity and has 
been already used in several topical applications for the prevention and the control of bacterial 
infections.255 In particular silver nanoparticles (nAg) are one of the most widely used antibacterial 
compounds in the clinical practice.208 nAg, through the release of silver ions, the generation of 
reactive-oxygen-species and the interaction with cell membranes, DNA and sulfur containing 
proteins have shown antibacterial activity both against Gram-positive and Gram-negative bacteria 
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strains, but also against fungi and viruses.208,256-261 nAg have also proved to be toxic for methicillin-
resistant strains of S. aureus and S. epidermidis,262 and to enhance the antimicrobial activity of 
antibiotics.263-265 
nAg toxicity for eukaryotic cells is also strongly debated; the same mechanisms that are active 
against bacterial cells can result in toxic effects also on eukaryotic cells, in particular membrane 
damage and reactive-oxygen-species (ROS) production. The latter can be worsened by the damages 
that nAg can induce on the proteins involved in anti-oxidant defense mechanisms.266-268 
Another issue related with the use of nAg is their stability, as the agglomeration in microparticles 
and aggregates significantly affects and decreases their antimicrobial properties.269 
Novel nanotechnological strategies for the development of biocompatible wide spectrum agents 
involve the preparation of systems, for example silver decorated polymeric nanostructures, which 
are able to guarantee a long-term stability of nAg, controlling and normalizing their size and shape 
and reducing their toxicity.208 
In this contest the preparation of a stable form of nAg, synthesized, dispersed and stabilized in 
polysaccharides, is an interesting strategy for the implementation of bioactive and antimicrobial 
properties in biomaterials. In particular, the process reported by Travan et al. in 2009 enables to 
synthesize, disperse and stabilize the nAg by the reduction of silver ions in the presence of chitlac 
(Figure 13).184 
 
Figure 13. Schematic representation of silver nanoparticle  
stabilization by chitlac. 
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In this form, the nAg are confined inside a polymer matrix and can be stabilized over time. At the 
same time, the system guarantees a slow release of silver ions that can exert the antimicrobial 
activity, without being toxic for eukaryotic cells. The chitlac containing silver nanoparticles system 
(chitlac-nAg) has been thoroughly investigated for the preparation of antimicrobial 
coatings,195,196,270 and tridimensional hydrogels and microbeads in combination with alginate.184 
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2 AIMS OF THE WORK 
Nanotechnology represents a fertile ground for the development of novel bioactive biomaterials. 
In tissue engineering, such biomaterials can be designed and prepared by taking advantage of 
engineered polysaccharides. The present work, by using the combination of different 
polysaccharides and organic/inorganic nanostructures, aims at the development and 
characterization of novel biomaterials to be employed in bone and neural tissue engineering. This 
thesis has three main objectives: 
2.1 CHARACTERIZATION OF FUNCTIONALIZED CARBON 
NANOTUBES (f-CNTs) DISPERSIONS AND NANOSYSTEMS 
Specific aims: 
 Evaluation of f-CNTs concentration, dispersibility and aggregation tendency in aqueous 
and polymeric dispersions by means of Low Field Nuclear Magnetic Resonance (LF-
NMR). 
 Spectroscopical, mechanical and rheological characterization of alginate/f-CNTs solutions 
and hydrogels by means of LF-NMR, uniaxial compression tests and rheological 
measurements. 
2.2 DEVELOPMENT OF A BRIDGING IMPLANT FOR THE SPINAL 
CORD INJURY TREATMENT 
The second objective is part of PRIN-MIUR project “Spinal injury: towards the development of 
cell-instructive scaffolds for nerve tissue repair” (2014-2017). 
Specific aims: 
 Preparation morphological and physical characterization of polysaccharide coated glass 
substrates 
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 Evaluation of biocompatibility and biological effects of the polysaccharide-coated glass 
substrates on two dimensional neuronal network model and on co-cultures of motoneuron 
progenitors and engineered mesoangioblasts. 
 Preparation and characterization of porous alginate scaffolds, functionalized with chitlac, 
with isotropic or anisotropic pore morphologies. 
2.3 DEVELOPMENT OF FILLERS FOR NON-CRITICAL BONE DEFECTS 
HEALING 
Specific aims: 
 Determination of the morphological differences and of the influence of pore morphology 
on stability, mechanical performances and biological properties of alginate/hydroxyapatite 
(HAp) scaffolds. 
 Implementation of alginate/HAp scaffolds with f-CNTs and biological characterization. 
 Development of an antimicrobial injectable bone filler based on alginate/HAp microbeads 
implemented with silver nanoparticles (nAg) 
 Characterization of stability, morphology, biocompatibility, biological properties and 
injectability of the microbeads 
 In vivo evaluation of biocompatibility and osteoconductive properties of the injectable filler 
on a rabbit model of non-critical bone defects. 
 Preparation and characterization of alginate/HAp materials implemented with collagen and 
gelatin. 
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3 RESULTS AND DISCUSSION 
The work described in this thesis deals with the preparation and characterization of polysaccharide-
based biomaterials, implemented with silver nanoparticles (nAg) and functionalized carbon 
nanotubes (f-CNTs), for applications in bone and neural tissue engineering. This work can be 
divided in three major sections: i) the first one is focused on the determination of the effects of the 
f-CNTs presence on the spectroscopical, rheological and mechanical properties of dispersions and 
polysaccharide-based nanosystems; ii) the second one describes the preparation of polysaccharide-
coated two-dimensional substrates for the evaluation of the biological effects of different 
polysaccharides on the behavior and function of neural cells, and the preparation of a 
tridimensional scaffold for neural tissue engineering; iii)  the third one describes the preparation 
and the characterization of polysaccharide-based tridimensional scaffolds and antimicrobial 
injectable fillers for the bone tissue engineering. 
3.1 CHARACTERIZATION OF FUNCTIONALIZED CARBON 
NANOTUBES DISPERSIONS AND NANOSYSTEMS 
As discussed in the introduction, several research groups have proposed the use of CNTs for 
biomedical and tissue engineering applications, in particular for the preparation of biocompatible 
nanocomposite biomaterials in the form of solutions, hydrogels or scaffolds.150,180,185  
In order to optimize the contribution of CNTs to the nanocomposite materials, it is very important 
to investigate how CNTs are dispersed within the biomaterial matrix and how they interact with 
the surrounding environment, namely with water molecules, polymeric chains and cells.150 In 
particular, the interaction between water molecules and CNTs modifies several properties of the 
material, like wettability, consequently affecting protein adsorption and cell adhesion.224,225 
However, the final aggregation state within the matrix is affected by the dispersion and stability of 
the initial aqueous CNTs systems. 
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Several techniques have been employed to evaluate the dispersion of CNTs inside polymeric 
matrices such as transmission and scanning electron microscopy,224 and scattering techniques, like 
dynamic light scattering or small angle x-ray scattering.271 Moreover, it has been recently 
demonstrated that the presence of CNTs in solution alters its echographic response and therefore 
they have been proposed as potential contrast agents.272  
In this work, Low Field-Nuclear Magnetic Resonance (LF-NMR) was used for the characterization 
of aqueous dispersions of MWCNTs, pristine or covalently functionalized with different chemical 
groups (Figure 14).252,273,274  
 
Figure 14. Schematic representation of the f-CNTs used in this work 
3.1.1 EVALUATION OF THE AGGREGATION TENDENCY OF FUNCTIONALIZED 
CARBON NANOTUBES DISPERSED IN AQUEOUS MEDIA 
It has been demonstrated that CNTs are able to interact with surrounding water molecules275,276 
and to influence the relaxation time of the latter, depending on the functional groups exposed on 
their surface.277,278 Therefore the T2 spin-spin NMR relaxometry of protons in water, being 
sensitive to the constraints of the molecule,279 can be a useful technique to quantitatively evaluate 
concentration, dispersion and aggregation of f-CNTs in water solutions. In fact, the stability of  
f-CNTs in water strongly depends on the nature and extent of their chemical substitution, in 
particular with polar and even ionic groups to reduce the unfavorable solute-solvent interactions. 
Visual inspection of suspensions of the f-CNTs in water at the concentration of 0.1 % (w/V) reveals 
such tendency, in particular for the pristine, un-derivatized f0-CNTs. Moreover, aggregation 
manifests as a significant time-dependent effect; sonication helps producing a visible dispersion of 
f-CNTs.  
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The effect of CNTs on the relaxation time of water and the aggregation tendency in aqueous 
systems has been evaluated measuring  2T  of the dispersions at different time intervals. f-CNTs 
have been dispersed in pure water and in culture medium (complete DMEM in water), in view of 
future studies on CNTs in cell-containing systems. Moreover, the chosen f-CNTs have been 
dispersed in an aqueous alginate solution (2% w/V) in order to evaluate the ability of LF-NMR to 
detect the aggregation tendency of CNTs in this condition. The reasons for choosing alginate are 
manifold: i) alginate is a very hydrophilic polymer, and as such it may severely affect the 
structuring of water and the ensuing effect on the solubility of co-solutes; ii) alginate is an anionic 
polyelectrolyte, and its negative charges may trigger different interactions with differently charged 
CNTs; iii) alginate is one of the most important biopolymers used in the preparation of scaffolds 
and, in general, in tissue engineering, which may be interesting areas of application of CNTs. 
In general, 2T  was found to be notably lowered upon addition of CNTs although such effect 
strongly depended on their dispersion state (the 2T  values recorded for water and for f-CNTs-free 
aqueous solutions are quite long: water, ~ 2400 ms; DMEM, ~ 2200 ms; alginate, ~ 1400 ms). 
Preliminary experiments were carried out for the various f-CNTs, in the absence or in the presence 
of co-solutes (DMEM or alginate), adjusting the sonication time for each case to the goal of 
reaching a visual disappearance of massive aggregation (i.e. good dispersion). The results are 
reported in Figure 15, A to C.  
RESULTS AND DISCUSSION 
 
38 
 
Figure 15.  Time dependence of the average relaxation time ( 2T ) of dispersions of f0-CNTs (A), 
f1-CNTs (B) and f2-CNTs (C), in pure water (), in DMEM (▲) and in alginate (). 
f-CNTs concentration: 0.1 % (w/v). 
As general statements, i) the 2T  values of all f-CNTs show a more or less marked time-
dependence; ii) the range of 2T  values span over two orders of magnitude, from about 45 ms (for 
f1-CNTs in DMEM) to that of pure water (for f0-CNTs at long times). Correspondingly, it is 
possible to identify three extreme types of behavior. In pure water, f0-CNTs display 2T  values, 
which started from values close to that of pure water, for further increase during the time interval 
of the experiment, practically reaching the value of the relaxation time of free water molecules 
after 40 minutes. The latter effect seemed to be clearly correlated with the ongoing massive 
macroscopic aggregation of CNTs.  
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f0-CNTs in DMEM, and both f1-CNTs and f2-CNTs in all conditions: i)  show much lower 2T  
values than f0-CNTs in water, indicating an initial condition of much better dispersion. As 
demonstrated by Cheng et al.,280 serum proteins are able to adsorb on the CNTs surface, a 
phenomenon that leads to a better dispersion of the CNTs;281 ii) seem to conform to an exponential 
increase of 2T  values with time (this is evident by plotting the data as a linear function of time: 
data not shown). This behavior can be clearly associated with an increasing association, however 
starting from values much lower than those of un-derivatized f0-CNTs in pure water. A discussion 
of the specific effect of the co-solute (DMEM or alginate) on the  2T  values is postponed to the 
following paragraph. 
Finally, the time dependence of the 2T  values of f0-CNTs in aqueous alginate show a peculiar 
behavior, inasmuch as after some sort of induction time of about 40 min, they show an abrupt 
increase which sigmoidally reaches a plateau at 2T  values not very far from those of water in 
aqueous alginate at 2% concentration. This behavior is at variance with both above described case: 
it is tempting to suggest an all-or-none equilibrium between two states of solvation/interaction with 
alginate. In an initial step, f0-CNTs might be rather well dispersed, until the rapid onset of a 
reorganization of the CNTs around the polyanion (which very rapidly achieves its final 
“equilibrium” condition), characterized by an overall effect on the relaxation time of water very 
similar to alginate itself. It should be recalled that the mass ratio of alginate-to-CNTs is 20:1, thus 
making the dominant role of the ionic polysaccharide very plausible. Given the limited time 
window of the experiments, it is not possible to make any speculation if also in the cases of f1-
CNTs and f2-CNTs with alginate, the observed strong increase of 2T  values at long times would 
also lead to some sort of plateau close to the 2T  value of CNT-free alginate solution, with 
generality of the process. 
Overall, comparing the relaxation results with the visualization of the f-CNTs dispersions over 
time, it can be concluded that T2-NMR is a reliable technique to detect aggregate formation. 
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3.1.2 CORRELATION BETWEEN 2r  AND CONCENTRATION OF FUNCTIONALIZED 
CARBON NANOTUBES DISPERSED IN AQUEOUS MEDIA 
f-CNTs have been dispersed at various concentrations in deionized water, in complete DMEM and 
in alginate solution (2% w/V in water), to verify if the hypothesis that a single type of associated 
(and solvated) CNT species in the initial step of solution dispersion was confirmed by an observed 
linearity of the dependence of  2T  values on concentration. Moreover, to exclude possible non 
homogeneous effects of sample preparation on the observed data, it was decided to subject the 
various samples to the same time of sonication, namely 30 minutes.  
The analysis performed by LF-NMR, right after the sample preparation and sonication, showed a 
good linear correlation between  2r  (with 
1
22

Tr ) and the CNTs concentration in water and in 
DMEM for all f-CNTs, except for the case of f0-CNTs when they are dispersed in water (Figure 
16, A and B). 
 
Figure 16. Concentration dependence of the average relaxation rate ( 2r ) of dispersions of f0-CNTs (), 
f1-CNTs () and f2-CNTs (▲) in water (A) and in DMEM (B). Data points taken at 30 min sonication. 
Given the calculated value of 2r  of water and DMEM from 2T  ( 2r water = 4.17·10
-4 s-1; 2r DMEM 
= 4.55·10
-4 s-1), it was decided to fit the observed data points with those constrained intercept values. 
The parameters resulted from the linear fitting (R2 and slope) are reported in Table 1. 
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Table 1. Parameters of the linear fitting for the f-CNTs dispersed in water 
and in DMEM. 
dispersant f0-CNTs f1-CNTs f2-CNTs 
 R2 slope R2 slope R2 slope 
water n.d. n.d. 0.9982 0.26 0.977 0.14 
DMEM 0.9936 0.11 0.9997 0.18 0.9998 0.09 
In other words, such procedure corresponds to assuming a constant contribution from “free” water 
(overwhelming in mass but practically negligible as to effects on 2r ) and attributing all the 
observed increase of 2r , with Cp, to f-CNT. The good statistical quality of the fit (as shown by R
2) 
seems to support the validity of the procedure. 
The experiments described in the previous paragraph showed the high tendency of f0-CNTs to 
aggregation and precipitation in water, thus not allowing them to be stably dispersed in water. At 
variance, DMEM was proved to increase the solubility and stability of f0-CNTs dispersions, given 
the linear correlation between concentration and 2r . 
In the case of f1- and f2-CNTs in DMEM, a decrease of 2r  is observed with respect to the 
corresponding values in pure water (slightly above 30%), pointing to trend which has been so far 
interpreted as deriving from some sort of association/phase separation. One should recall that 
DMEM contains salts (i.e. it has a significant value of ionic strength and hence may contribute to 
electrostatic shielding), as well as various components (first, but not only, glucose) deeply 
modifying (in particular, increasing) the solution viscosity. However, and more important, 
amphiphilic compounds (like proteins or other serum components) might effectively act as 
suspending agents for the hydrophobic CNTs,280 at the same time affecting the intrinsic relaxation 
properties of water. In fact, CNTs are known to be stabilized by surfactant micelles.282 The 
observed proportional decrease of 2r  in DMEM with respect to pure water could derive from an 
effect of the medium components on the intrinsic relaxation of water around CNTs. Alternatively 
(or, more probably, additionally) the effect could stem from an aggregation mechanism of CNTs, 
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usually referred to as a “closed association”,283 in which solute association does not proceed 
indefinitely upon increase of concentration (like in a usual association/precipitation equilibrium), 
but, rather, through the formation of soluble clusters of quasi-stoichiometric composition (like in 
micelle formation). In this view, using the linear fitting equation for the f1-CNTs and f2-CNTs 
dispersed in water, and the corresponding 2r  values (in DMEM) it is possible to estimate the 
soluble and the aggregate fractions of the f-CNTs in DMEM (Figure 17), respectively, assuming 
that the 2r  values in pure water correspond to a condition of optimal dispersion (no aggregation). 
 
Figure 17. Concentration of active (soluble,) and non-active (aggregated, ▲) components and total 
f-CNTs () as a function of the total f-CNTs concentration for f1-CNTs (A) and f2-CNTs (B) 
dispersed in DMEM. 
The percentage of the aggregated f-CNTs, as a function of the f-CNTs concentration, is reported 
in Figure 18. In this graph, the previous mentioned “closed association” phenomenon is clearly 
showed as the asymptotic relation between the f-CNTs aggregated fraction and the f-CNTs 
concentration. 
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Figure 18. Percentage of aggregated f-CNTs function 
of f-CNTs concentration for f1-CNTs () and 
f2-CNTs (▲) dispersed in DMEM. 
A useful pictorial representation of the two hypotheses is given by Figure 1, A and B, respectively, 
of Reference 282, in which the cross-section model of an individual fullerene nanotube in a 
cylindrical SDS micelle (A) and of a seven-tube bundle of fullerene nanotubes coated by a layer of 
sodium dodecyl sulphate (B) are modelled. On the basis of the 2r  data alone, it is impossible to 
ascertain the validity of either interpretation, or of both simultaneously. Further work is then 
required, in particular including the study of the separate effects of, e.g., ionic strength, nature and 
valence of the ionic species, viscosity of the aqueous system, specific effects of amphiphilic co-
solutes, possibly by using other types of techniques (e.g. scattering methods284).  
At any event, analysis of Figure 2 allows to state that 2r  of water molecules measured by means of 
low-field NMR can be a useful, quick and cost-effective technique for the quantification of 
dispersed f-CNTs in water. 
When the f-CNTs are dispersed in an alginate solution (2% w/V) the situation is more complicated. 
The concentration dependence of 2r  for the three types of f-CNTs is reported in Figure 19. 
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Figure 19. Concentration dependence of the average relaxation rate ( 2r ) of 
dispersions of f0-CNTs (), f1-CNTs () and f2-CNTs (▲) in alginate 
aqueous solution (2% w/V), after 30 minutes of sonication. 
From the graph reported in Figure 19 it can be seen that the three types of f-CNTs show three 
different types of behavior: i) f0-CNTs, similarly to what already seen in water, are not well 
dispersed and their 2r  values cannot be directly related to their concentration; ii) f1-CNTs manifest 
an initial very good dispersion, followed, for concentrations equal or larger than 0.04%, by a 
tendency to a negative deviation from linearity, which is a clear symptom of association; iii) f2-
CNTs show a good linear dependence of the  2r   with the CNTs concentration (R
2 = 1), which is a 
clear indication of a single type of  (good) dispersion in alginate. 
Going into detail, the behavior of  2r  of f1-CNTs in the first part of the concentration range (i.e. 
below 0.02%) is quite interesting. The alignment of the data points seems reasonably well linear, 
but, visually, with a higher slope than in water. A linear regression through the data points in 
aqueous alginate, in the first part of the concentration range, provides a satisfactory fitting, with 
slope = 0.33 and R2 = 0. 9998 (having used the 2r  value of aqueous 2% alginate as the intercept). 
The value of the slope is 25.5% larger than in pure water. This result is at variance with the 2r  
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value (derived from the initial 2T ) here above obtained at higher concentration (0.1%) and reported 
in Figure 15C. It points to the presence of a strong concentration dependence and suggests that, in 
very dilute conditions, alginate makes quaternarized f1-CNTs favorably interact with water, rather 
than among themselves, to an extent larger than in pure water. Given the positive charge of f1-
CNTs, it is tempting to propose that an electrostatic association takes place between the cationic 
CNTs and the polyanion. Once attracted by the ionic polysaccharide, f1-CNTs perceive a highly 
hydrated environment; at the same time, entropy will maximize the distribution of CNT-polymer 
contacts as well as the interpolymer distance because of polyanion-polyanion repulsion. The 
ensuing result will be an even better solvation of f1-CNTs than in pure water, with complete 
annihilation of any possible aggregation. However, when the CNTs concentration increases 
electrostatic interactions may produce an opposite effect, since increased cationic CNT 
accumulation in the “condensation volume” of the polyanionic polyelectrolyte produces an 
increase of their local concentration and favor CNT association, with an ensuing decrease of 2r . 
Although such clusters of aggregated CNTs are likely to be still associated with the polysaccharide 
chains, further experiments are required to verify this and to shed light on the topology of the 
macromolecular complexes. This association is observed for concentrations larger than about 
0.03%. Use of the fitting parameters can be made much in the same way as it has been done DMEM 
case, i.e. allowing for the calculation of the 2T -active (soluble) and the non-active (aggregated) 
fractions of CNTs, respectively. The results are reported in Figure 20.  
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Figure 20. Concentration dependence of the soluble (void symbols) and the 
aggregated (full symbols) fractions of f1-CNTs dispersed in 2% aqueous alginate. 
From the graph, it can be observed that the presence of alginate favors solubility of f1-CNTs at very 
low concentrations. Moreover, it can be appreciated the presence of two domains, with a sigmoid 
transition from the “soluble dispersion” regime to that of “aggregate”. 
Regarding the behavior of 2r  of f2-CNTs, it is similar to that of the dispersion in water and in 
DMEM, with a slope of 0.11 that indicate a “closed association” effect that is less extended respect 
to the case of DMEM (see Table 1). In the same way of what done for the DMEM dispersions, the 
2T -active (soluble) and the non-active (aggregated) fractions of CNTs can be calculated (Figure 
21). 
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Figure 21. A) Concentration of active (soluble,) and non-active (aggregated, ▲) components and of total  
f2-CNTs () as a function of the total f2-CNTs concentration dispersed in alginate. B) Percentage of aggregated 
f2-CNTs as a function of f2-CNTs concentration, dispersed in alginate. 
Again, an asymptotic behavior of the aggregated fraction, as a function of the CNTs concentration, 
can be appreciated, although less marked than in the case of DMEM dispersions.  Alginate seems 
to be able to bring out a different behavior between f1-CNTs and f2-CNTs, inasmuch as the former 
CNTs pass from a very hydrated microenvironment to a rather massive aggregation, depending 
upon their concentration (i.e. on the CNT/alginate ratio), whereas the interaction with alginate of 
the latter ones seem to give rise just to a (solubilizing) modulation of an otherwise persisting 
tendency to produce close-association complexes. 
3.1.3 MECHANICAL AND SPECTROSCOPICAL CHARACTERIZATION OF 
ALGINATE/FUNTINALIZED CARBON NANOTUBES SOLUTIONS AND HYDROGELS 
3.1.3.1 Characterization of alginate/f-CNTs solutions 
 Rheological behavior of alginate/f-CNTs solutions 
Solutions of alginate (2% w/V) and f-CNTs (0.1 and 1% w/V, respectively) were characterized by 
means of steady state shear flow experiments. A shear thinning behavior was observed for all 
samples although at low values of the shear rate a variable tendency to conform to a Newtonian 
plateau was observed (Figure 22). 
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Figure 22. Flow curves for alginate alone () and with f1-CNTs () and f3-CNTs () with a total concentration of 
CNTs of 0.1 % (w/V) (A) and 1 % (w/V) (B), respectively. In all cases, alginate concentration was 2 % (w/V). 
It was found that the flow curve of the alginate solution was significantly affected by f-CNTs only 
at a concentration of 1% (Figure 22B) while at the concentration of 0.1% such influence on the 
rheological behavior of the polysaccharide was very small (Figure 22A).  
Focusing on Figure 22B, the increase of the viscosity at low ?̇? in the case of f1-CNTs can be 
explained considering the electrostatic interactions between the protonated amino moieties252 on 
nanotubes and the carboxylate groups of alginate. This is in line with recent observations on 
mixtures of oppositely charged polysaccharides.193 The marked enhancement of η at low ?̇? upon 
the addition of f3-CNTs turns out to be more puzzlingly. Given the nature of the f3-CNTs 
functionalization, it is possible that this type of CNTs is able to establish wider interactions with 
alginate chains, respect to f1-CNTs. Moreover, it is possible that the carboxylic groups of f3-CNTs 
form hydrogen bonds between each other, leading to a partial and local aggregation of CNTs.  
Possible support to this hypothesis might derive from the observed higher deviation from the Cox-
Merz rule (Figure 23) found in the latter case.285 While this rule (which states that η*(ω) = η(𝛾)̇) 
typically holds for homopolymers solutions, it generally fails for nanocomposites.286 In particular 
f3-CNTs (Figure 23C) showed the highest deviation from the Cox-Merz rule suggesting a non-
homogeneity of the solutions and the presence of microscopic aggregates that influence the 
viscosity.287 The presence of an inhomogeneous system could also be responsible of the very 
marked shear thinning of the flow curve. 
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Figure 23. Comparison between the viscosity – shear rate ( -  , ) and the complex viscosity- pulsation 
(* - , ●) dependence (Cox-Merz rule) for alginate alone (A) and with the addition of f1-CNTs (B) and  
f3-CNTs (C). Same conditions as in Figure 1b. In the graphs is also reported the difference between  and  
* as Δ (-∙-), compared with the ideal trend (--). 
 NMR relaxometry of f-CNTs/alginate solutions 
The behavior of alginate/f-CNTs solutions has been investigated through NMR relaxometry in 
order to get information about the dispersion stability and the organization of water molecules 
around CNTs. The time span from the preparation, up to 10 minutes was investigated and no 
prolonged time effect was investigated. In general terms, in the presence of f-CNTs a decrease of 
the relaxation time of the water molecules (Table 2) can be observed in the presence of f-CNTs in 
comparison with the solution of alginate alone ( 2T  = 1586.31 ms), showing that the effect of CNTs 
prevailed over the one of the polysaccharide. 
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Table 2. Average proton relaxation times ( 2T ) of 
alginate solutions (2% w/V) in the presence of f-CNTs 
at 0.1% w/V and 1% w/V. 
f-CNTs 
concentration 
f1-CNTs f3-CNTs 
2T  (ms) 
0.1% w/V 223.9 240.9 
1% w/V 18.1 10.5 
Alginate alone (2% w/V): 2T  = 1586.3 ms. 
In both cases, the average proton 2T  decreased upon increasing the f-CNTs concentration. A 10-
fold increase of concentration produced an about 12-fold decrease of 2T  for f1-CNTs and an almost 
double (23-fold) effect for f3-CNTs.   
The variation of 2T  when the concentration of CNTs is increased seems to be related to the 
variation of viscosity. It can be observed that respect to the f1-CNTs, with the f2-CNTs there is a 
larger increase of viscosity and a larger decrease of 2T . This can be an additional indication of the 
higher complexity of the system respect to the f1-CNTs, due to the possible presence of micro-
domains (namely, CNTs aggregates). 
3.1.3.2 Characterization of alginate/f-CNTs hydrogels 
Following the approach reported in the materials and methods section, highly homogeneous 
alginate hydrogels were obtained with a good dispersion of the f-CNTs. 
 Rheological characterization of alginate/f-CNTs hydrogels 
Mechanical spectroscopy was used to determine the viscoelastic properties of the alginate/f-CNTs 
hydrogels under small oscillatory shear. Prior to the measurement, the linear viscoelastic range for 
each sample was determined for each sample by means of a stress sweep test. 
RESULTS AND DISCUSSION 
 
51 
The mechanical spectra (Figure 24) showed that in all cases the addition of f-CNTs did not modify 
at all the character of firm gels of the alginate-based systems, since G' is one order of magnitude 
higher than the G'' and both are basically constant over three decades of frequency.279 In addition, 
it was noticed that the presence of the f-CNTs at a concentration of 1% (w/V) reinforces the 
tridimensional structure in all cases.  
 
Figure 24. Mechanical spectra of calcium alginate hydrogels as such (black symbols) and in the presence of  
f1-CNTs (A) and f3-CNTs (B) at a total CNTs concentration of 0.1 % (w/V) (circle) and 1 % (w/V) (triangles), 
respectively. Full symbols indicates G' and void symbols indicates G''. 
The frequency sweep test were interpreted in terms of the generalized Maxwell model composed 
of a sequence of elements in parallel (spring and dashpot) to which an additional spring has been 
added: 
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where f is frequency,  is pulsation (= 2f), n is the number of Maxwell elements considered, Gi, 
i and i represent, respectively, the spring constant, the dashpot viscosity and the relaxation time 
of the ith Maxwell element while Ge is the spring constant of the last Maxwell element which is 
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supposed to be purely elastic. The fitting of the experimental data was performed assuming that 
relaxation times are not independent each other, but they are scaled by a factor 10.279 
The number of the Maxwell elements was selected to minimize the product χ2*Np, where χ2 is the 
sum of the squared errors while Np (= n + 2; Ge, 1 plus Gi) indicates the number of fitting 
parameters. The experimental data were efficiently fitted by the generalized Maxwell model as 
reported in Figure 24. For all the hydrogels, four Maxwell elements were sufficient to describe the 
system and to determine the shear modulus G by summing the spring constants of the Maxwell 
elements (equation 3): 
𝐺 = 𝐺𝑒 + ∑ 𝐺𝑖
𝑛
𝑖=1         (3) 
As previously determined on alginate hydrogels (2% w/V), the error associated with the shear 
modulus, calculated repeating the experiment on different replicates, is always less than 3%.279 
The shear modulus G confirmed that the presence of f-CNTs at a concentration of 1% for all the f-
CNTs slightly but neatly (about 33%) increased the mechanical properties of the hydrogels  
(Table 3).  
Table 3. Shear modulus (G, in kPa) of alginate hydrogels  
(2% w/V) in the presence of f-CNTs at 0.1% w/V and 1% w/V. 
f- CNTs 
concentration 
f1-CNTs f3-CNTs 
G (kPa) 
0.1% w/V 7.8 ± 0.1 7.9 ± 0.1 
1% w/V 10.4 ± 0.1 10.5 ± 0.1 
Alginate alone (2% w/V): G = 7.4 ± 0.2 kPa. 
 Uniaxial compression tests of alginate/f-CNTs hydrogels 
Cylindrical shape hydrogels have been prepared in order to analyze their mechanical performance 
in the presence of carbon nanotubes under uniaxial compression test.  
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Compression tests showed that mechanical properties are influenced by the concentration and the 
type of functionalization of f-CNTs. In general, a decrease of the mechanical properties is observed 
in the presence of f-CNTs (Table 4). f1-CNTs (1% w/V) turn out to be the best choice since the 
compression modulus value is very close to that of alginate one and the σUCS is the highest among 
the alginate/f-CNTs hydrogels analyzed. In the case of f1-CNTs containing hydrogels, the increase 
in nanotube concentration from 0.1 % to 1 % led to an increase of both the ultimate compression 
strength (UCS) and the energy at break. At variance, the opposite behavior was noticed when f3-
CNTs were used. It can be hypothesize that the increase of f3-CNTs concentration plays a negative 
effect on the mechanical properties due to the presence of the CNTs aggregates and to the possible 
interaction between the carboxylic groups of the CNTs with the calcium ions competing with the 
carboxylic groups of the alginate chains.  
Table 4. Ultimate compression strength (σUCS) and compression modulus (E) of alginate 
hydrogels (2% w/V) in the presence of f-CNTs at 0.1% w/V and 1% w/V. 
f-CNTs concentration 
f1-CNTs f3-CNTs 
σUCS (kPa) E (kPa) σUCS (kPa) E (kPa) 
0.1% w/V 240.3 ± 19.1 31.4 ± 1.1 390.9 ± 34.4 28.9 ± 1.5 
1% w/V 383.1 ± 8.1 35.7 ± 1.8 248.5 ± 36.4 34.9 ± 2.9 
Alginate alone (2% w/V): σUCS = 444.6 ± 29.6 kPa; E = 37.4 ± 1.9 kPa. 
Small discrepancies were observed comparing rheology (shear modulus) and compression tests, 
which can be reasonably explained by taking into account the anisotropy typical of these complex 
materials. 
 NMR relaxometry of f-CNTs/alginate hydrogels 
Alginate-based hydrogels containing f-CNTs have been characterized by LF-NMR water 
relaxometry. In general terms, the average relaxation time values of nanostructured hydrogels are 
lower than the alginate control ones ( 2T  = 156.81 ms) (Table 5). These results follow the same 
trend already reported for the f-CNTs/alginate solutions. Since rheological analyses suggested that 
the mesh size is not affected by the presence of CNTs (at least for 0.1 %), it was possible to assert 
RESULTS AND DISCUSSION 
 
54 
that the differences in the relaxometry behavior of the water molecules are related both to the 
concentration and to the functionalization of the carbon nanotubes. 
Table 5. Average proton relaxation time ( 2T , in ms) of 
alginate hydrogels (2% w/V) in the presence of f-CNTs 
at 0.1% w/V and 1% w/V. 
f-CNTs 
concentration 
f1-CNTs f3-CNTs 
2T  (ms) 
0.1% w/V 33.5 114.9 
1% w/V 12.3 21.6 
Alginate gel alone (2% w/V): 2T  =  156.8 ms. 
The effect of the gelation on the water relaxation time of the water can be evaluated from the ratio 
of the 2T relaxation rate of the hydrogel with the respective solution (Table 6). 
The measured value of 2T  is a combination of several factors, e.g. the mobility of the water protons 
(1H), the concentration of macromolecules in the sample, the exchange of protons between the 
water and the macromolecules, as well as the local magnetic environment of the sample.288  
Table 6. Ratio between the average 2T  for the 
solutions and the average 2T  for calcium hydrogels in 
the presence of f1-CNTs or f3-CNTs at a total CNTs 
concentration of 0.1 % and of 1 % (w/V). 
f-CNTs concentration f1-CNTs f3-CNTs 
0.1% w/V 6.7 2.1 
1% w/V 1.5 0.5 
Alginate alone (2% w/V): ratio = 10.1 
Upon gelation, there is a general decrease of the 2T
279,288 in all cases except in the case of f3-CNTs 
at 1% (w/V), for which a slight increase can be observed. The latter could be due to the aggregation 
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of CNTs already discussed, which impedes interactions with water. The presence of these 
aggregates (or interaction domains) could be proved by the decreased strength of this type of 
hydrogels (which formation is hindered by the presence of the aggregates) 
As in the case of the solutions, the increase of the f-CNTs concentration in the hydrogels, leads to 
a decrease of the 2T : a 10-fold increase of concentration produced a 2.7-fold decrease of 2T  for f1-
CNTs and, likewise in the solutions, a 5.3-fold effect for f3-CNTs. Also in this case this effect could 
be traced back to the presence of interaction domains and aggregates. 
As in the case of the alginate/f-CNTs solutions, combining the data collected for the hydrogels, the 
organization of the CNTs and the polymer matrix can be inferred. In particular, the rheological 
analysis show that CNTs at 0.1% (w/V) do not affect the mechanical properties of the hydrogels 
and at 1% (w/V) there is a reinforcement of the structures; whereas the mechanical strength 
decreases with f1-CNTs 0.1% (w/V) and with f3-CNTs 1% (w/V). The hypothesis on the decrease 
in the case of f3-CNTs seems confirmed by the LF-NMR analysis, which outcomes seem to indicate 
the presence of CNTs aggregates (that are not present at 0.1% w/V). 
The low mechanical strength with f1-CNTs 0.1% (w/V) is probably due to the interference of these 
f-CNTs with the coordination of calcium ions by alginate chains. However, if the concentration 
and hence, the solid fraction is increased, hydrogel strength is also increased. 
The huge differences in the relaxation time with differently f-CNTs seem to point at strong 
interactions between water and f-CNTs suggesting an improvement of the wettability of the 
structures leading to better biological properties.230  
3.1.4 CONCLUSIONS 
The evaluation of dispersibility and aggregation tendency of different f-CNTs dispersed in aqueous 
media has been performed by LF-NMR: in particular, the analysis of 2T  of water molecules allows 
for determining the aggregation of f-CNTs in water solutions, and a linear dependence between 2r
and CNTs concentration for well dispersible f-CNTs, can be found when they are dispersed in 
water, and for all the f-CNTs (even the pristine CNTs) when they are dispersed in culture medium. 
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Moreover, LF-NMR is useful to analyze he effect of the addition of serum proteins (contained in 
DMEM) or alginate, as a dispersant, on suspensions of cationic and neutral f-CNTs. Serum proteins 
showed to be much more able to guarantee a good dispersion of all the f-CNTs overcoming the 
difficulties represented by the high hydrophobicity of the f0-CNTs and the positive charges of the 
f1-CNTs. 
Alginate/f-CNTs solutions and hydrogels have been analyzed by means of LF-NMR, rheological 
measurements and uniaxial compression tests in order to determine the effects of the f-CNTs 
presence: the analysis revealed that f-CNTs are able to highly reduce the water protons relaxation 
time of both solutions and hydrogels, but their presence exerts a slight effect on the rheological 
properties in terms of an increase of solutions viscosity and hydrogels shear modulus, and a 
decrease of the mechanical properties of the hydrogels, depending on the chemical 
functionalization of the CNTs. 
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3.2 DEVELOPMENT OF A BRIDGING IMPLANT FOR THE SPINAL 
CORD INJURY TREATMENT 
Natural biopolymers, and in particular polysaccharides, are being widely explored and investigated 
for the preparation of a bridging implant scaffold for the Spinal Cord Injury (SCI) treatment.94 The 
strategy described and adopted in this work is based on tridimensional freeze-casted alginate 
scaffolds, whose biological properties were tailored by the addition of chitlac and of neurotrophines 
(NTs) expressed by engineered mesoangioblasts (MABs). 
3.2.1 EVALUATION OF THE BIOLOGICAL PROPERTIES OF POLYSACCHARIDE-
BASED SUBSTRATES (2D MODEL) 
The evaluation of the biological properties of the polysaccharides employed has been performed 
analyzing the morphology, the differentiation and the electrophysiological activity of neural cell 
cultures, grown on the surface of polysaccharide-coated glass substrates. The effects of chitlac and 
of the combination of chitlac/alginate have been compared with the effect of chitosan and 
chitosan/alginate coatings (used as controls). 
3.2.1.1 Preparation of polysaccharide-coated glass surfaces 
The method for the preparation of the polysaccharide coatings is based on the electrostatic 
interactions between the polysaccharides and between them and the glass surface. The glass 
substrates have been treated to introduce negative charges, which were exploited to establish 
interactions between the glass surface and the amino groups of chitlac and chitosan. The approach 
based on the electrostatic interactions between polysaccharides and activated surfaces has been 
already successfully exploited to coat methacrylic surfaces195,289 or alginate scaffolds with 
chitlac.155 Various physical and chemical approaches have been tested for the activation of the glass 
surface: treatment with sulfuric acid, plasma cleaning and treatment with piranha solution. 
Preliminary studies pointed out that the treatment with piranha solution was the most effective in 
introducing negative charges on glass surface. The mixed layers have been prepared alternating 
chitlac or chitosan layers to alginate layers following the layer-by-layer deposition approach. 
Single layers of polycations (chitosan or chitlac) or mixed layers of polycation-polyanion-
polycation (chitosan or chitlac with alginate) were obtained, as reported in Figure 25. 
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Figure 25. Scheme of the four different types of coatings based on the polysaccharides chitosan, chitlac and alginate. 
The morphology of the layers was investigated by means of Confocal Laser Scanning Microscopy 
(CLSM), coating the glass substrates with fluorescein labelled chitosan (-fluo), chitlac (-fluo) 
and/or alginate (-fluo); in the case of the coatings composed of mixed layers (chitosan/alginate or 
chitlac/alginate) only one labelled polymer per sample was used. Figure 26 collects the confocal 
images of the four different surfaces.  
 
Figure 26. Confocal microscopy imaging (top view) of the four different 
polysaccharide-based coatings. A) Chitlac-fluo; B) chitlac-fluo/alginate; 
C) chitlac/alginate-fluo; D) chitosan-fluo; E) chitosan-fluo/alginate; 
F) chitosan/alginate-fluo. 
The images point out the presence of fluorescent coatings all over the analyzed surfaces: putting 
the coated surfaces under intense laser irradiation results in bleached areas, which confirms the 
presence of a continuous fluorescent coating. Preliminary tests proved that the glass substrate does 
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not possess any auto-fluorescence (data not shown). The spots with more intense signals indicate 
surface areas where the fluorescently labelled polysaccharide accumulated upon drying the 
polymer solutions on the glass substrate. The thickness of the polysaccharide layers has been 
measured by means of Atomic Force Microscopy (AFM): to evaluate the thickness of the coatings 
a scratch was made on the coated surfaces. The values obtained are reported in Table 7. 
Table 7. Thickness of the polysaccharide coatings, 
determined by AFM. 
Polysaccharide coating Thickness (nm) 
Chitosan 104 ± 24 
Chitlac 5 ± 2 
Chitosan/alginate 213 ± 32 
Chitlac/alginate 24 ± 18 
The values indicates that there are differences in the polysaccharide adsorption onto glass surfaces: 
with chitosan, which possesses a high number of positive charges, is possible to obtain thicker 
coatings; moreover, the addition of alginate leads in both cases (chitlac and chitosan) to thicker 
coatings. 
When biomaterials are implanted into the body, protein adsorption onto the foreign surface occurs 
within seconds from implantation, so that cells approaching the biomaterial surface interact with 
the adsorbed protein layer; surface properties like hydrophilicity, wettability and charge are key 
driving mechanisms for protein absorption processes, and thus, for the biological response;290 these 
surface features can be expressed by studying surface free energy parameters. 
Contact angle measurements were performed putting the four different polysaccharide-coated 
surfaces in contact with polar (water and ethylene glycol) and apolar (diiodomethane) liquids. The 
values obtained are reported in the Table 8: the contact angle values between water and the chitlac 
containing surfaces are lower than the chitosan containing ones, meaning that their wettability and 
hydrophilicity are higher. This result can be related to the chemical nature of chitlac and is in line 
with the recent findings of D’Amelio et al.,197 who showed that the lactitol side-groups of chitlac 
determine a stronger interaction with water (solvation zone) with respect to chitosan. 
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Table 8. Contact angles of three reference liquids on the four different polysaccharide-based 
surfaces. 
Polysaccharide 
 coating 
Contact angles for liquids θ (◦) 
Water                            
(γTOT = 72.8 mJ/m2) 
Ethylene Glycol     
(γTOT = 48.0 mJ/m2) 
Diiodomethane                      
(γTOT = 50.8 mJ/m2) 
Chitosan 58.5 ± 6.2 36.6 ± 6.9 42.4 ± 4.6 
Chitlac 15.8 ± 4.3 11.9 ± 2.6 44.7 ± 3.1 
Chitosan/alginate 67.8 ± 6.3 30.1 ± 4.4 36.7 ± 5.0 
Chitlac/alginate 45.3 ± 5.3 13.9 ± 3.6 29.3 ± 3.1 
From the contact angles data the surface free energy parameters were calculated; in fact, according 
to the Van Oss theory, it is possible to correlate contact angles with surface energy of a solid 
material by means of the Young-Duprè equation which enables to calculate the surface energies as 
a sum of the dispersive (LW) and acid-base (AB) contributions, which take into account the non-
polar and polar interactions, respectively.291 This approach was used to calculate surface free 
energy parameters and work of adhesion of the investigated surfaces (Table 9). 
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Table 9. Surface free energy parameters and work of adhesion parameters calculated by contact angle measurements. 
γLW is the apolar term of the specimens surface free energy; γ+ and γ−, are respectively the acid and base terms of the 
specimens surface free energy; γAB is the polar term of the specimens surface free energy. γTOT is the total surface free 
energy of the specimen and is given by the sum of γLW and γAB. The polarity is the ratio between γAB and γTOT. Work 
of adhesion WAB is due to acid-base interactions between polar liquids and surfaces and is reported as value and as 
percentage referred to the total work of adhesion. Contact angles of three reference liquids on the four different 
polysaccharide-based surfaces. 
Polysaccharide 
coating 
Surface free energy parameters [mJ/m2] 
polarity 
(%) 
Work of adhesion 
γLW γ+ γ- γAB γ tot 
WAB  H2O 
[mJ/m2] 
WAB 
H2O % 
WAB 
EG 
[mJ/m2] 
WAB% 
EG 
% 
chitosan 38.41  
±2.47 
0.23 
±0.21 
22.69 
±1.31 
4.57  
±2.09 
42.97 
±3.26 
10.63 
±4.93 
53       37% 20        18% 
chitlac 37.18 
±1.68 
0.28 
±0.01 
63.60 
±0.04 
8.44 
±0.02 
45.64 
±1.70 
18.49 
±0.29 
86              50% 29        25% 
chitosan/alginate 41.21 
±2.47 
0.73  
±0.12 
9.84 
±1.17 
5.36 
±0.54 
46.56 
±2.56 
11.51 
±1.32 
40       31% 20         18% 
chitlac/alginate 41.80 
±1.50 
0.57 
±0.03 
30.76 
±0.39 
8.36  
±0.23 
50.16 
±1.51 
16.67 
±0.68 
64      41% 26        22% 
The total surface energy γTOT of the four different surfaces ranges from 42.97 to 50.16 mJ/m2, in 
line with previous investigations on polysaccharide-coated methacrylic surfaces.195 In the case of 
the chitlac coating, the higher value of the acid-base interactions  (γAB) causes a considerable 
increase in the surface polarity with respect to the chitosan coating (chitlac: 18.49%, chitosan: 
10.63%); the increase of surface polarity associated with chitlac is verified also in the case of the 
mixed layer with alginate (chitlac/alginate: 16.67%, chitosan/alginate: 11.51%). Table 9 shows 
also that the presence of chitlac is associated with a significant increase of acid−base interactions 
with water: from 53 mJ/m2 to 86 mJ/m2 for the monolayers and from 40 mJ/m2 to 64 mJ/m2 for 
mixed layers; while the dispersive contribution (γLW) is almost constant among all the surfaces. 
The increase of acid−base interactions with water can be ascribed to the higher density of polar 
functional groups of chitlac. This result stems from the different chemical structure of the 
macromolecules adsorbed on the surface, i.e. the presence of the lactose residues in the case of 
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chitlac, which determines a higher density of surface hydroxyl sites. These results suggest that 
surface energy parameters and interfacial interactions of polar liquids provide a reasonable 
description of the acid−base character of the polysaccharide-based surfaces. Conversely, the 
dispersive interactions did not vary between chitlac or chitosan containing surfaces. This finding 
is in line with what reported by Lamour et al.,292 Assero et al.293 and Hallab et al.294 on similar 
polymer based coatings. 
3.2.1.2 Biological effects of the polysaccharides in two-dimensional conditions 
With the exception of the analyses performed to assess the involvement of galectin-1 in the 
biological effects of the polysaccharides, the evaluation of the biocompatibility and the biological 
effects of the polysaccharides has been performed by immunofluorescence staining and 
electrophysiological measurements in collaboration with prof. Laura Ballerini laboratories (SISSA, 
Trieste, Italy). 
 Polysaccharide biocompatibility 
The biocompatibility of the polysaccharides has been assessed evaluating adhesion, morphology 
and viability of dissociated hippocampal neurons (as a simplified in vitro neuronal network model) 
grown on all the polysaccharide-coated substrates. Chitosan/alginate substrates have been excluded 
from the analyses because they were not able to sustain cell growth.  
From the immunofluorescence images reported in Figure 27 it can be seen that the dissociated 
hippocampal cultures grew on all three substrates, but some differences in the network growth 
patterns can be appreciated: switching from chitosan to chitlac and to chitlac/alginate, neurons tend 
to grow in a widespread, uniform network without forming aggregates. The absence of aggregates 
can be the cause of the lower neuronal density on chitlac/alginate surfaces. 
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Figure 27. Representative images of hippocampal cultures after 8-10 days, on chitosan (A), chitlac (B) and 
chitlac/alginate (C) (n=number of coverslips; red: β-tubulin III (βtub III,) green: Glial Fibrillary Acid Protein 
(GFAP), blue: DAPI). Distribution and density have been evaluated from 5 culture series. 
The health status of neuronal cells was further analysed by means of electrophysiological 
evaluation of neuronal passive membrane properties like membrane input resistance (Rin) and cell 
capacitance (Cm). These parameters are related to cell dimensions: a larger cell possesses a higher 
number of ion channels, thus a low resistance. The presence of higher number of ion channels on 
a larger cell means also a more extended conducting surface (which is opposed to the non-
conducting membrane) that results in larger capacitance. Figure 28 shows the values of the 
measured parameters; no statistical differences can be observed between chitlac and 
chitlac/alginate; on the other hand, the resistance is higher and the capacitance is lower for neurons 
grown on chitosan. Altogether, the higher dimensions and the more spread neuronal network on 
chitlac and chitlac/alginate, indicate a healthier morphology of neurons in the presence of chitlac. 
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Figure 28. Plot showing membrane passive properties for chitosan 
(■, n=73), chitlac (, n=102) and chitlac/alginate (, n=103) 
neurons, from 26 culture series. (*: P<0.05; **: P<0.01; 
***: P<0.001) 
The results obtained from the analysis of the membrane passive properties are confirmed by the 
measurement of the βtub III positive area (μm2), reported in Figure 29, which is significantly higher 
in neurons grown on chitlac-based substrates, suggesting an increased neuronal arborisation since 
the number of neurons is unchanged (see Figure 27). 
 
Figure 29. βtub III positive area (μm2) of neurons grown on 
chitosan, chitlac and chitlac alginate. (*: P<0.05; **: P<0.01; 
***: P<0.001). 
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 Analyses of neuron functionality 
In order to analyze the functionality and the formation of synaptic connections within the neuronal 
network, single-cell patch-clamp records were performed, and the occurrence of heterogeneous 
spontaneous postsynaptic currents (PSCs) was monitored; this is a widely accepted method for the 
identification of functional synapse formation.295 Figure 30A shows sample traces of the PSCs for 
the three conditions. PSCs frequency was significantly increased (+ 62%) in the case of 
chitlac/alginate compared to the chitlac one, and it was even higher (+ 128%) when comparing it 
with the chitosan coating (Figure 30B). On the contrary, no significant differences were found 
between chitlac and chitosan neurons, even though an increasing trend was observed when neurons 
grew on chitlac. Similar results obtained by PSCs amplitude analysis are shown in Figure 30C: 
chitlac/alginate neurons displayed an increased (+ 36% and + 35% over chitlac and chitosan, 
respectively) PSCs amplitude. 
 
Figure 30. Spontaneous PSCs recorded from neurons sampled from the three experimental conditions. 
A) Representative traces recorded in voltage-clamp mode from chitosan (black, n=64), chitlac (red, n=85) 
and chitlac/alginate (blue, n=97) hippocampal neurons. B) Plot showing the increased PSCs frequency in 
the chitlac/alginate neurons compared to chitlac and chitosan neurons. C) PSCs amplitude plot showing the 
enhanced effect encountered in the chitlac/alginate condition over the chitlac and chitosan conditions. 
(*: P<0.05; **: P<0.01; ***: P<0.001). 
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In order to clarify whether the increased synaptic activity could be assigned to the neuronal network 
density or to neuritic arborisation and a possibly increased synaptogenesis, neurons have been 
marked with biocytin and the neurites have been counted right after their exit from the soma and 
at three increasing distances (25, 50 and 75 μm from the cell soma). Table 10 contains the results 
found. Due to the low number of stained neurons still adherent to the chitosan-coated substrate 
after the procedure, it was not possible to perform statistical analysis. Nevertheless, it can be 
suggested the presence of a decreased neuritic arborisation in the chitosan experimental group 
when compared to the other two groups, based on the obtained data. 
Table 10. Values of neurites counting obtained from the biocytin labelled neurons from 
each experimental condition. Chitosan (n=2), chitlac (n=9), chitlac/alginate (n=11) 
(Analysis performed by Dr. Jummi Laishram). 
Polysaccharide 
 coating 
Neurites 
exiting the 
soma 
Neurites at 
25 μm from 
the soma 
Neurites at 50 
μm from the 
soma 
Neurites at 75 
μm from the 
soma 
Chitosan 4.0 ± 0.0 4.50 ± 0.71 7.0 ± 0.0 7.0 ± 1.14 
Chitlac 5.0 ± 1.66 7.11 ± 3.14 10.22 ± 2.95 8.44 ± 3.40 
Chitosan/alginate 5.60 ± 1.63 7.90 ± 4.06 8.70 ± 3.47 7.20 ± 4.94 
 Galectin-1 analyses 
Considering the significant differences observed for the neurons grown on chitlac containing 
surfaces, the possible mechanism responsible for these differences has been further investigated. It 
has been shown that galectins, and in particular galectin-1, can be involved in the molecular 
recognition of chitlac and in the triggering of cellular processes.198 
The presence of galecin-1 and the differences in its expression among the three conditions have 
been analyzed by means of ELISA assay, on the culture medium harvested after 8 days, and 
immunofluorescence staining of neurons after 8 days. The preliminary ELISA results (Figure 31) 
suggest an increased secretion of galectin-1 for cultures grown on supports functionalized with 
chitlac/alginate (although not statistically significant when comparing with chitosan and chitlac). 
The highest values observed in the case of the support coated with chitlac/alginate are probably 
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due to the larger amount of chitlac deposition in the presence of alginate, which probably 
contributes to an increased biological activity. 
 
Figure 31. Galectin-1 quantification. Plot showing the 
significantly increased galectin-1 levels secreted by neurons 
belonging to the chitlac/alginate condition (number of 
supernatant samples analysed, n = 4, *: P<0.05) 
The immunofluorescence staining (Figure 32) seems to confirm (preliminary results) the increased 
expression of galectin-1 in neurons grown on chitlac/alginate surfaces, which show several spots 
indicating the presence of galectin-1 molecules. 
 
Figure 32. Immunofluorescence staining of neurons grown on chitosan (A), chitlac (B) and chitlac/alginate 
(C), showing the presence of galectin-1; red: βtub III, green: galectin-1. The arrows indicate the galecin-1 spots. 
More in details, the analysis of the fluorescence intensity of the galectin-1 spots (calculated 
applying a threshold to the signal) shows that the intensity of the galectin-1 signals is higher on 
chitlac and chitlac alginate substrates (Figure 33). 
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Figure 33. Galectin-1 fluorescence intensity spots 
normalized for the βtub III positive area. (number of 
images analysed, n = 4, *: P<0.05; **: P<0.01) 
The involvement of galecin-1 in the nerve tissue regeneration processes is very complex: it 
regulates the embryonic development of nerve tissue; it can be secreted by growing axons and 
reactive Schwann cells, and trigger different responses depending on its red ox state: in the oxidized 
form galectin-1 stimulates the macrophages secretion of axonal regeneration promoting factors, 
while in the reduced form it induces astrocyte differentiation and enhanced their producton of 
BDNF, which plays an important role in the survival, differentiation, and synaptic plasticity of 
neurons.296-298 
In this context, galectin-1 may thus be considered as a means for the prevention of neuronal loss in 
cases of injury to the CNS (Central Nervous System).296 In this framework, the results of this work 
are particularly interesting, linking substrate interactions and galactin-1 expression with synaptic 
network reconstruction and activity, but further work is required in order to clarify the molecular 
mechanism that lies behind the galectin-1 involvement, and the possible involvement of other 
isoforms of this protein. 
 Effect of mesoangioblasts releasing neurotrophines on motoneuron progenitors 
 differentiation 
As previously anticipated, the strategy for the design of a spinal cord implant tackled in this work 
is based on the incorporation of engineered MABs secreting NTs, for a controlled and continuous 
release of NGF (Nerve Growth Factor) and BDNF (Brain Derived Neurotrophic Factor), whose 
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trophic effects have been tested in vitro on cultured neuronal cells and brain slices.123 These MABs, 
due to their intrinsic high adhesin-dependent migratory capacity, can reach perivascular targets 
especially in damaged areas,299 and thus could represent a suitable tool for spinal injury treatment 
based on cell replacement strategy. Both NGF and BDNF are important secretory proteins, 
regulators of survival, differentiation, and maintenance of nerve cells playing a pivotal role in 
neurodevelopment and neuroprotection. BDNF in particular supports the survival of existing 
neurons and encourages the growth and differentiation of new neurons and synapses through 
axonal and dendritic sprouting. In addition, several reports suggested a role for BDNF and NGF in 
the modulation of synaptic transmission.300,301 
In order to determine the effects of both polysaccharides and neurotrophine expressing MABs, 
motoneuron progenitors (D7) have been co-cultured with MABs (here referred as D16), BDNF-
expressing MABs (here referred as A9) or NGF-expressing MABs (here referred as F10), on the 
three different substrates. Control and NTs producing-MABs were able to efficiently grow on 
chitosan, chitlac and chitlac/alginate in a similar manner. When co-cultured with the three types of 
MABs on the different substrates and let differentiate, D7 progenitors gave rise to both neurons 
and astrocytes (data not shown). The percentage of choline acetyltransferase (ChAT) positive cells 
has been measured in order to determine the percentage of differentiated motoneurons, the results, 
showed in Figure 34, indicate more ChAT positive motoneurons when D7 progenitors are 
differentiated on chitlac/alginate. 
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Figure 34. Percentage of D7 differentiation in the presence of MABs and 
NTs secreting MABs, in the three different conditions (chitosan, black; 
chitlac, red; chitlac/alginate, blue) (*: P<0.05; **: P<0.01; ***: P<0.001). 
 Effect of MABs releasing NTs on hippocampal network 
Based on the previous results, the chitlac/alginate substrates (best performing in terms of network 
synaptic activities) have been chosen for an additional set of electrophysiological experiments in 
order to determine the effects of NTs secreting MABs on the neuronal activity of dissociated 
hippocampal cells. Figure 35 shows the passive membrane properties determined by 
electrophysiological recordings: these displayed a trend going from control to the D16 to F10 to 
A9 MABs co-cultures, reaching a statistical difference between the two extremities. Overall, the 
data indicate the good viability and activity of neurons and that the presence of MABs does not 
negatively affect health status and size of neurons. 
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Figure 35. Plot showing membrane passive properties for 
neurons cultured alone (Ctrl, ■, n=18) and co-cultured with 
MABs D16 (, n=29), A9 (, n=26) and F10 (, n=25). 
(*: P<0.05; **: P<0.01; ***: P<0.001). 
The morphological analysis showed that neurons grew readily in all the four conditions and cell 
density counting analysis showed an almost identical neuronal density (data not shown). On the 
other hand, βtub III positive area was significantly higher in neurons grown together with all types 
of MABs compared to hippocampal neurons alone (Figure 36). 
 
Figure 36. βtub III positive area (μm2) of neurons alone (Ctrl) 
and co-cultured with D16, A9 and F10 MABs. (*: P<0.05; 
**: P<0.01; ***: P<0.001). 
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Regarding heterogeneous PSCs (Figure 37), both PSCs frequency and peak amplitude were further 
boosted by the presence of the NTs, while the peak amplitude was also increased when primary 
neurons were co-cultures with control MABs, meaning that MABs per se were able to interfere 
with the neuronal network formation. Taking together, the improvement in the synaptic activity 
driven by the chitlac/alginate substrate can be further implemented by the additional inclusion of 
NTs like BDNF and NGF. 
 
Figure 37. PSCs frequency (A) and PSCs amplitude (B) plots of voltage-clamped hippocampal neurons cultured in 
the four different conditions. (Ctrl, black, n=14; D16, red, n=20; A9, green, n=16; F10, blue, n=17). 
From the results, it can be concluded that chitlac can exert a positive effect on the adhesion, the 
growth and the function of the cells analyzed. This key aspect of the work can be related to the 
chemical nature and differences between chitlac and chitosan, which lead to differences in the 
surface energies. It is widely accepted that neurons and cells in general, are able to sense the 
features of the growth substrate and actively respond to it.302 Moreover, the findings of this work, 
are in line with previous reports by Lamour et al.292 who recently pointed out how the arrangement 
of polar and apolar groups at the nanoscale level is a key factor in generating the surface energy 
gradients that PC12 cells are able to sense, thus suggesting that surface free-energy gradients are 
critical for biological processes such as nerve regeneration on biomaterials.  
3.2.2 TRIDIMENSIONAL STRUCTURES FOR NEURAL TISSUE ENGINEERING 
Driven by the positive biological results obtained with neurons and the combination of alginate and 
chitlac, which indicate that these polysaccharides are good candidates to be employed in the 
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bridging implant strategy, the work here described has proceeded with the development of alginate 
tridimensional scaffolds enriched with chitlac. 
The general approach was to exploit the freeze-casting of alginate hydrogels, reticulated with 
calcium ions, in different conditions to prepare porous scaffolds with different pore morphology. 
In order to obtain a homogeneous gelation, an insoluble form of Ca2+ (CaCO3) was dispersed within 
the alginate solution, and the calcium release was induced by the acidification of the medium 
triggered by the slow hydrolysis of δ-glucono lactone (GDL). The scaffolds obtained have been 
functionalized with chitlac by means of physical adsorption. Both isotropic and anisotropic porous 
scaffolds have been prepared and characterized in terms of material properties. 
3.2.2.1 Preparation and characterization of alginate/chitlac scaffolds 
Scaffolds with anisotropic pores were prepared by the Ice Segregation Induced Self Assembly 
(ISISA) process. This technique, based on the immersion of the hydrogel in liquid nitrogen at 
controlled speed, enabled to tailor the dimensions and the porosity of the structures by tuning the 
dimensions of the mold and the immersion speed in the liquid nitrogen bath.110 The alginate 
hydrogels (contained in syringes) were frozen by the ISISA process to enable the formation of 
columnar ice crystals which, after freeze-drying (in vacuum conditions), left room for aligned 
anisotropic pores (Figure 38).  
 
Figure 38. Left: schematic representation of the ISISA method in which a syringe containing alginate 
hydrogels is immersed at controlled speed in a liquid nitrogen bath. Right: formation of columnar ice crystals 
within alginate hydrogels. 
RESULTS AND DISCUSSION 
 
74 
The influence of the syringe diameter and of the immersion speed on the final porous structure was 
preliminarily assessed: the optimal conditions in terms of structural homogeneity were obtained 
with syringes of 13 mm diameter at a dipping speed of 8 mm/min. The characterization of the 
scaffolds obtained with the ISISA process (ISISAsc) was carried out as a direct comparison with 
scaffolds with the same formulation but with isotropic pores (here referred to as CRyo-Prepared 
IsOtropic scaffolds, CRIOsc); the manufacturing of CRIOsc was previously described147,155 and is 
based on freezing the hydrogels at slow rate in a cryostat with a controlled temperature ramp. These 
procedures enabled to obtain freeze-dried scaffolds that can easily be cut and shaped with a scalpel, 
especially in the rehydrated form. Figure 39 reports the macroscopic images of the starting 
hydrogel and of the CRIOsc and ISISAsc obtained from it. 
 
Figure 39. Images of the alginate hydrogel (A; h = 18 mm, ø = 16 mm) and the 
resulting structures obtained with the CRIO (B; h = 18 mm, ø = 16 mm) and 
the ISISA (C; h = 18 mm, ø = 11 mm) processes. 
 Morphological and physical-chemical characterization 
The images point out the macroscopic homogeneity of the scaffolds obtained with the two different 
techniques. A deeper insight into the porous structure of the scaffolds was obtained by Scanning 
Electron Microscopy (SEM) imaging; Figure 40 reports the comparison between the two 
microstructures. 
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Figure 40. SEM micrographs of alginate scaffolds obtained 
with the CRIO process (A, longitudinal; B, cross sections) and 
with the ISISA process (C, longitudinal; D, cross sections). 
SEM images point out the anisotropic porous structure of the ISISAsc, which display aligned 
columnar pores, at variance with the isotropic porosity of the CRIOsc; these columnar pores create 
large domains of aligned channels. 
The processes here adopted for the preparation of tridimensional scaffolds from alginate hydrogels 
enable to achieve isotropic (CRIOsc) or anisotropic (ISISAsc) structures, in line with the results of 
several authors with materials of similar94,147,155 or different nature.107,152 In particular the ISISAsc, 
compared with other anisotropic structures reported in the literature,105,152 showed a narrow 
distribution of pore dimensions and a pore morphology with a high degree of homogeneity. 
For a quantitative analysis of the porous structures of ISISAsc and CRIOsc, micro-Computed 
Tomography (µ-CT) analyses were performed. The analysis of the µ-CT data was carried out 
according to a procedure previously described,147 which made it possible to obtain quantitative data 
on the solid fraction (BV/TV: Solid Volume/Total Volume), on the thickness of the alginate 
structures delimitating the pores (Tb.Th.: Trabecular Thickness) and on the average dimension of 
the pores (Tb.Sp.: Trabecular Spacing). It was also possible to quantify both the interconnectivity 
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of the structures (expressed as Trabecular Number “Tb.N.”303,304 and their Degree of Anisotropy 
(DA). These latter parameters have been calculated by Equation (4) and (5): 
𝑇𝑏. 𝑁 =
1
𝑇𝑏. 𝑇ℎ. +𝑇𝑏. 𝑆𝑝.
                                                                                                       (4) 
𝐷𝐴 = 1 −
𝑠ℎ𝑜𝑟𝑡 𝑎𝑥𝑖𝑠
𝑙𝑜𝑛𝑔 𝑎𝑥𝑖𝑠
                                                                                                              (5) 
The degree of anisotropy DA equals 0 for a perfectly isotropic structure and 1 for a perfectly 
anisotropic structure. 
The reconstruction of the tridimensional structures shown in Figure 41 points out the different 
structure of scaffolds obtained with the two techniques. 
 
Figure 41. 3D reconstruction form μ-CT analysis of CRIOsc (A), 
and of ISISAsc (B). 
Table 11 reports the quantitative analysis of the morphology of CRIOsc and ISISAsc; data show 
the differences in the morphology between the two types of scaffolds, being the DA of ISISAsc 
1.7 times the DA of CRIOsc. Moreover, ISISAsc possess the proper porosity and pore size (Tb.Sp) 
to be used for neural tissue engineering applications.94,99,100 
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Table 11. Quantitative characterization of the microstructure of the alginate scaffolds. BV/TV: bone 
volume/total volume; Tb.Th.: trabecular thickness; Tb.Sp.: trabecular spacing; Tb.N: trabecular number; DA: 
degree of anisotropy. 
Scaffold BV/TV Porosity (%) Tb.Th. (μm)a) Tb.Sp. (μm)a) Tb.N (mm-1) DA 
CRIOsc 0.19 ± 0.04 81 ± 4 32.55 ± 0.19 178.12 ± 14.01 5.00 ± 2.35 0.52 ± 0.05 
ISISAsc 0.40 ± 0.02 60 ± 2 31.71 ± 1.18 46.08 ± 18.10 12.86 ± 4.43 0.93 ± 0.02 
a)In Tb.Th and Tb.Sp, linear dimensions are given ± std. dev. (6 experiments). Linear resolution is 8 µm. 
Following a protocol already used for alginate scaffolds,155 CRIOsc and ISISAsc have been 
incubated with chitlac solution in order to adsorb the chitlac on their surface. Figure 42A shows 
the adsorption kinetic of fluorescein labelled chitlac within the scaffolds, determined by 
fluorimetric measurements; Figure 42B shows the complete coating of both scaffolds structures 
and the deep permeation of the structure. 
 
Figure 42. A) Adsorption kinetic of chitlac on alginate CRIOsc (■) and ISISAsc (). 3D reconstruction of chitlac 
coated CRIOsc (B) and ISISAsc (C) from CLSM imaging. 
The wettability and the initial swelling of the structures are important features influencing cell 
adhesion and colonization inside the structure. A biodegradable scaffold should favor cell adhesion 
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and proliferation while being gradually degraded at a rate which is synchronous with tissue 
regeneration; moreover, upon contact with body fluids, it should be able to withstand the initial 
swelling without exerting excessive compression towards the surrounding tissue, thus maintaining 
its original shape.147,305 In order to characterize the swelling and degradation behavior, the scaffolds 
were incubated in simulated body fluid and these parameters were monitored as a function of time. 
The time-dependent swelling behavior of the scaffolds in Simulated Body Fluid (SBF) is reported 
in Figure 43A. An initial rapid liquid uptake was observed in the first 10 minutes (up to ~3000% 
of swelling ratio); then the swelling remains almost constant. Despite the massive uptake of liquids, 
a small volume variation of the structures occurs (+ 1.9 ± 0.2 %). The considerable swelling of the 
scaffolds pointed out the high interconnectivity of the pores. The water uptake and the trend of 
swelling were found to be similar to the rates of swelling reported in the literature for tridimensional 
structures with isotropic147,306 or anisotropic porosity.107 As the swelling rate can be related to the 
hydrophilicity of the material,305 these scaffolds can be considered as highly hydrophilic scaffolds. 
Moreover, these materials are able to absorb a large amount of fluids without losing their structural 
integrity, an important property that is known to affect the exchange of fluids, nutrients and 
catabolic products.307,308 
 
Figure 43. Weight variation of the ISISAsc during the swelling (A) and the degradation experiment 
(B). Data are averaged on three parallel runs. 
Scaffolds proved also to be very stable in SBF (incubated at 37°C) during 35 days (Figure 43B), 
showing a weight decrease of only 1.36 %. Overall, these studies pointed out that the scaffolds 
swell instantaneously to a large extent and display a slow rate of degradation (in vitro) within the 
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first month of immersion in SBF; this behavior is particularly advantageous for neural tissue 
engineering applications, being the healing rate of neural tissue very low. 
The stability of the scaffolds has been analyzed also in terms of release of the adsorbed chitlac in 
saline solution (NaCl 0.15 M). The graph reported in Figure 44 shows that the amount released 
from the scaffolds is very low over time and reaches rapidly a plateau, proving that the structures 
are able to retain chitlac within the polymer matrix. 
 
Figure 44. Chitlac-fluo release from CRIOsc (■) and ISISAsc () in saline solution expressed as 
percentage of the total chitlac-fluo contained: (A) release at given solution shift; (B) cumulative release. 
Data were averaged on three independent experiments 
An important issue related to the use of calcium alginate hydrogel-derived scaffolds is the release 
of calcium ions in the extracellular environment and its possible toxicity.31 The release of calcium 
ions from ISISAsc has been evaluated by soaking them in saline and measuring the calcium 
concentration with Induced Coupled Plasma – Optical Emission Spectroscopy (ICP-OES). The 
results are reported in the graphs of Figure 45. It can be noticed an initial burst of calcium release 
(approximately the 35 % of the total calcium content); after the first two saline changes, the calcium 
release reaches a plateau of low values. Thus, being the calcium release almost limited to the first 
two saline changes, curing the scaffolds in physiological medium could remove the excess of 
calcium without affecting the scaffold stability. 
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Figure 45. Release of calcium ions from ISISAsc reported as fraction released over the total calcium 
content (A) and as μmol of calcium per mg of scaffolds (B). 
 Scaffolds mechanical properties 
In order to be suitable for neural tissue engineering (and in general for all the applications of tissue 
engineering) tridimensional scaffolds have to possess specific mechanical properties. In particular, 
in the case of neural tissue engineering, the scaffolds have to be soft enough to avoid mechanical 
stress to the tissue, without being too much weak. ISISAsc containing chitlac have been analyzed 
by means of uniaxial compression tests in order to determine their compression modulus. Figure 
46 reports a representative stress/strain curve obtained from the mechanical analysis. 
 
Figure 46. Representative stress/strain curve of ISISAsc analyzed 
by uniaxial compression tests. 
0.0 0.2 0.4 0.6 0.8 1.0
0
20
40
60
80
100
120
140
 
 
S
tr
es
s 
(k
P
a)
Strain (mm/mm)
RESULTS AND DISCUSSION 
 
81 
Analyzing the data from the mechanical tests in the linear range of deformation, it was possible to 
calculate the compression modulus, which was found to be 14 kPa (± 1 kPa). The compression 
modulus for nerve tissue has been reported to be between 3 and 300 kPa,6 in particular, Francis et 
al.94 reported a compression modulus of 5 kPa for scaffolds to be employed in spinal cord tissue 
regeneration.  
Altogether, data obtained from the morphological, physical-chemical and mechanical 
characterization indicate that the chitlac containing ISISAsc can be used for the development of a 
bridging implant strategy for spinal cord tissue regeneration. 
3.2.3 CONCLUSIONS 
Polysaccharide coated glass substrates have been prepared in order to analyze the biological effects 
of alginate, chitosan and chitlac on neural cell cultures. An effective strategy based on charge 
interactions was employed to prepare these polysaccharide-based coatings, whose thickness can be 
modulated by increasing the number of polysaccharide layers. The analysis of contact angles and 
of surface energies showed that the presence of the lactose branches on the chitosan backbone 
caused a considerable increase of surface hydrophilicity, polarity and acid-base work of adhesion.  
Immunofluorescence and electrophysiological investigations showed that hippocampal derived 
neural cells were able to growth on all the substrates, but only on chitlac and chitlac/alginate 
substrates it was possible to observe the formation of a wide and interconnected neural network 
with a good electrophysiological activity. ELISA and immunofluorescence analyses of galectin-1 
suggested that this protein is more expressed when neurons are grown on chitlac/alginate and 
chitlac substrates and that it has a possible biological role in the observed effects. Additional 
experimental evidence will be necessary to clarify whether the enhanced proliferation of neurons 
on chitlac-based substrates can be ascribed solely to the combined effect of the more hydrophilic 
and polar layer or also the biological activity of the polysaccharide. 
In a similar way, chitlac/alginate substrates proved to be the best substrate for the differentiation 
of motoneuron progenitors in the presence of wild type and engineered MABs secreting NTs. The 
combination of NTs secreting MABs and the chitlac/alginate substrates has been tested for the 
culture of neuronal cells: the electrophysiological results showed that there is an improvement of 
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the neural activity when the neurons cultured on chitlac/alginate substrates are in the presence of 
NTs secreting MABs and that the development of alginate/chitlac scaffolds enriched with 
engineered MABs could be a good strategy for the preparation of a bridging implant for the spinal 
cord injury treatment. 
Alginate/chitlac scaffolds have been prepared by embedding tridimensional alginate porous 
structures with chitlac. The porosity of the alginate structures has been tailored by using two 
different freezing methods, in order to obtain isotropic (spherical) and anisotropic (aligned) pores. 
The confocal microscopy imaging showed that the structures are completely embedded with 
chitlac. The swelling and stability behaviors as well as the mechanical properties of these constructs 
make them particularly appealing for neural tissue engineering applications.  
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3.3 DEVELOPMENT OF FILLERS FOR THE HEALING OF  
NON-CRITICAL BONE DEFECTS 
The strategy tackled for the development of bone fillers has been focused on two different forms 
of materials, both based on polysaccharides (structural and bioactive components) and 
hydroxyapatite (HAp, osteoconductive component). The first form is represented by tridimensional 
porous structures, whose pore morphology has been tailored and studied with respect to the 
material properties. The second form is represented by injectable microparticles dispersed in 
polysaccharide mixtures. 
3.3.1 TRIDIMENSINALS SCAFFOLDS: EVALUATION OF PORE MORPHOLOGY 
EFFECTS AND ENRICHMENT WITH FUNCTIONALIZED CARBON NANOTUBES 
The scaffolds characterized in this work are designed to be employed in the filling and healing of 
non-critical bone defects. The first part of the work has been focused on the physical, mechanical 
and biological effects of different pore morphologies of the scaffolds, prepared applying the ISISA 
or the CRIO processes; the second part describes the biological characterization of differently 
functionalized carbon nanotubes and their use for the implementation of the scaffolds.  
3.3.1.1 Characterization of scaffolds with different pore morphology 
In order to prepare the bone scaffolds with different pore morphology, the methods previously 
described for the preparation of scaffolds for neural tissue engineering have been applied to 
alginate/HAp hydrogels. In fact, to improve both biological and mechanical properties of the 
scaffolds, HAp was employed for the preparation of the composite hydrogels.147 The concentration 
of HAp needed to be optimized to avoid interference with the gelation and the freezing of the 
hydrogels; previous data showed that CRIOsc can be prepared with up to 3% w/V HAp without 
affecting the gelation process and the morphology of the porous structure.147 In the present work, 
the ISISAsc were prepared with various concentrations of HAp and the resulting structures were 
evaluated; when HAp concentrations higher than 0.5% w/V where used, the homogeneity of the 
scaffold was negatively affected (data not shown). In contrast, with HAp 0.5% w/V the porous 
structure was not affected and therefore this initial concentration was selected. 
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 Morphological and physical-chemical characterization 
In order to compare the morphology of the constructs obtained with the two different techniques 
under the same conditions, both CRIOsc and ISISAsc were prepared with an initial concentration 
of solid HAp equal to 0.5% w/V, which, after dilution upon addition of GDL solution, reduces to 
0.35% w/V. The final concentration of HAp lies into the range normally used for such kind of 
application and is considered sufficient to induce a biological effect.107,309,310 
Figure 47 shows the SEM images of the two types of scaffolds containing HAp. The images show 
that, compared to the alginate-CaCO3 scaffolds of Figure 40, the addition of HAp does not 
significantly affect the porous morphology of both scaffold. 
 
Figure 47. SEM micrographs of scaffolds with HAp obtained with the 
CRIO process (A, longitudinal; B, cross sections) and with the ISISA 
process (C, longitudinal; D, cross sections). 
CRIOsc and ISISAsc have been analyzed by means of μ-CT in order to investigate their 
morphology and the differences with the scaffolds prepared with CaCO3. The reconstruction of the 
tridimensional structures shown in Figure 48 points out the different structure of scaffolds obtained 
with the two techniques; moreover, it shows that the addition of HAp had a minor influence on the 
morphology of the structures. 
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Figure 48. 3D reconstruction form -CT analysis of CRIOsc 
without HAp (A) or with HAp (B), and of ISISAsc without 
HAp (C) or with HAp (D). 
Table 12 reports the quantitative analysis of the morphology of CRIOsc and ISISAsc. The use of 
HAp had a minor influence on the tridimensional properties of the scaffolds: in particular, the pore 
dimension and the porosity of both structures were not affected (p > 0.05) and the degree of 
anisotropy of the CRIOsc decreased by 27% (p < 0.05). The pore interconnectivity did not change 
significantly for the CRIOsc (p > 0.05) and it slightly decreased for the ISISAsc (-22%, p < 0.01). 
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Table 12. Quantitative characterization of the microstructure of the alginate scaffolds. BV/TV: bone 
volume/total volume; Tb.Th.: trabecular thickness; Tb.Sp.: trabecular spacing; Tb.N: trabecular number; DA: 
degree of anisotropy. 
Scaffold BV/TV Porosity (%) Tb.Th. (μm)a) Tb.Sp. (μm)a) Tb.N (mm-1) DA 
CRIOsc CaCO3 0.19 ± 0.04 81 ± 4 32.55 ± 0.19 178.12 ± 14.01 5.00 ± 2.35 0.52 ± 0.05 
CRIOsc HAp 0.20 ± 0.03 80 ± 3 33.82 ± 1.83 183.96 ± 15.22 4.61 ± 2.26 0.38 ± 0.03 
ISISAsc CaCO3 0.40 ± 0.02 60 ± 2 31.71 ± 1.18 46.08 ± 18.10 12.86 ± 4.43 0.93 ± 0.02 
ISISAsc HAp 0.34 ± 0.04 66 ± 4 32.41 ± 0.78 67.85 ± 10.73 10.08 ± 5.07 0.90 ± 0.03 
a)In Tb.Th and Tb.Sp, linear dimensions are given ± std. dev. (6 experiments). Linear resolution is 8 µm. 
From the data obtained by SEM and μ-CT, it is possible to conclude that the structures match the 
requirements for osteoconductivity and bone tissue regeneration. Indeed, they present a high 
porosity, the values of which are similar to those claimed as good for bone scaffolds and 
fillers.107,152,311,312 Moreover the interconnectivity of the pores, determined as the Tb.N. value, is 
very high and similar to that of osteoconductive scaffolds recently described.147,155 
Swelling and degradation behaviors of both scaffolds have been evaluated in simulated body fluid. 
The possibility that HAp precipitates on the scaffold from the SBF solution was taken into account. 
Cursory X-ray Photoelectron Spectroscopy (XPS) experiments revealed traces of HAp on scaffolds 
made of alginate without HAp (data not reported). However, a conservative estimate of the 
theoretical maximum amount of HAp that could precipitate provides a very low value (about 1.4 
mg), which becomes totally negligible if compared with the amount of adsorbed water (from 350 
to 800 mg). 
The time-dependent swelling behavior of the alginate/HAp scaffolds in SBF is reported in Figure 
49A. The re-swelling behavior of the composite scaffolds did not significantly differ between 
CRIOsc and ISISAsc. An initial rapid liquid uptake was observed in the first 10 minutes (up to 
~1900% of swelling ratio); then the swelling slightly increased up to ~2300% and ~2200% for the 
CRIOsc and the ISISAsc respectively. The lower swelling rate of the ISISAsc can be ascribed to 
the lower porosity of these scaffolds, in line with the results reported by Ghadiri et al.306 Despite 
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the massive uptake of liquids, a small volume variation of the structures occurs only for the CRIOsc 
(+ 9%). 
 
Figure 49. Weight variation of the CRIOsc () or the ISISAsc () during the swelling (a) and the degradation 
experiment (b). Data are averaged on three parallel runs. 
Both scaffolds show good stability in SBF (incubated at 37°C) during 35 days (Figure 49B), 
showing no weight loss in the case of CRIOsc and a weight decrease of only 11% in the case of 
ISISAsc. In both cases, the degradation rate is lower than the one reported by Turco et al. with 
similar scaffolds:147 this could be ascribed to the lower content of solid fraction (HAp) in both 
CRIOsc and ISISAsc, which hampers to a minor extent the reticulation of alginate. 
Similarly to what has been observed for scaffolds containing CaCO3, the swelling behavior of the 
HAp containing scaffolds is similar to that of scaffolds already discussed in literature107,147 and 
indicates that these structures are highly hydrophilic; moreover, also in this case the scaffolds were 
able to maintain their structural integrity after the absorption of a large amount of fluids and proved 
to be very stable in simulated body fluid, showing important characteristics for the employment in 
the healing of bone defects. 
 Mechanical properties of the scaffolds 
The scaffolds proposed in this work are meant to be used as temporary fillers to accelerate the 
repair of non-critical defects and small lesions of the bone tissue. Although these conditions are 
less demanding than those for load-bearing implants, it is nonetheless important to characterize the 
mechanical properties of the scaffolds, especially considering the implantation procedure, which 
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involves considerable compression forces during the surgical insertion. To this end, uniaxial 
compression tests in static and cyclic conditions on hydrogels and rehydrated scaffolds have been 
performed. 
The results of Table 13 point to a marked improvement of the mechanical properties of the 
hydrogels in the presence of HAp: in particular, compression modulus, strength and toughness 
increased by 63%, 46% and 46% (respectively) with respect to CaCO3 hydrogels, without affecting 
significantly the deformation at break of the hydrogels. The amount of calcium ions (responsible 
for the egg-box structure) in the CaCO3 case (30 mM) is twice as large as in the case of HAp 
(15mM); therefore, the better mechanical properties shown in the case of HAp hydrogels must 
derive from the contribution of the dispersed solid and not from a larger number of gel junction 
structures. This finding is in full agreement with the results of Turco et al.147 The undissolved 
fraction of HAp contributes to the mechanical strength of the hydrogel, while endowing the 
material with bioactive properties. 
Table 13. Mechanical properties of hydrogels based con CaCO3 or HAp, 
analyzed by means of uniaxial compression test. 
Hydrogel E (kPa) σUCS (kPa) 
Toughness 
(kJ/m3) 
Deformation at 
break (%) 
CaCO3 38.4 ± 6.3 177.9 ± 12.4 26.2 ± 1.8 52.6 ± 1.2 
 HAp 62.6 ± 3.2 260.5 ± 16.4 38.3 ± 2.7 53.0 ± 1.0 
The freeze-dried scaffolds have been tested in the rehydrated state in order to simulate the stress 
conditions that the material undergoes after implantation in contact with body fluids.  
It should be noticed that CRIOsc have an isotropic structure, which means that their mechanical 
properties are not dependent on the load direction; in contrast, ISISAsc have an anisotropic 
structure and the tests have been performed loading the samples along the main direction of pores. 
Compression tests revealed that rehydrated CRIOsc possess higher modulus and toughness than 
rehydrated ISISAsc (Table 14). 
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Table 14. Mechanical properties of hydrogel based con 
CaCO3 or HAp, analyzed by means of uniaxial 
compression test. 
Rehydrated scaffold E (kPa) 
Toughness 
(kJ/m3) 
CRIOsc 155.5 ± 51.3 5.69 ± 0.38 
 ISISAsc 28.3 ± 9.1 2.63 ± 0.33 
The inferior performance of the ISISAsc can be attributed to the sliding of the columnar trabeculae 
while applying compression forces (see Figure 47). 
The mechanical properties of both types of scaffolds (in the wet state) are in line with those 
previously reported for biopolymer-based bone scaffolds.147,313 Moreover, when rehydrated they 
display a “sponge-like” behavior and can be compressed up to 60% of their original dimensions 
without breaking the porous structure. It should be noticed that during the compression, absorbed 
water was observed to be released by both types of scaffolds and was eventually re-absorbed after 
the removal of the load. 
Cyclic loading tests have been performed in order to investigate the response of the rehydrated 
scaffolds to cyclic loads. These tests were carried out by cyclically applying and removing a 
constant load to the rehydrated structures; upon removal of the load, scaffolds were able to reabsorb 
some of the water leaked during the compression and to partially recover their original shape (as 
sample height). 
This peculiar behavior is shown in Figure 50. The load-displacement graphs (Figure 50A and B) 
show that at each compression the scaffolds displayed an initial elastic strain followed by a change 
of slope corresponding to the start of the water-release process; the graph highlights the 
considerable “shape-recovery” capability of the scaffold, which enabled the structure to re-expand 
at the end of each cycle when the load was removed. The recovery of the original shape is expressed 
in Figure 50C as the percentage of height regained after each cycle: as the number of cycles 
increased, the recovery progressively stabilized at about 85-88% of the initial scaffold height, 
which indicates that this mechanical feature was maintained during cyclic loads. The shape-
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recovery ability of both scaffolds is comparable to that of scaffolds based on chitosan314 and PCL315 
recently developed for bone tissue regeneration. 
 
Figure 50. Load/displacement curve of the compression cycle performed in the cyclic loading test on CRIOsc (A) 
and ISISAsc (B). For clarity, only cycles 1, 3, 5, 7, 10 are reported. Variation of height recovered (C), toughness (D) 
of the CRIOsc () or the ISISAsc () during the cyclic loading test. Dotted lines have been drawn to guide the eye. 
Besides highlighting the property of the material of displaying reversible deformations, the cyclic 
mechanical tests were also aimed at evaluating the variation of toughness (Figure 50D) of the 
scaffolds under repeated loads; after an initial decrease, in both cases the toughness values tend to 
stabilize around plateau values (~3.4 kJ/m3 and ~1.2 kJ/m3 for CRIOsc and ISISAsc respectively), 
in line with the shape-recovery trend.  
Overall, the mechanical analysis indicates that, when rehydrated, both scaffolds behave as a 
“spongy” material that can be deformed to a large extent without breaking. They displayed a 
considerable recovery of the initial shape during cyclic loading, while toughness and stiffness 
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(modulus) of the material tended to reach progressively plateau values, higher for the CRIOsc than 
for the ISISAsc. This behavior can be particularly appealing for bone implants subjected to cyclic 
loadings (e.g. jawbone defects) and it matches the surgical need of cutting and shaping the scaffold 
before implantation to ensure a good fit within the defect cavity.316,317 
 Biological tests on scaffolds 
The biocompatibility of the scaffolds depends on their ability to improve the adhesion and the 
proliferation of cells seeded onto the porous structures. In order to evaluate the effect of the pore 
arrangement and shape on these aspects, the viability, the osteocalcin expression and the alkaline 
phosphatase (ALP) activity of an osteoblast cell-line (MG63) seeded in the scaffolds have been 
studied. 
The viability of cells was evaluated by means of a colorimetric assay (MTS) and the results are 
shown in Figure 51: for both scaffold types, the cells were viable and kept proliferating during the 
3 weeks of test (p < 0.01 for day 21 compared to day 1). No significant difference in the 
proliferation rate was observed between the two different types of structures (p > 0.05). 
 
Figure 51. Proliferation rate of osteoblasts seeded on 
CRIOsc () and ISISAsc (). 
The osteocalcin expression and the ALP activity of the MG63 cells seeded inside the scaffold types 
were determined in order to evaluate a possible cellular differentiation. The analysis revealed that 
both parameters remained comparably low during the experiments and did not vary from day 1 to 
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day 21 regardless of the scaffold structure, which indicates that within this timeframe no 
differentiation processes occurred (data not shown). 
The proliferation of the osteoblasts within the scaffolds was further investigated by carrying out 
SEM analysis on both types of structures (CRIOsc and ISISAsc). Figure 52 shows that, in both 
cases, the cells colonized the porous structures and were able to form clusters of numerous round-
shaped osteoblasts which adhered to the scaffold walls, in agreement to what previously reported 
for osteoblasts on alginate based scaffolds.306,308,318 The images point out the presence of 
extracellular matrix surrounding the clusters, which stresses the good cell viability and activity. 
 
Figure 52. SEM micrographs of MG63 seeded on CRIOsc (A, B)  
and ISISAsc (C, D). 
This investigation shows that, in the CRIOsc, the cell clusters were typically formed within the 
cavities of the isotropic pores, whereas in the ISISAsc the cell clusters adhered to the walls of the 
columnar pores, whose dimensions appear particularly suited for a widespread colonization of 
osteoblasts. 
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3.3.1.2 Scaffold enrichment with functionalized carbon nanotubes 
In the perspective of tailoring the properties of the alginate/HAp scaffolds with CNTs, the effects 
of f1 and f3-CNTs (section 3.1.3), on the viability and the proliferation of MG63 cells have been 
analyzed. In the literature, several positive effects of CNTs have been reported, like the support to 
adhesion and growth of osteoblasts, the triggering of differentiation of human mesenchymal stem 
cells, the enhancing of deposition of HAp and extracellular matrix by osteoblasts and, in some 
cases, the inhibition of differentiation and activity of osteoclasts.180,236  
The f-CNTs have been added to cultured cells at three different concentrations and the cell viability 
was evaluated after 24 and 72 hours of incubation.  
It has been reported that CNTs can interfere with the routinely used colorimetric and fluorimetric 
assays319-322 due to their absorbance and quenching capability; for these reasons the viability of the 
treated cells was evaluated through a modified version of the LDH assay proposed by Ali-Boucetta 
and coworkers in 2011.319 The assay confirmed not to be influenced by the presence of the tested 
f-CNTs in these experimental conditions. The results (Figure 53) indicate that the levels of 
intracellular LDH are similar for the cells treated with f-CNTs and for untreated cells, which allows 
to conclude that the functionalized f-CNTs considered in this work did not show any toxicity for 
the MG63 cell line. Statistical analysis did not allow concluding for the presence of a dose-response 
mechanism. 
 
Figure 53. Viability of MG63 cells expressed as the ratio between cell number at day 0 and after 24 hours (white 
bars) or 72 hours (gray bars) in the presence of dispersed f1-CNTs (A) or f3-CNTs (B), at the concentration of 100, 
50 or 10 μg/mL respectively. Control cells are seeded with DMEM and Triton X100 (0.01% V/V in DMEM) has 
been used as a positive control of toxicity. 
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After demonstrating the biocompatibility of the f-CNTs, these have been used to prepare 
alginate/HAp scaffolds for the evaluation of their ability of support the adhesion and growth of 
osteoblasts. For this application, CRIOsc containing HAp have been chosen, because of their better 
mechanical properties; f-CNTs have been dispersed in water (final concentration: 0.1% w/V) and 
added to the alginate/HAp solution prior to the gel formation. 
 
Figure 54. Viability of MG63 cells seeded in scaffolds of alginate (■), 
alginate/f1-CNTs (), alginate/f3-CNTs (); expressed as the ratio 
between cell number at day 1 and day 3 or 7. Statistical differences were 
determined by means of Student’s t test. ***P < 0.001. 
The proliferation trends in the alginate scaffolds are reported in Figure 54. Despite there were no 
differences in cell proliferation (Figure 53); when the f-CNTs are embedded within the scaffolds a 
different trend can be seen. At the concentration used for the preparation of the scaffolds, the f1-
CNTs did not affect the colonization and the proliferation of the cells, whereas, the f3-CNTs, after 
7 days were not able to sustain the proliferation of the osteoblasts (Figure 54). In the literature, no 
negative effects have been reported in the use of oxidized or, in general, negatively charged CNTs 
for the preparation of bone scaffolds.209,323 The absence of any effect on the osteoblast adhesion 
and proliferation for the f1-CNTs can be an intrinsic characteristic or a consequence of their low 
concentration. Regarding the f3-CNTs it can be hypothesized that the wider interactions between 
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f3-CNTs and alginate, and the presence of micro-domains affected the gelation and the scaffolds 
pore formation (discussed in section 3.1.3), leads to a structure less osteoconductive than the 
scaffolds prepared with f1-CNTs or the scaffolds without f-CNTs. 
3.3.2 INJECTABLE NANOCOMPOSITES IMPLEMENTED WITH ANTIMICROBIAL 
SILVER NANOPARTICLES AND BIOACTIVE COMPONENTS 
A novel injectable bone filler is here described. The filler is based on alginate/HAp microbeads 
dispersed in a polysaccharide mixture in order to obtain an injectable formulation. The microbeads 
have been implemented in two different ways: i) by adding silver nanoparticles (nAg) in order to 
implement antimicrobial properties; ii) by embedding gelatin or chitlac in order to improve their 
bioactive properties. 
3.3.2.1 Preparation and in vitro characterization of antimicrobial injectable bone fillers 
Microbeads based on the mixture of the selected polysaccharides were prepared by exploiting the 
gel-forming properties of alginate: the rationale was to employ alginate as the structural component 
of the beads and to incorporate the bioceramic HAp to endow them with features suitable for the 
stimulation of bone tissue growth. To further implement the bioactivity of the beads, chitlac was 
added to the polymer mixture, also in the presence of antimicrobial nAg (chitlac-nAg). The 
hydrogel beads were prepared by dropping the aqueous mixtures of the biopolymers with HAp into 
an aqueous solution of CaCl2; in order to control the size of the beads, an electrostatic generator 
was used (Figure 55).  
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Figure 55. Schematic representation of the preparation of the microbeads: the 
alginate/HAp/chitlac(-nAg) solution is dropped in a CaCl2 solution and a voltage is applied. 
This method enabled to obtain hydrogel microbeads with a narrow size distribution and average 
size of 990 (± 60) µm, as determined by optical microscopy imaging; Figure 56A-C point out that 
the size distribution was similar for microbeads with (nAg-MB) or without (MB) silver 
nanoparticles. 
 
Figure 56. A) Dimension distribution of MB (white) and nAg-MB (grey). On the right, microbeads aspect: 
B), MB, C) nAg-MB. 
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The concentrations of alginate and HAp were optimized in order to reach a compromise between 
the maximization of the concentration of the osteoconductive component and the formation of a 
stable alginate mesh in the microbeads.147  
Alginate microbeads have also been analyzed by means of confocal microscopy, using fluorescein-
labelled chitlac, in order to evaluate the distribution of chitlac inside the alginate/hydroxyapatite 
matrix. Figure 57 shows the image of a sectioned microbead, which highlights the homogenous 
distribution of chitlac. 
 
Figure 57. Confocal microscope images of alginate/HAp microbead 
containing fluorescein-labelled chitlac. A) xy top view; B) yz cross 
section; C) xz cross section. 
 Morphological and physical-chemical characterization 
In order to obtain the dried composite powder required for the preparation of the injectable filler, 
the hydrogel beads were dehydrated by air flux, thus obtaining the dried composite particles. The 
dried particles were analyzed by SEM in order to evaluate size and morphology (Figure 58); as 
expected, drying the hydrogel microbeads led to a significant reduction of their dimensions (MB: 
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250 ± 40 µm; nAg-MB: 270 ± 40 µm). These values are in the range commonly employed for the 
preparation of composite bone fillers based on HAp or β-tricalcium phosphate (β-TCP).172,324  
The SEM analysis enabled also to highlight how the bead surfaces are roughened by the presence 
of HAp crystals that protrude from both MB and nAg-MB particles (Figure 58B and D). 
 
Figure 58. SEM micrographs of MB (A, B) and nAg-MB (C, D). E) Distribution of microbeads dimension: 
MB (white) and nAg-MB (grey). 
The swelling behavior and stability were investigated by incubating the dried microbeads in SBF 
at 37 °C and replacing it at fixed days. The size variation of the particles over time is reported in 
Figure 59A: the data show how the microbeads underwent a considerable swelling that led to an 
increase of their dimension, owing to the presence of the hydrophilic polysaccharides. The 
microbeads rapidly (approximately 2 days) reached a swelling equilibrium, with an increase of the 
diameter of 3.5 times and of volume of about 43 times with respect to the initial dimension. The 
swelling rate of MB and nAg-MB was similar (Figure 59A) and did not affect the morphology of 
the microbeads (Figure 59 B and C).  
The experiment, extended for 31 days, pointed out the excellent morphological stability of the 
microbeads, which did not show any significant degradation in physiological-like conditions. 
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Figure 59. A) Diameter changes during the swelling/stability experiment: (■), MB, (○) nAg-MB. 
On the right, microbeads aspect after 12 days of experiment: B), MB, C) nAg-MB. 
Considering the final application, the swelling and degradation behavior of the microbeads 
represent a positive feature of the material, enabling the injectable filler to adapt to the bone defect 
and firmly remain in situ for several weeks, thus assisting the natural bone regrowth process. 
In fact, the prolonged stability of an injectable material is a key factor in the regeneration of the 
bone tissue,325-327 as it takes several weeks to have new bone tissue formation.328  
The amount of silver contained in the nAg-MB has been quantified by means of ICP-OES; the 
analysis revealed that 1 mg of microbeads contains 9.78 ± 1.46 ng of silver (data averaged on three 
samples). 
The silver release from the nAg-MB has been measured by soaking the microbeads in deionized 
water and in saline solution (NaCl 0.15); in order to put the particles in contact with abundant 
liquid, the ratio between the volume of water/solution and the volume of microbeads was 10. To 
mimic real conditions, the solutions were changed every 24 h and the microbeads were subjected 
to mechanical agitation. The silver released from the microbeads over time was reported both as 
percentage of silver released each day (Figure 60A) or as cumulative release (Figure 60B).  
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Figure 60. Silver released by the microbeads (nAg-MB) soaked in deionized water (○) or in saline solution (■) 
expressed as percentage of the total silver contained: (A) release at given solution shift; (B) cumulative release. Data 
were averaged on three independent experiments. 
The data point out that for both water and saline solution the silver released upon daily shifts is 
typically lower than 1%, while after 7 days the cumulative silver release was (5.69 ± 0.95)% in 
saline solution and (0.36 ± 0.12)% in water. The higher release in saline is explainable considering 
that the presence of ions can accelerate the swelling of the polymer mesh, which increases the 
release of the entrapped nanoparticles. However, in both cases, the silver release was very low 
since only 0.56 ng per mg of beads is released after 7 days, which indicates the structural stability 
of the polymer mesh. 
The profile of the silver released from the nAg-MB appears particularly appealing for bone tissue 
engineering applications, since it ensures a gradual long-term administration of the antimicrobial 
agent, thus avoiding a burst release of metal ions that could potentially be toxic for the cells of the 
surrounding tissues.  
 Antibacterial and biological properties of microbeads 
The antimicrobial properties of nAg-MB were assessed in terms of inhibition of bacterial growth 
and eradication of biofilms produced by three bacterial strains: S. aureus, P. aeruginosa and S. 
epidermidis. These strains have been selected because of their role in bone-related infections and 
their antibiotic-resistance mechanisms.329-333 The assays have been performed incubating the 
microbeads (nAg-MB or MB) in direct contact with bacteria for chosen times. 
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For S. aureus and P. aeruginosa, the growth inhibition assay was performed by incubating the 
bacterial suspension with the dried microbeads for 4 hours, after which the colony forming units 
(CFU) were measured; in both cases, the nAg-MB induced a significant decrease of the CFU, 
whose number was reduced by several orders of magnitude (Figure 61A-B). 
In the case of S. epidermidis, no antibacterial effect was detected after 4 hours of incubation (data 
not shown). For this reason, the incubation was prolonged to 24 hours, which revealed to be a 
sufficient time for the nAg-MB to exert a bactericidal effect; in fact, a decrease of more than 4 
orders of magnitude was found in the case of the silver-containing particles (Figure 61). The higher 
resistance of S. epidermidis was in line with the results reported in a previous work by  
Marsich et al.155  
 
Figure 61. Growth inhibition assay of bacteria treated with microbeads (MB or nAg-MB), compared to the growth 
control (Ctrl). S. aureus (A), P. aeruginosa (B) were incubated for 4 hours, while S. epidermidis (C) were incubated 
for 24 h. Statistical differences were determined by means of Student’s t test. **P < 0.01; ***P < 0.001. 
Once verified the effectiveness of the silver-containing particles in inhibiting bacterial growth, a 
further test has been carried out to evaluate their effect towards pre-formed biofilms. This assay 
was performed on S. aureus and P. aeruginosa strains, since S. epidermidis does not produce a 
self-protecting biofilm; the bacteria biofilms were put in contact with the microbeads for four hours 
and the bacteria viability was quantified using the Green Biofilm Cell Stain assay, which exploits 
the fluorescence intensity of the biomass as an indicator of viable bacteria within the biofilm. The 
results are reported in Figure 62. In the case of S. aureus, the nAg-MB displayed a strong anti-
biofilm activity, since a 69% decrease of the fluorescence intensity was measured with respect to 
the control. In the case of P. aeruginosa the nAg-MB determined a 26% of the biofilm fluorescence 
intensity; this milder effect could be ascribed to the high content of alginate in the P. aeruginosa 
biofilm, which represents a physical barrier towards antimicrobial agents.334  
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Figure 62. Effect of microbeads on biofilms of S. aureus (A) and P. aeruginosa (B) after 4 hours of contact with the 
materials (Green Biofilm Cell Stain assay). Ctrl: untreated biofilm; MB: biofilm treated with MB; nAg-MB: biofilm 
treated with nAg-MB. Statistical significance was evaluated by Student’s t test. *P < 0.05; 
**P < 0.01; ***P < 0.001. 
The viability of bacteria within biofilms was also evaluated by the Live/Dead assay, which, by 
means of a fluorescence microscope, enables to distinguish between viable cells (green) and dead 
cells (orange-red); Figure 63 collects the images of the biofilms after 4 hours of treatment with the 
particles, compared to untreated (control) biofilms. 
 
Figure 63. Effect of microbeads on biofilms of S. aureus (A-C) and P. aeruginosa (E-G) after 4 hours 
of contact with the materials (Live/Dead assay). Control: untreated biofilm; MB: biofilm treated with 
MB; nAg-MB: biofilm treated with nAg-MB. For all images, green fluorescence (SYTO® 9) indicates 
live cells whereas red fluorescence (Propidium iodide) refers to dead ones. 
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In the case of S. aureus, the images clearly show the abundance of viable bacteria (green) in the 
case of untreated (Figure 63A) and MB-treated biofilms (Figure 63B); at variance, the treatment 
with nAg-MB causes a clear inactivation of bacteria cells, appearing as red particles (Figure 63C).  
In the case of P. aeruginosa, the antimicrobial effect of the nAg-MB can be inferred by the 
abundance of orange/red biomass (Figure 63G), at variance with control (Figure 63E) and MB-
treated bacteria (Figure 63F). 
Overall, the Live/Dead results are in line with the results of the Green Biofilm Cell Stain assay, 
both pointing out the antimicrobial effect of nAg-MB on pre-formed biofilms.  
After studying the antimicrobial activity of the microbeads, their effect towards eukaryotic cells 
was evaluated by the lactate dehydrogenase (LDH) assay, which enables to quantify the release of 
the LDH enzyme due to cellular damage; the assay has been carried out by putting an osteoblasts 
cell line (MG63) in direct contact the cells with microbeads for 24 and 72 hours (accordingly to 
the ISO 10993−5 standard335). Figure 64 shows the results of this cytotoxicity study as well as a 
qualitative evaluation of the morphology of the cells in contact with the materials. 
 
Figure 64. Evaluation of material cytotoxicity towards MG63 osteoblast-like cells. A) LDH assay after 24 h (white) 
and 72 h (grey) on cells in direct contact with the materials. Ctrl: adhesion control on multiwell, MB: cells in contact 
with MB, nAg-MB: cells in contact with nAg-MB, PS: cells in contact with polystyrene membrane (negative 
control), PU/Zn: cells in contact with polyurethane/zinc membranes (positive control). Statistical differences were 
determined by means of Student’s t test. *P < 0.05; **P < 0.01. B) Microscopic image of the cells after 72 hours 
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The results of Figure 64A pointed out that both MB and nAg-MB particles were associated with 
low values (<15%) of LDH release, which remained significantly lower than the positive 
(cytotoxic) control (polyurethane/zinc); these quantitative data were confirmed by the qualitative 
investigation of cell morphology (Figure 64B), which highlighted the healthy conditions of the 
cells proliferated on the multiwell floor in direct contact with both types of microbeads. 
Once verified the non-cytotoxicity of the material, a further in vitro study was carried out in order 
to evaluate the microbeads surface as substrate for osteoblast adhesion and proliferation; the test 
was performed by seeding the cells directly on the microbeads (Figure 65A) and measuring their 
proliferation with the Alamar Blue assay after 7 days. 
 
Figure 65. A) Schematic representation of the proliferation test performed by seeding MG63 cells on 
the surface of the microbeads; B) Proliferation rate of MG63 cells on the surface of MB (■) or  
nAg-MB (○); the rate was measured normalizing the intensity values (I) obtained at days 4 and 7 on 
the first culture day (I0). Statistical differences were determined by means of Student’s t test.  
NS: non significant; ***P < 0.001. 
The results reported in Figure 65B showed that the number of cells significantly increased after 1 
week of culture on both MB and nAg-MB particles at a comparable rate. This result is particularly 
important keeping in mind the potential use of the material as a bone filler; in fact, the 
polysaccharide-HAp particles were proved to represent an efficient growth substrate for 
osteoblasts. This result is in line with previous investigations of some authors of the papers, which 
pointed out the excellent osteoconductive properties of chitlac-based substrates.155,195,196 
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 Preparation of an injectable formulation 
As soon as the composite microbeads were characterized, their ability to support osteoblasts 
proliferation assessed, and their antimicrobial activity (in the presence of silver nanoparticles) 
demonstrated, the material was employed for the preparation of an injectable system based on dried 
MB suspended in a liquid medium. The medium was selected through a preliminary screening of 
polysaccharide solutions by evaluating the homogeneity and stability over time of the paste 
resulting from the dispersion of the microbeads in the polysaccharide solution (data not shown); 
this screening study enabled to select alginate solution (4% w/V) with 30% w/w of microbeads as 
the best performing formulation, since this composition could be stored within syringes for 10 days 
maintaining the particles homogeneously distributed within the alginate medium (Figure 66A).  
In order to assess the injectability of this formulation, the force required to extrude it through a 
syringe with a nozzle diameter of 2 mm was tested by means of a universal testing machine. This 
diameter nozzle is in the typical range for cannulas used for bone cement injections.324 The results 
of the mechanical tests are reported in Figure 66B (blue line).  
 
Figure 66. Injectability of MB microbeads dispersed in polysaccharide solutions. A) Image of the syringe 
employed to extrude the injectable pastes. B) Load-displacement (representative) curves recorded by 
compressing the plunger to extrude the paste out of the syringe. Blue line: 4% (w/V) alginate with 30% (w/w) 
microbeads; Magenta line: 3% (w/V) alginate / 1% hyaluronic acid with 30% (w/w) microbeads. 
The data showed that it was possible to push the syringe plunger for the whole length of the syringe 
(50 mm) without stacking the particles or blocking the nozzle, thus achieving a 100% extrusion of 
the paste with an average compression load of 17 N (± 5 N). These values are in line with injectable 
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materials developed by other authors (Sohrabi et al.,174 Sohrabi et al.,336 Tadier et al.324) and 
highlight the capability of this bone filler to be injected in a surgical procedure: moreover, phase-
separation phenomena were not observed during the extrusion. 
In order to evaluate the morphology of the particles in the dispersion medium, a SEM investigation 
has been performed after withdrawing the microbeads from the alginate solution (Figure 67): the 
images qualitatively showed that the particles displayed a smoother surface than the native 
microbeads. This could be ascribed to the adsorption on the microbeads surface of some alginate 
from the solution. 
 
Figure 67. SEM micrographs of alginate-coated  
microbeads (A, B) and of native microbeads (C, D). 
The confocal microscope images reported in Figure 68, of microbeads dispersed in 4% w/V 
alginate-fluo show how the alginate contained in the solution is adsorbed on the microbeads 
surface.  
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Figure 68. Confocal microscope images of alginate/HAp microbead 
containing fluorescein-labelled alginate. A) xy top view; B) yz cross 
section; C) xz cross section. 
3.3.2.2 In vivo characterization of injectable filler biocompatibility and bioactivity 
 Optimization of material injectability 
The primary goal of this experimental study is to compare osteoconductivity of the novel injectable 
bone-filler (with and without nAg) with that of commercial bone filler used in orthopedic surgery 
(HydroSet™, Stryker, NJ, USA). 
Prior to the in vivo analysis, ex vivo experiments (performed on bones harvested from non-
dedicated animals) have been performed in order to qualitatively evaluate the injectability of the 
formulation. Two problems had to be overcome regarding the material preparation: the phase 
separation between the microbeads and the alginate/hyaluronic acid mixture, and the stacking of 
the microbeads inside the syringes.  
Preliminary evaluations allowed to select a paste prepared dispersing microbeads (30% w/w) in 
alginate solution (4% w/V). This type of paste was stable over time (no phase separation 
phenomena), but could be hardly applied into the bone defects; in fact this paste formulation was 
not easily injectable.  
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In a second attempt, a minor content of microbeads (15% w/V) have been dispersed in hyaluronic 
acid (3% w/V). Hyaluronic acid has been selected as the additional solution component, given its 
healing capability and lubricating properties.337 This approach improved the injectability of the 
paste, although a separation between the two phases can be observed. The pastes need to be re-
suspended and concentrated, discharging an uncontrolled amount of solution before their use. 
After these preliminary attempts, several compositions of the liquid dispersant were prepared by 
mixing both polyanions (alginate and hyaluronic acid) and polycations (chitlac), as reported in 
Table 15. The resulting pastes obtained with 30% (w/w) microbeads were evaluated. 
Table 15. List of the injectable formulations tested. 
Formulation 
Composition of the liquid medium 
(to disperse 30% w/w microbeads) 
1 Alginate 4% w/V 
2 Alginate 3% w/V; hyaluronic acid 1% w/V 
3 Alginate 2% w/V; hyaluronic acid 2% w/V 
4 Chitlac 3% w/V 
5 Alginate 4% w/V; chitlac 1% w/V 
6 Alginate 3% w/V; chitlac 1% w/V 
In all the cases, except for formulations 1 and 2, a phase separation was observed, so all other 
formulations were discharged. Different syringes have been prepared dispersing microbeads with 
and without nAg (40% and ~30% w/w) in formulations 1 and 2. The best formulation was 
composed by 30% w/w microbeads dispersed in a mixed solution of alginate (3% w/V) and 
hyaluronic acid (1% w/V) (formulation 7). The mechanical tests revealed that the presence of 
hyaluronic acid led to a considerable decrease of the force required for the extrusion of the 
injectable filler, with an average compression load of 2 N (± 1N) required for the plunger to push 
the paste out of the syringe (Figure 66B, magenta line). This finding suggests that the addition of 
hyaluronic acid to the alginate-microbeads paste is able to lubricate the particles during the 
extrusion through the syringe, while implementing the bioactive properties of the injectable 
biomaterial. 
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 Implantation procedures and preliminary μ-CT evaluation 
Formulation 7 (microbeads 40% w/w dispersed in alginate/hyaluronic acid mixture 3% and 1% 
w/V respectively) has been used for the in vivo analysis. The evaluation of in vivo biocompatibility 
and osteoconductivity of fillers is based on a rabbit model of non-critical bone defects. Medial 
longitudinal defects have been created on the distal femur condyles as reported in Figure 69; these 
defects have been filled with the injectable formulations, with a positive control (HydroSet™, 
Stryker, NJ, USA) or left empty in order to compare the healing of treated defects with the normal 
healing rate of non-critical bone defects. The formulations tested showed to be easily injectable in 
the bone defects, achieving an optimal filling of defects, comparable with that of positive control. 
After implantation, animals showed a normal behavior, without movement impairing, infections or 
adverse and inflammatory reactions. 
 
Figure 69. Schematic representation of the in vivo study design. In 
each rabbit lateral (1 and 4) and medial (2 and 3) defect were created 
on both the condyles and randomly filled with the materials or the 
controls, so each rabbit received all the treatments. 
Following the indications reported by Urist et al.328 the animals have been euthanized 6 and 12 
weeks after implantation in order to evaluate: i) after 6 weeks: the earliest deposits of new bone 
from osteoprogenitor cells in the interior of well vascularized excavation chambers (that usually 
occurs at 4 to 6 weeks): ii) after 12 weeks: bone formation from proliferating connective-tissue 
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cells associated with vascularization calcification and replacement of the nests of cartilage by the 
typical route of endochondral ossification (that usually occurs at 8 to 16 weeks). 
At the explantation of the knees no adverse tissue reaction have been observed. Preliminary μ-CT 
data have been collected by analyzing the bone defects as showed is Figure 70. 
 
Figure 70. Schematic representation VOIs analyzed by μ-CT. 
Figure 71 reports the cross-section views of the reconstructed μ-CT VOIs (Volume Of Interest) of 
the explant after 6 and 12 weeks. From these images it is possible to appreciate the optimal defect 
filling achieved with the materials tested if compared to the positive control. 
 
Figure 71. Cross section view of μ-CT reconstruction of VOIs. Dark regions represent areas in which is 
not present mineralized material (bone tissue or tested materials) (scale bar = 1 mm). 
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A preliminary evaluation of the μ-CT data has been performed by measuring, after a segmentation 
process and the application of thresholds, the percentage of dark volume over the total VOI 
analyzed. These values are an estimation of the volume that is not occupied by mineralized material 
(implants or new bone tissue). The values are reported in Figure 72. 
 
Figure 72. Percentage of Dark Voxel Volume over the total VOI analyzed 
at 6 weeks (empty bars) and 12 weeks (filled bars) after the implantation. 
Values are expressed as median and 25th and 75th percentiles. 
From the graph reported in Figure 72 it is possible to observe that at 6 weeks the percentages of 
volume not occupied by mineralized matrix is comparable between void control and tested 
materials. Since Figure 71 shows that the defect are well filled by the tested materials, it is 
reasonable to think that the values at 6 weeks are affected by the low radio-opacity of the 
microbeads. Indeed, at 12 weeks, it is possible to appreciate similar values of volume occupied by 
mineral matrix between positive control and tested materials, which could suggest a possible 
regeneration of bone tissue in the presence of tested materials. 
Despite these preliminary good results, it is necessary to evaluate the histology of the explants in 
order to distinguish between implanted biomaterials and bone tissue and to confirm the 
regeneration of bone tissue. 
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3.3.2.3 Implementation of bioactive properties 
In order to tailor the bioactive properties of the alginate/HAp materials, the possibility of the 
addiction of bioactive components has been addressed. In preliminary experiments (data not 
showed) attempts to combine alginate and bovine tendon collagen have been performed. The 
difficulties to solubilize collagen and to mix it to alginate led to the choice of gelatin for the 
implementation of material bioactive properties. As discussed in the introduction, the denaturation 
process of collagen favors the exposition of RGD peptides and the decrease of collagen 
immunogenicity; moreover, it makes the gelatin more soluble and miscible with other 
polymers.55,56,60,61 
In order to analyze the effects of gelatin on alginate/HAp material stability and biological 
properties, microbeads and scaffolds have been prepared using three different concentrations of 
gelatin. 
The microbeads swelling and stability behavior has been analyzed, as previously reported, by 
soaking the microbeads in SBF and analyzing their diameter variation. Figure 73 shows that the 
microbeads are able to swell and uptake liquid form the environment and are stable over time. The 
swelling and stability behavior is different between these microbeads and the chitlac-containing 
microbeads, owing to the different macromolecular structure. 
 
Figure 73. Diameter changes during the swelling/stability experiment for 
control microbeads (■) and microbeads containing gelatin 0.05% (), 
gelatin 0.1% () and gelatin 0.2% (). 
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Microbeads stability has also been analyzed in terms of the release of gelatin from the polymer 
matrix. The experiments have been performed in saline solution and the gelatin has been quantified 
by micro BCA (bicinchoninic acid) assay. The graphs reported in Figure 74 shows that the amount 
of gelatin released from the microbeads is very low (< 5% over the total gelatin content) and it 
reaches a plateau after few days. Comparing the release profile with the swelling behaviour it can 
be hypothesized that the release of gelatin is due to the initial swelling of the microbeads and that 
after this initial swelling an equilibrium is reached. 
 
Figure 74. Gelatin release from microbeads containing gelatin 0.05% (■), gelatin 0.1% () and gelatin 0.2% () in 
saline solution expressed as percentage of the total gelatin contained: (A) release at given solution shift;  
(B) cumulative release. Data were averaged on three independent experiments. 
Finally, biological effects of gelatin-containing samples have been evaluated in vitro on osteoblasts 
grown into alginate/HAp/gelatin scaffolds. Data are reported in Figure 75 and show that there are 
no differences in the adhesion and proliferation of osteoblasts seeded in alginate/HAp scaffolds, 
with or without gelatin. 
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Figure 75. Proliferation rate of MG63 cells into alginate/HAp  
scaffolds (■) containing gelatin 0.05% (), gelatin 0.1% () and 
gelatin 0.2% (); the rate was measured normalizing the intensity 
values (I) obtained at days 3 and 7 on the first culture day (I0). 
Despite positive biological effects of gelatin have been reported for cells encapsulated in 
alginate/gelatin hydrogels,56 in this work it was not possible to point out any positive effect of 
gelatin addition. It will be necessary to further evaluate the biological effects of gelatin in terms of 
morphology and metabolic activity of adhered osteoblasts. 
3.3.3 CONCLUSIONS 
Porous composite scaffolds were developed from alginate/HAp hydrogels by exploiting different 
freezing techniques (CRIO and ISISA) that enable to tailor the pores morphology/dimension. Upon 
contact with fluids, these materials are able to rapidly uptake large amounts of water and to 
maintain a structural integrity for several weeks. Moreover, after rehydrating the dried material, 
the scaffolds are able to withstand high deformations without breaking and display a peculiar 
shape-recovery behavior, which appears particularly advantageous when positioning and adapting 
the biomaterial to the bone defect cavity. In vitro biological tests proved that, on both types of 
scaffolds, osteoblasts are able to proliferate and to produce extracellular matrix, as a proof of the 
favorable microenvironment (alginate/HAp) and of the suitable porous structures. Interestingly, 
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osteoblasts seeded on ISISAsc were able to penetrate and proliferate within the columnar aligned 
pores.  
The modified LDH employed, turned out to be a reliable method to evaluate the viability of cells 
in the presence of f-CNTs; the results so obtained demonstrated that for all dispersible (non-
aggregating) f-CNTs, no detrimental effect on the viability of osteoblast-like MG63 cells was 
detected over three days in the range of concentration tested. The f-CNTs, embedded in a 
tridimensional structure showed different biological properties: positively charged f-CNTs were 
not able to affect the adhesion and the proliferation of the osteoblasts, whereas the negatively 
charged f-CNTs hampered the osteoblasts growth. 
Microbeads based on hydroxyapatite, alginate, and chitlac-nAg were developed and characterized 
for the preparation of injectable bone fillers. The dried microbeads displayed a rapid swelling in 
contact with simulated body fluids and maintained their integrity for more than 30 days. The 
evaluation of silver leakage from the microbeads showed that the antimicrobial metal is slowly 
released in saline solution, with less than 6% of silver released after 1 week. In vitro antimicrobial 
tests proved that the microbeads displayed bactericidal effects toward S. aureus, P. aeruginosa and 
S. epidermidis and were also able to damage pre-formed bacterial biofilms. The microbeads did 
not exert any cytotoxic effect towards osteoblast-like cells, which were also able to colonize and 
proliferate on their surface. Upon suspension of the particles in alginate (or alginate/hyaluronic 
acid) solution, a homogenous and time-stable paste was obtained; mechanical tests enabled to 
quantify the extrusion forces from surgical syringes, pointing out the good injectability of the 
material. Moreover, the best injectable formulation has been successfully used for the in vivo 
evaluation of material biocompatibility and osteoconductivity on a rabbit model of non-critical 
bone defect. 
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4 CONCLUDING REMARKS 
The present work describes the preparation and the characterization of polysaccharide-based 
nanocomposite biomaterials for bone and neural tissue engineering. Several analyses have been 
performed in order to characterize and optimize the materials. Moreover, the effects of the presence 
of functionalized carbon nanotubes (f-CNTs) and silver nanoparticles (nAg) in the polymer-based 
constructs have been analyzed. 
4.1 CHARACTERIZATION OF FUNCTIONALIZED CARBON 
NANOTUBES (f-CNTs) DISPERSIONS AND NANOSYSTEMS 
Low Field-Nuclear Magnetic Resonance (LF-NMR) has been used, for the first time, for the 
characterization of the dispersibility and aggregation tendency of f-CNTs: it was possible to 
correlate the aggregation behavior of f-CNTs with the 2T  of water molecules and to discriminate 
the ability of different mediums (water, polymeric solutions, culture media) to disperse pristine and 
functionalized CNTs. Moreover, for well dispersible f-CNTs, a linear correlation between the water 
2r  and the f-CNTs concentration was found, suggesting that this technique could be used for the 
evaluation of the concentration of f-CNTs that, for example, are released from a material. 
The investigation of the effects of the f-CNTs presence in polymer matrices (performed by 
spectroscopical, rheological and mechanical analyses of alginate-based solutions and hydrogels) 
showed that LF-NMR is a very sensitive technique that can be profitably flanked to the commonly 
used techniques, for a comprehensive characterization of CNTs based materials. 
4.2 DEVELOPMENT OF A BRIDGING IMPLANT FOR THE SPINAL 
CORD INJURY TREATMENT 
Alginate and chitlac proved to be good candidates for the preparation of tridimensional porous 
structures to be employed in the development of a bridging implant strategy for the spinal cord 
injury treatment. Chitlac alone and in combination with alginate showed to be biocompatible and 
to improve the physiological activity of neural cells. Moreover, a synergistic effect of the 
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combination of chitlac and neurotrophine secreting engineered mesoangioblasts was observed on 
neural cell morphology and activity. Altogether these results set the bases for the preparation of 
alginate-based tridimensional scaffolds enriched with chitlac and with neurotrophines secreting 
cells for the restoring of the lost synapses in spinal cord injury. 
Alginate/chitlac scaffolds have been prepared with isotropic/spherical and aligned pores. The 
scaffold showed suitable properties for the employment in neural tissue engineering: in particular, 
swelling behavior and mechanical properties were found to be similar to the nerve tissue ones. In 
vitro experiments will be performed by seeding hippocampal-derived neurons on the scaffolds and 
analyzing their morphology and activity. 
The introduction of f-CNTs will be adopted as a strategy for the implementation of scaffold 
electrical conductive properties and bioactivity. In order to evaluate the biological effects of  
f-CNTs they have been combined with chitlac for the preparation of chitlac/f-CNTs coated glass 
substrates that will be used for the growth of hippocampal derived neurons. 
4.3 DEVELOPMENT OF FILLERS FOR NON-CRITICAL BONE DEFECTS 
HEALING 
The pore morphology of alginate/HAp scaffolds has been tailored by applying two different freeze-
drying techniques and the implications on stability, mechanical and biological properties of the 
constructs were analyzed. It was found that both structures possess similar stability and biological 
properties and different mechanical properties. Overall, both CRIOsc and ISISAsc represent 
advantageous solutions for the treatment of bone defects since they can be cut and press-fit into 
bone defects while maintaining shape and structural integrity. While isotropic scaffolds display 
higher mechanical properties, anisotropic scaffolds appear particularly suited to give a preferential 
directionality to cell colonization. 
Antimicrobial injectable bone fillers have been developed by dispersing alginate/HAp microbeads 
containing nAg in polysaccharide solutions. The microbeads showed good stability and proved to 
be biocompatible and to exert antibacterial activity. The formulations, prepared by dispersing the 
microbeads in alginate and hyaluronic acid solutions and mixtures, could be easily injected and 
preliminary results on an on a rabbit in vivo model of non-critical bone defects showed that the 
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injectable fillers are biocompatible and osteoconductive. Overall, this novel antimicrobial bone-
filler appears as a promising osteoconductive material for the treatment of bone defects, in 
particular when possible infections could compromise the bone-healing process. 
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5 MATERIALS AND METHODS 
5.1 MATERIALS 
LF1060 sodium alginate samples isolated from Laminaria hyperborea were provided by FMC 
BioPolymer AS (Norway). The (viscosity average) relative molecular mass (“molecular weight”, 
MW) was found to be approximately 120000 as determined by capillary viscosimetry according to 
Vold et al.338 The composition of the alginate sample was determined by means of 1H-NMR339,340 
and resulted to be FG = 0.68, FM = 1 - FG = 0.32, FGG = 0.57, FGM+MG = 0.22, FMM = 0.21,  
NG>1 = 14. K11675 sodium alginate samples isolated from Laminaria hyperborea was provided by 
Kerry Group (Ireland). The relative molar mass (“molecular weight”, MW) was found to be  
186600 ± 1100, as determined by capillary viscosimetry. The composition of this alginate sample 
was determined by means of 1H-NMR and resulted to be FG = 0.71, FM = 0.29, FGG = 0.55,  
FGM+MG = 0.31, FMM = 0.13, NG>1 = 12.2. FG and FM denote the mole fraction of alginate monomers 
as α-L-guluronic acid (G) and β-D-mannuronic acid (M), respectively, FGG indicates the fraction 
of G dimers, FMM indicates the fraction of M dimers and FGM+MG indicates the fraction of any mixed 
sequence of G and M (irrespective of sequence). NG>1 is the number-average number (?̅?𝑛) of  
G monomer in homopolymeric sequences having ?̅?𝑛 ≥ 2. 
Hyaluronic acid samples (MW 1500000) were provided by FMC BioPolymer AS (Norway). 
Highly deacetylated chitosan (residual acetylation degree approximately 16 % as determined by 
means of 1H-NMR), was purchased from Sigma-Aldrich (Chemical Co. USA). The relative MW 
of chitosan, determined by intrinsic viscosity measurements, was found to be around 690000.181  
Chitlac (lactose modified chitosan, CAS registry number 85941-43-1) was prepared according to 
the procedure reported elsewhere starting from highly deacetylated chitosan.181,192 The composition 
of chitlac was determined by means of 1H-NMR and resulted to be: glucosamine residue 27 %,  
N-acetylglucosamine 18 % and 2-(lactit-1-yl)-glucosamine 55 %. The calculated relative MW of 
chitlac is around 1.5 × 106.  
Hydroxyapatite (HAp) powder was from Fluka (U.S.A.). Silver nitrate (AgNO3), ascorbic acid 
(C6H8O6), CaCO3, δ-gluconolactone (GDL), LDH (lactate dehydrogenase)-based TOX-7 kit,  
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in-vitro toxicology assay (Resazurin based, Alamar Blue) TOX-8 kit, phosphate buffered saline 
(PBS), Luria–Bertani (LB) broth, LB Agar and Brain Heart Infusion (BHI) were purchased from 
Sigma-Aldrich (Chemical Co. USA). Trypsin/EDTA solutions, Fetal Bovine Serum (FBS), 
penicillin streptomycin 100X, l-glutamine 100X and Dulbecco’s modified Eagle’s medium 
(DMEM) were purchased from EuroClone (Milan, Italy). FilmTracer™ FM® 1-43 Green Biofilm 
Cell Stain and FilmTracer Live/Dead biofilm viability kit were purchased from Invitrogen 
(U.S.A.). CellTiter Aqueous One Solution cell proliferation assay kit (MTS assay) was from 
Promega (U.S.A.). ELISA kits for human osteocalcin and mouse galectin-1 quantification were 
purchased from Invitrogen (U.S.A.). All other chemicals were of analytical grade. 
5.2 PREPARATION OF POLYSACCHARIDES AND BIOMATERIALS 
5.2.1 CHEMICAL MODIFICATION OF POLYSACCHARIDES AND SYNTHESIS OF 
NANOSTRUCTURES 
5.2.1.1 Chemical modification of polysaccharides 
 Alginate-fluo  
200 mg of alginate LF1060 were dissolved in 70 mL of MES buffer (50 mM; pH 5.5.). 
Fluoresceinamine (1 mg/mL in methanol) was added to the alginate solution to label 1/500 of 
available carboxylic groups. Then an amount of EDC (1.5 times the monomeric units of alginate) 
and of NHS (1:1 with EDC) were added to the solution. The reaction mixture was stirred 2 hours 
at room temperature. Then the mixture was dialyzed (dialysis membrane Spectrapore,  
MWCO 12000) three times against NaHCO3 0.05 M, two times against NaCl 0.1 M and against 
deionized water until the conductivity of the external solution was below 2 μS/cm at 4 °C. All 
procedures were carried out under dark condition. The pH was adjusted to 6.8 – 7.2 and then the 
solution was filtered through 0.45 μm filters and freeze-dried. 
 Chitosan-fluo  
90 mg of chitosan in 30 mL of deionized water (pH was adjusted to 5.5 with HCl). Then 200 μL 
of a fluorescein isothiocyanate (FITC) solution (0.5 mg/mL in sodium carbonate buffer, 0.5 M) 
were added to the solution. The reaction mixture was stirred 24 hours at room temperature. Then 
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the mixture was dialyzed (dialysis membrane Spectrapore, MWCO 12000) three times against 
NaHCO3 0.05 M, two times against NaCl 0.1 M and against deionized water until the conductivity 
of the external solution was below 2 μS/cm at 4 °C. All procedures were carried out under dark 
condition. The pH was adjusted to 4.5 and then the solution was filtered through 0.45 μm filters 
and freeze dried. 
 Chitlac-fluo  
200 mg of chitlac were dissolved in 70 mL sodium carbonate buffer (0.5 M). 20 μL of a FITC 
solution in the same buffer (5 mg/mL) were added drop wise to the chitlac solution to label 1/2000 
of available amino groups. Then the mixture was dialyzed (dialysis membrane Spectrapore, 
MWCO 12000) three times against NaHCO3 0.05 M, two times against NaCl 0.1 M and against 
deionized water until the conductivity of the external solution was below 2 μS/cm at 4 °C. All 
procedures were carried out under dark condition. The solution was filtered through 0.45 μm filters 
and freeze dried. 
5.2.1.2 Functionalization of carbon nanotubes 
Multi-walled carbon nanotubes (MWCNTs) have been modified through two different kinds of 
reactions in order to achieve differently charged moieties on the carbon sidewall. Pristine 
MWCNTs (f0-CNT; diameter 20-30 nm, length 0.5-2 µm) have been purchased from 
Nanostructured & Amorphous Materials Inc., with a degree of purity greater than 95%. Pristine 
MWCNTs have been directly analyzed (f0-CNTs) or functionalized through the diazonium  
salt-based arylation reaction252 (f1-CNT), the 1,3-dipolar cycloaddition of azomethines ylides 
reaction254 (f2-CNT) and an oxidative reaction employing nitric acid
274 (f3-CNT). 
5.2.1.3 Preparation of silver nanoparticles 
Silver nanoparticles (nAg) were obtained by reducing silver ions with ascorbic acid in chitlac 
solution. Freeze-dried chitlac was dissolved in deionized water to obtain a 4 g/L solution. Silver 
nitrate (AgNO3) was added to chitlac at final concentration of 1 mM; then, ascorbic acid was added 
at final concentrations of 0.5 mM. The solution was kept for 4 hours at room temperature in 
darkness and then stored at 4 °C. 
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5.2.2 PREPARATION OF HYDROGELS AND SCAFFOLDS 
5.2.2.1 Alginate/f-CNTs hydrogels and scaffolds 
Homogeneous calcium hydrogels have been prepared by blending the alginate (K11675) solution 
(final concentration 2% w/V) with CaCO3 (30mM) followed by the addition of the slowly 
hydrolyzing GDL (60mM). Gels with f-CNT were prepared by adding the suspended f-CNTs to 
the slurry prior to the addiction of the GDL. The suspension was degassed prior to the addition of 
GDL to avoid bubble formation. The Ca-polymer gelling solutions were cured in 24 wells tissue 
culture plates (Ø = 16 mm, h = 18 mm) (Costar, Cambridge, MA) or in a Petri dish  
(diameter = 3 mm, h = 18 mm) (Sarstedt, Newton, NC) for the rheological and mechanical tests, 
and directly in NMR tubes for relaxometry experiments.  
For the preparation of f-CNTs alginate (K11675) scaffolds, HAp (final concentration 3% w/V) has 
been added to the alginate/f-CNTs solution. The reticulation has been triggered by the addiction of 
GDL and the Ca-polymer gelling solution was cured in 24 wells tissue culture plates (Ø = 16 mm, 
h = 18 mm) (Costar, Cambridge, MA). The hydrogels were then stepwise cooled by immersion in 
a liquid cryostat (circulating bath 28L, VWR, Radnor, PA, U.S.A.). Ethylene glycol in water (3:1) 
was used as refrigerant fluid. Temperature was decreased stepwise from 20 to -20 °C by 5 °C steps 
with 30 min intervals for equilibration; the samples were then freeze-dried (with an ALPHA 1-2 
LD plus freeze-drier, CHRIST, Osterode am Harz, Germany),  for 24 h to obtain porous scaffolds. 
This freezing process has been indicated as cryo-prepared isotropic, CRIO. 
5.2.2.2 Preparation of alginate/HAp scaffolds with different pore morphology 
Homogeneous calcium alginate hydrogels gels were prepared by blending the alginate (LF1060) 
solution (final concentration 2% w/V) with CaCO3 (30 mM) or HAp (0.5% w/V) followed by the 
addition of GDL (60 mM). In the former case, a perfectly transparent hydrogel was obtained, 
confirming the complete dissolution of CaCO3 (as anticipated by Ström et al.
341), corresponding to 
free Ca2+ 30 mM. On the contrary, only 30% of total HAp was solubilized by GDL (corresponding 
to a concentration of free calcium 15 mM), leaving a total of 0.35% w/V as solid component. The 
suspension was degassed prior to the addition of GDL to avoid bubble formation. The Ca-polymer 
gelling solutions were cured in 24 well tissue culture plates (diameter = 16 mm, height = 18 mm) 
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(Costar, Cambridge, MA) or in syringes of different diameters (9 mm; 13 mm; 15.5 mm)  
(NiPro, Belgium). The gels were taken out from the mold after 24 h for the compression tests or 
freeze casted to obtain the scaffolds. The hydrogels in the tissue-culture plate were freeze-casted, 
as explained in the previous paragraph, to obtain isotropic porous scaffolds (CRIOsc). The syringes 
were cooled following the Ice Segregation Induced Self Assembly (ISISA) process, by immersion 
in a liquid nitrogen bath (-196 °C) at different speed (16.2, 8.04 and 3.24 mm/min) using a syringe 
pump with tunable speed. The samples were freeze-dried for 24 h to obtain anisotropic porous 
scaffolds (ISISAsc). The specimens were cylindrical in shape with an average thickness of 18 mm 
and 60 mm, and diameter of 16 mm and 11 mm, for the CRIOsc and the ISISAsc (upon preparation 
within the syringe) respectively; after preparation, the scaffolds were cut into the desired 
dimensions depending on the specific analysis. 
5.2.2.3 Alginate/HAp scaffolds containing gelatin 
Homogeneous calcium alginate hydrogels gels were prepared by mixing alginate (LF1060) (final 
concentration 2% w/V) and gelatin (final concentration 0.05% w/V, 0.1% w/V, 0.2% w/V) at  
40° C in the presence of HEPES (final concentration 0.01 M) and NaCl (final concentration  
0.15 M). HAp (final concentration 3% w/V) has been added to the polymeric mixtures followed 
by the addition of GDL (60 mM). The Ca-polymer gelling solutions were cured in 24 well tissue 
culture plates (diameter = 16 mm, height = 18 mm) (Costar, Cambridge, MA). The hydrogels were 
then freeze-casted, as explained in the previous paragraph, to obtain isotropic porous scaffolds. 
5.2.2.4 Chitlac adsorption on alginate scaffolds 
In order to quantify the amount of chitlac adsorbed in the scaffolds, CRIOsc and ISISAsc prepared 
with CaCO3 (10 mm of diameter and height) have been incubated in chitlac-fluo (1.5 mL per 
scaffold, 0.2% w/V). At defined intervals of time, the solution was removed and the fluorescence 
was measured (λexc 485 nm, λem 520 nm, FLUOstar Omega, BMG LABTECH, Germany). The 
amount of adsorbed chitlac was calculated from the difference between the initial and the residual 
concentration of the chitlac-fluo solution, using a calibration curve obtained by solubilizing  
chitlac-fluo in water. 
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5.2.3 PREPARATION OF MICROBEADS 
5.2.3.1 Alginate/HAp/chitlac-nAg microbeads 
Microbeads were prepared following a well-defined protocol previously reported184,194 
Alginate/chitlac-nAg microbeads (nAg-MB) were obtained from alginate/chitlac-nAg mixtures 
(final concentrations: alginate (LF1060) 2% w/V, HAp 3% w/V, chitlac-nAg 0.2% w/V) in aqueous 
NaCl solution (final concentration 0.15 M) with HEPES (final concentration 0.01 M, pH 7.4). 
Control microbeads (MB) were prepared using chitlac 2 g/L (without nAg). The microbeads were 
obtained by dripping the polymer blend into a gelling solution (aqueous 0.05 M CaCl2). The droplet 
size was controlled by use of a high voltage electrostatic bead generator (7.5 kV, 162 mL/h, steel 
needle with 0.7 mm outer diameter, 1 cm distance from the needle to the gelling solution) according 
to a procedure previously described.184 The gel microbeads obtained were stirred for 30 min in the 
gelling solution, washed three times in deionized water and dried under air flux. Microbeads were 
sterilized for 1 h, under UV irradiation, before the use in the biological tests. 
5.2.3.2 Alginate/HAp/gelatin microbeads 
Alginate/gelatin microbeads were obtained from alginate/gelatin mixtures (final concentrations: 
alginate (LF1060) 2% w/V, HAp 3% w/V, gelatin 0.05% w/V, 0.1% w/V and 0.2% w/V) in 
aqueous NaCl solution (final concentration 0.15 M) with HEPES (final concentration 0.01 M,  
pH 7.4), solubilizing gelatin at 40 °C. The microbeads were obtained by dripping the polymer blend 
into a gelling solution (aqueous 0.05 M CaCl2) in the same conditions used for the preparation of 
nAg-MB. 
5.2.4 POLYSACCHARIDE COATING OF GLASS SUBSTRATES 
Glass coverslips (O. Kindler GmbH) were treated with Piranha solution  
(H2SO4 : H2O2 (30% w/w) = 3 : 1) at 80 °C for 1h, thoroughly washed with deionized water and 
methanol and finally air-dried. Chitlac was solubilized in HCl (until pH 4.5), chitosan was 
solubilized in acetic acid 0.02 M and alginate was solubilized in deionized water. All 
polysaccharide solutions have been used at the concentration of 0.5 w/V. For each coating step, 
200 μL of polymer solution were poured onto the activated glass coverslip. 
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In order to prepare the monolayer coated coverslips, after the activation with the piranha solution, 
chitlac or chitosan were placed on the coverslips. After 1 hour of incubation at room temperature, 
the excess of the solution was removed and the coverslips were washed twice for 1 hour with 
HEPES (10 mM, pH 7.4). The coverslips were washed with deionized water and air-dried. 
In order to prepare the mixed layer coated coverslips, after the activation with the piranha solution, 
chitlac or chitosan were placed on the coverslips. After 1 hour of incubation at room temperature, 
the excess of the solution was removed and the coverslips were washed with deionized water  
(pH 4.5) or acetic acid 0.02 M respectively and dried in air. Then alginate was placed on the chitlac 
or chitosan coated coverslips and incubated at room temperature for 1 hour. The excess was 
removed and the coverslips were washed with deionized water and air-dried. Finally, additional 
chitlac or chitosan solution was placed on the coverslips. After 1 hour of incubation, the excess of 
the solution was removed and the coverslips were washed twice for 1 hour with HEPES (10 mM, 
pH 7.4). The coverslips were washed with deionized water and air-dried. 
5.3 MORPHOLOGICAL, CHEMICAL AND PHYSICAL 
CHARACTERIZATION 
5.3.1 LOW FIELD NUCLEAR MAGNETIC RESONANCE (LF-NMR) 
LF-NMR characterization was performed by means of a Bruker Minispec mq20 (0.47 T). 
Transverse relaxation time (T2) measurements were performed at 25 °C according to Carr-Purcell-
Meiboom-Gill (CPMG) sequence with a 90°-180° pulse separation of 0.25 ms (number of scans 4; 
delay 5 s, from 500 to 1000 time intervals). The T2 discrete distribution was determined by fitting 
the experimental time (t) decay of the signal, related to the extinction of the x-y component of the 
magnetization vector (Mxy), with the sum of exponential functions (I(t)): 
𝐼(𝑡) = ∑ 𝐴𝑖𝑒
−𝑡 𝑇2𝑖⁄
𝑚
𝑖=1
                                                                                                                            (6) 
where Ai are the (dimensionless) pre-exponential factors proportional to the number of protons 
relaxing with the relaxation time T2i. This fitting allowed determining the different relaxation times 
(T2i) of the water molecules subpopulations in the sample with the respective spin density (A2i). 
MATERIALS AND METHODS 
 
128 
The chosen number of subpopulations was identified with that minimizing the product χ2*Np, 
where χ2 is data fitting chi-square value, and Np is the number of model parameters used, recalling 
that each exponential function introduced requires two parameters.279 2T  and 2r  are defined as: 
𝑇2 =
∑ 𝐴𝑖 ∙ 𝑇2𝑖𝑖
∑ 𝐴𝑖𝑖
     (7)               2r =
1
𝑇2
        (8) 
LF-NMR characterization has been performed on f-CNTs dispersed, at different concentrations, in 
deionized water, in complete culture medium (DMEM) and in salt-free aqueous alginate solution 
(2% w/V in deionized water), and on alginate/f-CNTs hydrogels. 
5.3.2 MORPHOLOGICAL ANALYSES 
5.3.2.1 Scanning Electron Microscopy of scaffolds and microbeads 
The microbeads were air-dried at room temperature for 24h and subsequently mounted on 
aluminum stubs covered with two-sides conductive carbon adhesive tape. Freeze-casted scaffold 
samples were sectioned at various planes mounted using the same set up used for microbeads.  
Next, the samples were sputtered with gold (Sputter Coater K550X, Emitech, Quorum 
Technologies Ltd, UK) and immediately analyzed by means of a scanning electron microscope 
(Quanta250 SEM, FEI, Oregon, USA) operated in secondary electron detection mode. The working 
distance was adjusted in order to obtain the suitable magnification; the accelerating voltage was set 
to 30 kV. 
5.3.2.2 Confocal Laser Scanning Microscopy of coated coverslips and microbeads 
Coated glass coverslips were prepared labeling only one of the polymers composing the coating. 
The coverslips were prepared in dark conditions and mounted on microscope slides.  
Microbeads have been prepared using the same protocol reported in the previous paragraphs, 
substituting chitlac with chitlac-fluo, in order to analyze the chitlac distribution within the 
microbeads. 
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IN order to analyze the distribution and the adsorption of the alginate contained in the dispersant 
solution, on the microbeads surface, microbeads (30% w/w) have been dispersed in an  
alginate-fluo solution (4% w/V). 
Images were taken with a Nikon Eclipse C1 microscope, with an objective Nikon Plan Fluor 20X 
(2.10 WD, dry) using an argon laser (488 nm) and an acquisition channel of 515/30 nm. Images 
were analyzed with ImageJ software. 
5.3.2.3 Micro-computed tomography 
X-ray microcomputed tomography of samples was obtained by means of a custom made cone-
beam system called TOMOLAB.342 Samples were positioned onto the turn-table of the instrument 
and acquisitions were performed with the following parameters: distance source-sample (FOD), 
100 mm; distance source-detector (FDD), 400 mm; magnification, 3.1×; binning, 2 × 2; resolution, 
8 μm; tomography dimensions (pixels), 1984 × 1024; slices dimensions (pixels), 1984 × 1984; 
number of tomographies, 1440; number of slices, 864; E = 40 kV, I = 200 μA; exposure time,  
1.8 s. The slices reconstruction process was achieved by means of commercial software (Cobra 
Exxim). Input projections and output slices are represented by files (one file per projection and one 
file per slice) using arrays of 16-bit integers. Custom produced MatLab code has been used to get 
a proper segmentation of the slices using Otsu’s method343 and to obtain numerical values of 
structural features like porosity, interconnection, pore, and trabecular size by means of parallel 
plate model.344 
5.3.2.4 Atomic Force Microscopy (AFM) 
AFM images have been acquired using a MFP-3D Stand Alone AFM (Asylum Research,  
Santa Barbara, CA). Measures were carried out at 25 °C working in dynamic mode. High-
resolution images (1024 × 1024 pixels frames) were acquired at 0.75 lines/s scan speed. The 
polysaccharide coating thickness has been measured after removing the coating with a scratch. 
5.3.2.5 Contact angle and surface energies 
Contact angles of the surfaces were measured using a Microscope Leica MZ16 equipped with a 
camera Leica DFC320 using the sessile drop method.345 Both polar (ultrapure water and ethylene 
glycol) and apolar (ultrapure di-iodomethane) liquids were used in order to allow surface energy 
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calculations. A droplet of liquid (4 μL) was placed on the surface. The profile of the water drop on 
the surface was recorded after 10 s to avoid time-dependent angle variations among samples. 
Contact angles were measured by means of an image analysis software (Image Pro Plus 6.2). For 
statistical analysis, 10 measurements for each surface type were averaged. The surface energy 
parameters were calculated from the contact angle values of the probe liquids according to the 
acid−base method proposed by Van Oss:291 briefly, the values of the contact angles of the three 
liquids were used in the Young−Duprè equation ((1 + cos θ)γl= 2[(γsLW γlLW )1/2 + (γs+ γl− )1/2 + 
(γs− γl+ )1/2]), which enables to calculate the values of the Lifshitz-van der Waals contribution of 
surface tension γLW and the acid−base (AB) components γ+ and γ− of the material. The surface 
polarity was calculated as the ratio between the AB contribution and the total surface tension (γtot 
= γLW + γAB, where γAB= (γs+ γl− )1/2). Considering the thermodynamic work of adhesion between 
surface and liquids, the total work is given by WT= WAB + WLW where WAB = (1 + cos θ)γl - 2[(γsLW 
γlLW)1/2 and WLW=2[(γsLW γlLW)1/2, while the WAB% is obtained by dividing WAB by WT. More 
details on the calculations can be found in Travan et al.195 
5.3.3 SWELLING, DEGRADATION AND RELEASE STUDIES 
5.3.3.1 Preparation of Simulated Body Fluid 
Evaluation of the in vitro scaffold stability was performed with SBF346 with a pH of 7.40 and ion 
concentrations nearly equal to those of human blood plasma (Na+ 142.0, K+ 5.0, Mg2+ 1.5,  
Ca2+ 2.5, Cl− 147.8, HCO3
− 4.2, HPO4
2− 1.0, SO4
2− 0.5 mM). The SBF was prepared by dissolving 
reagent-grade chemicals of NaCl, NaHCO3, KCl, K2HPO4, MgCl2·6H2O, CaCl2, Na2SO4 in 
distilled water and buffering at a pH of 7.40 with tris(hydroxymethyl)aminomethane 
(CH2OH)3CNH2 and 1.0 M HCl at 36.5 °C. 
5.3.3.2 Swelling and degradation behavior of scaffolds 
Scaffold specimens were cylindrical in shape with an average thickness of 4 mm and diameter of 
16 mm and 11 mm for the CRIOsc and the ISISAsc respectively. The swelling behavior was 
quantified by measuring the changes in sample weight as a function of sample immersion time in 
SBF. Wet weights were determined after blotting with a filter paper to remove the surface liquid 
and the swelling ratio was calculated using the Equation (9): 
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𝐸𝑠𝑟(%) = (
𝑊𝑠 − 𝑊𝑑
𝑊𝑑
) × 100                                                         (9) 
where Esr is the amount of absorbed water (weight percent) by the polymer matrix, and Wd and Ws 
are the weights of the samples in the dry and the swollen state, respectively. The results were taken 
as the mean values of three measurements. The dimensions of the dried scaffolds, and of the 
rehydrated scaffolds (at the end of the experiment) were measured with a caliper. 
Structural stability and integrity in SBF was evaluated during 5 weeks at 37 °C. The samples were 
immersed in 8 mL of SBF. Wet weight was measured after 10 min equilibration and at 7, 14, 21, 
28 and 35 days of immersion after blotting on filter paper. Soaking SBF was changed after each 
measurement. Weight variation was calculated using the Equation (10): 
𝑤𝑒𝑖𝑔ℎ𝑡 𝑣𝑎𝑟𝑖𝑎𝑡𝑖𝑜𝑛 (%) = (1 −
𝑊𝑡𝑛
𝑊10𝑚𝑖𝑛
) × 100                                                  (10) 
where Wtn and W10min are the wet weights of the samples at the defined time and after 10 min of 
swelling, respectively. 
5.3.3.3 Swelling and stability of microbeads 
Each test was performed in triplicate on a known number of beads (70-100 range). The diameter 
variation of the microbeads was measured by collecting the images with a Pentax K100D camera 
mounted on an optical microscope (Olympus CK 2, Tokyo, Japan); the diameter of beads 
population was measured by means of an image analysis software (ImageJ, U.S.A.). The 
microbeads were analyzed every two days from the beginning of the swelling experiment. The 
soaking solution was changed every two days. 
5.3.3.4 Evaluation of silver content and silver release 
The total amount of silver in the nAg-MB and released from nAg-MB, soaked in saline or in 
deionized water, was determined by Inductively Coupled Plasma - Optical Emission Spectroscopy 
(ICP-OES) using an Optima 8000 ICP-OES Spectrometer (PerkinElmer, USA) equipped with an 
S10 Autosampler (PerkinElmer, USA). The analysis were conducted using a calibration curve 
obtained by dilution (range: 0–10 mg/L) of a silver standard solution (10.015 mg/mL) for ICP-OES 
analyses (Sigma-Aldrich, USA). The limit of detection (LOD) at the operative wavelength of 
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328.068 nm was 0.016 mg/L. The precision of the measurements as relative standard deviation for 
the analysis was always less than 5%. 
The total amount of silver in the nAg-MB (ng Ag/mg beads) was measured upon treatment with 
concentrated H2SO4 and solubilization with concentrated HNO3. About 9 mg of microbeads were 
degraded in 60 µL of H2SO4, than the volume was adjusted to 1.2 mL with HNO3 to ensure the 
solubilization of silver precipitates. At the end, the volume was adjusted to 5 mL with deionized 
water. The average amount of silver was calculated as the mean of silver quantity measured in three 
samples. 
For the quantification of silver released from the nAg-MB, about 50 mg of sample were incubated, 
in agitation, with a volume ratio solution/microbeads of 10. Every 24 h, supernatants from the 
microbeads suspensions were collected and analyzed and fresh solution was added to the 
microbeads. After the last solution change, the microbeads were washed with filtered deionized 
water to recover all the precipitated silver salts; the solution was then filtered (0.22 µm) and 
collected. 
5.3.3.5 Calcium release from scaffolds 
The total amount of calcium released from the scaffolds soaked in saline, was determined by  
ICP-OES, using the same equipment described before. The analysis were conducted using a 
calibration curve obtained by dilution (range: 0–100 mg/L) of a calcium standard solution  
(10 mg/mL) for ICP-OES analyses (Sigma-Aldrich, USA). The LOD at the operative wavelength 
of 317.933 was 0.02 mg/L. The precision of the measurements as relative standard deviation for 
the analysis was always less than 5%. 
For the quantification of calcium released from the scaffolds, about 40 mg of sample were 
incubated, in agitation, with a volume ratio solution/scaffolds of 10. Every 24 h, supernatants were 
collected and analyzed and fresh solution was added to the scaffolds. 
5.3.3.6 Release of gelatin from microbeads 
For the quantification of the total content of gelatin, 300 mg of microbeads of each type were 
degraded in 50 mL of solving buffer (sodium citrate tribasic 0.05 M, NaCl 0.1 M, pH 7.4). The 
solution was then centrifuged at 16000×g for 5 min and the gelatin was quantified in the 
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supernatants after dilution 1:10 in NaCl 0.15 M. For the quantification of gelatin released from the 
microbeads, 300 mg of microbeads were incubated in agitation with 10 mL of NaCl 0.15 M. Every 
24 h, supernatants were collected and analyzed and fresh solution was added to the microbeads. 
Gelatin contained in the solutions obtained from the microbeads degradation and from the release 
experiments, has been quantified using Micro BCATM Protein Assay Kit (Thermo Fisher Scientific, 
Milan, Italy) using a calibration curve obtained by solubilizing gelatin in NaCl 0.15 M at the 
concentrations indicated in the kit protocol. 
5.3.3.7 Release of chitlac from alginate scaffolds 
For the quantification of chitlac released from the scaffolds, CRIOsc and ISISAsc scaffold samples 
containing chitlac-fluo (10 mm of diameter and height) were incubated in agitation with 5 mL of 
NaCl 0.15 M. Every 24 h, supernatants were collected and their fluorescence measured  
(λexc 485 nm, λem 520 nm, FLUOstar Omega, BMG LABTECH, Germany) and fresh solution was 
added to the scaffolds. Chitlac-fluo has been quantified using a calibration curve obtained by 
solubilizing chitlac-fluo in NaCl 0.15 M. 
5.3.4 MECHANICAL CHARACTERIZATION OF MATERIALS. 
5.3.4.1 Steady state shear flow viscosity and mechanical spectroscopy 
Rheological characterization was performed by means of a controlled stress rheometer Haake 
Rheo-Stress RS150, operating at 25 °C. To avoid water evaporation from the systems, the 
measurements were led in a water saturated environment realized by using a glass bell (solvent 
trap) containing a wet cloth. 
The linear viscoelastic range was determined for each sample by means of a stress sweep test 
consisting in measuring elastic (G') and viscous (G'') moduli variation with increasing shear stress 
(1 Pa < τ < 103 Pa) with a solicitation frequency of 1 Hz. 
The analysis of the hydrogels was performed using a shagreened plate and plate apparatus (HPP20 
profiliert: diameter = 20mm) as measuring device. The gap between the two plates was determined 
for each sample through a series of short stress sweep tests (f = 1 Hz; stress range 2-5 Pa; maximum 
deformation < 0.02%) until a constant value of the elastic modulus G' was achieved avoiding 
MATERIALS AND METHODS 
 
134 
excessive gel squeezing. The mechanical spectrum of hydrogels was determined by measuring the 
elastic (G') and viscous (G'') moduli variation in the frequency range from 10 to 0.01 Hz at constant 
shear stress τ = 4 Pa, well within the linear viscoelastic range that spans up to at least 50 Pa. 
The analysis of the solutions was performed using a plate and cone apparatus (C60/1°) as a 
measuring device. The Newtonian plateau and the non-linear region were determined for each 
solution by steady state shear flow experiments with the applied shear stress ranging from 0.1 to 
100 Pa. 
5.3.4.2 Uniaxial compression tests of hydrogels and scaffolds 
Compression tests have been performed with an Universal Testing Machine (Mecmesin MultiTest 
2.5-I) equipped with a 100N Load Cell. A constant compression speed of 6 mm/min was used up 
to sample failure. For each type of hydrogel, 7 replicates were averaged. The compression modulus 
(E), the Ultimate Compression Strength (σUCS), the deformation at break and the toughness were 
determined. The compressive modulus was calculated from the initial linear range of the stress 
strain curves (from 2 to 5% of strain). The hydrogels were compressed up to sample failure, while 
the rehydrated scaffolds were compressed until 60% of strain 
The cyclic loading tests were performed by applying 10 cycles of compression (with a constant 
load of 2.5 N and 1 N for CRIOsc and ISISAsc scaffolds respectively) at 6 mm/min followed by 
the removal of the load and a pause time of 2 min to allow uptake of the water loss and the shape-
recovery of the scaffolds. The CRIOsc have been analyzed as prepared, while the ISISAsc were 
cut to obtain a height of 12.4 mm, to ensure the same aspect ratio (1.125) of CRIOsc. The 
rehydration of the scaffolds have been performed in deionized water at room temperature for  
2 hours. 
5.3.4.3 Preparation of the injectable bone-filler and injectability evaluation 
The microbeads (30%w/w) were dispersed in the polysaccharide solution and transferred into 
syringes (1 mL, nozzle diameter 2 mm, Chemil, Italia). The solution was composed either by 
alginate (4% w/V) or by a mixture of alginate (3% w/V) and hyaluronic acid (1% w/V).  
The injectability tests were performed by applying an axial compression load to the syringe plunger 
by means of a Universal Testing Machine (Mecmesin MultiTest 2.5-I) coupled with a 100 N load 
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cell, applying a compression rate of 15 mm/min, along 50 mm of plunger displacement and 
recording the load applied. For each formulation, 5 replicates have been used, the average load in 
the plateau region was measured and standard deviations calculated. 
5.4 BIOLOGICAL CHARACTERIZATION 
5.4.1 ANTIBACTERIAL PROPERTIES OF nAg-MB 
The antibacterial activity of nAg-MB was evaluated using strains of Staphylococcus epidermidis 
(ATCC® 12228TM), Staphylococcus aureus (ATCC® 25923TM) and Pseudomonas aeruginosa 
(ATCC® 27853TM), and using MB as a control. 
5.4.1.1 Growth inhibition assay 
Bacterial suspensions were prepared by adding 20 µL of bacteria, preserved in glycerol, to 5 mL 
of LB broth. The obtained suspensions were incubated overnight at 37 °C. After 24 h, 500 µL of 
bacterial suspension was diluted in 10 mL of broth and grown up for 90 min at 37 °C in order to 
restore an exponential growth phase. Bacterial concentration was measured by means of optical 
density (OD) at 600 nm. The bacterial suspension was then diluted in 10 % (v/v) LB broth in PBS 
to obtain a final concentration of 106 bacteria/mL. 1 mL of bacterial suspension was added to each 
microbeads sample (50 mg). S. aureus and P. aeruginosa were incubated at 37 °C for 4 h,  
S. epidermidis for 24 h. Tests were carried out in shaking condition at 140 revolutions per minute 
(rpm). At the end of incubation, bacterial suspension was collected and serially diluted in PBS 
(from 10-1 to 10-5) and 25 µL of each suspension were plated on LB agar. After overnight incubation 
at 37 °C, the colony forming units (CFU) were counted. Outcomes were compared with a 
suspension of bacteria grown in liquid medium as control. Data are reported as the mean of three 
independent determinations. 
5.4.1.2 Biofilm formation 
Bacterial suspensions of S. aureus and P. aeruginosa were prepared by adding 20 µL of bacteria, 
preserved in glycerol, to 5 mL of BHI broth enriched with 3% w/v sucrose. The obtained 
suspensions were incubated overnight at 37 °C. After 24 h, bacteria were diluted 1:100 in the same 
broth and plated (200 µL/well) into 96-well plates. For confocal laser scanning microscopy 
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analyses, bacteria were plated on sterile 13 mm tissue culture coverslips (Sarstedt, USA) placed on 
the bottom of culture plate wells. Plates were incubated at 37 °C for 24 h allowing biofilm 
formation. After 24 h, broth was removed and formed biofilm was carefully rinsed with 100 µL of 
sterile PBS in order to remove non-adherent cells. 200 µL of 10% LB in PBS were then added to 
each well and microbeads were deposited on the bacterial layer. Biofilms treated with microbeads 
were then incubated at 37 °C for 4 h; then the viability of the biomass was assessed, as described 
in the following paragraph.  
5.4.1.3 Viable biomass assessment 
The test was performed staining the biofilm with the FilmTracer™ FM® 1-43 Green Biofilm Cell 
Stain. The staining solution was prepared by diluting 10 μL of stock solution into 990 μL of DMSO, 
followed by diluting 100 μL into 0.9 mL of filter-sterilized water. After the biofilm incubation 
period, microbeads and medium were gently removed from the plates and each well was carefully 
rinsed with filter-sterilized deionized water, in order to remove non-adherent cells. 20 µL of 
staining solution were placed into each well and the plates were incubated for 30 minutes under 
lightproof conditions at room temperature. After the incubation period, each well was washed with 
filter-sterilized deionized water; then 80 µL of deionized water were added and the fluorescence 
was read with a spectrofluorimeter (λexc 485 nm, λem 520 nm, FLUOstar Omega, BMG LABTECH, 
Germany). Outcomes were expressed as fluorescence units. 
5.4.1.4 Live/Dead biofilm viability 
Confocal laser scanning microscopy (CLSM) studies were addressed at detecting viability/death 
of bacteria grown in the biofilm community. FilmTracer Live/Dead biofilm viability kit was used. 
Dead cells were stained by propidium iodide, (red fluorescence: λexc 514 nm; λem 590 nm) whereas 
live cells by SYTO® 9 (green fluorescence: λexc 488 nm; λem 515 nm). Staining was performed on 
biofilms grown on coverslips as described above, according to the manufacture’s protocol. Images 
were acquired on a Nikon Eclipse C1si confocal laser-scanning microscope with a Nikon Plan 
Fluor 20× as objective. Resulting stacks of images were analyzed using ImageJ software. 
MATERIALS AND METHODS 
 
137 
5.4.2 IN VITRO CHARACTERIZATION OF MATERIALS ON OSTEOBLASTS 
Osteosarcoma MG-63 (ATCC® CRL-1427) human cell line was cultured in DMEM high glucose 
(Euro-Clone, Italy), 10 % heat-inactivated fetal bovine serum (Sigma Aldrich, Chemical Co. USA), 
100 U/mL penicillin, 100 µg/mL-1 streptomycin and 2 mM L-glutamine in a humidified 
atmosphere of 5 % CO2 at 37 °C. 
5.4.2.1 Modified lactate dehydrogenase test on f-CNTs 
Cytotoxicity of dispersed f-CNTs at different concentration was evaluated on MG63 cells with a 
modified version of the lactate dehydrogenase cytotoxicity assay (SIGMA TOX-7LDH assay).319  
f-CNTs were used as sterile stock solutions at 1 mg/mL in water. Stock dispersions were sonicated 
for 30 min prior to use in cell culture studies and used at final concentration of 10, 50 and  
100 µg/mL diluting the stock solution in complete DMEM. 500 µL of f-CNTs/DMEM solutions 
were used for each well. Cells were seeded into 24-well plates (30000 cells per well) and incubated 
24 hours before the cytotoxicity test. The experiments were performed in triplicate. Cells were than 
incubated for 24 and 72 hours with f-CNTs (f1, and f3) diluted with medium at the different 
concentrations After 24 and 72 hours the medium was removed and cells were lysed with 10 μL of 
lysis buffer (of the SIGMA TOX-7 kit) mixed with 100 μL serum free media for 45 min at 37 °C. 
The cell lysate was then diluted with 800 µL of serum free media and centrifuged at 16100×g for 
5 min to allow the precipitation of the f-CNTs. 45 μL of the supernatant was mixed with 90 μL of 
LDH substrate mix in a 96-well plate and incubated for 20 min at R.T. in light-proof conditions. 
The colorimetric reaction was quenched by adding 13.5 μL of HCl 1N. The absorbance was 
measured at 490 nm (A490) and 690 nm (A690), with a Tecan Nano Quant Infinite M200 Pro plate 
reader. The proliferation rate of the cells was calculated using the following equation: 
𝑃𝑟𝑜𝑙𝑖𝑓𝑒𝑟𝑎𝑡𝑖𝑜𝑛 𝑅𝑎𝑡𝑒 =
(𝐴490−𝐴690𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑎𝑛𝑑 𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠) − (𝐴490−𝐴690𝑚𝑒𝑑𝑖𝑢𝑚 𝑎𝑙𝑜𝑛𝑒)
(𝐴490−𝐴690𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠) − (𝐴490−𝐴690𝑚𝑒𝑑𝑖𝑢𝑚 𝑎𝑙𝑜𝑛𝑒)
     (11) 
5.4.2.2 Lactate dehydrogenase test on microbeads 
In vitro cytotoxicity of nAg-MB was evaluated by using lactate dehydrogenase cytotoxicity assay 
(SIGMA TOX-7LDH assay), and using MB as a control. UV-sterilized microbeads were placed in 
Dulbecco’s modified Eagle’s medium, inactivated fetal bovine serum 10 %, penicillin 100 U/mL, 
MATERIALS AND METHODS 
 
138 
streptomycin 100 µg/mL and L-glutamine 2 mM for 24 h. After 24 h of incubation, the cytotoxicity 
test was performed by direct contact of the cells with the swollen microbeads (20 mg per well). 
Cells were seeded into 24-well plates (30000 cells per well) and incubated 24 hours before the 
cytotoxicity test. The experiments were performed in triplicate. Cells were than incubated for  
24 and 72 hours with microbeads. After 24 and 72 hours, the medium was collected and the test 
was performed following the manufacturer’s protocol. The absorbance was measured at 490 nm 
and 690 nm, with a Tecan Nano Quant Infinite M200 Pro plate reader. The cytotoxicity was 
calculated using the following equation: 
% 𝐿𝐷𝐻 𝑟𝑒𝑙𝑒𝑎𝑠𝑒 = 100 ×
(𝐴490−𝐴690𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠) − (𝐴490−𝐴690𝑚𝑒𝑑𝑖𝑢𝑚)
(𝐴490−𝐴690𝑐𝑒𝑙𝑙 𝑙𝑦𝑠𝑎𝑡𝑒) − (𝐴490−𝐴690𝑚𝑒𝑑𝑖𝑢𝑚)
                  (12) 
normalizing the values for the total LDH of the control cell lysate. Polystyrene (PS) was used as a 
negative control; zinc embedded polyurethane (PU/Zn) membrane was used as positive control.  
5.4.2.3 Viability of osteoblasts seeded into alginate scaffolds 
For cell seeding onto scaffolds, porous freeze-casted scaffolds (prepared with HAp 0.5% w/V, 
gelatin or f-CNTs) were cut to obtain samples with similar dimension (diameter = 11 mm;  
height = 10 mm), sterilized under UV light (3 × 20 minutes), rehydrated in 5 mM CaCl2 for 10 
minutes and immersed in complete cell culture medium for 24 h in 24-well culture plates to ensure 
chemical equilibration. Osteosarcoma cells, suspended in 40 L of medium, were loaded on the 
scaffolds. After 4 h, the scaffolds were placed into fresh, sterile 24-well culture plates and 1.5 mL 
of complete medium was added. 
The viability and growth rate of MG63 osteosarcoma human cell line on Alg/HAp scaffolds was 
assessed as a function of time using the MTS assay according to the protocol provided by the 
manufacturer (CellTiter Aqueous One Solution cell proliferation assay kit from Promega).  
40000 cells suspended in 40 µL of culture medium were seeded on UV-sterilized scaffolds and 
incubated at 37 °C in a humidified air atmosphere of containing 5% CO2. MTS assays were 
performed at different endpoint from cell seeding. Briefly, after 4 h of incubation with the MTS 
reagent in a humidified 5% pCO2 atmosphere, the medium was collected from the scaffolds and 
absorbance was measured with a Nano Quant Infinite M200 Pro (Tecan, Swiss) plate reader at a 
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wavelength of 490 nm. The background absorbance obtained from an empty scaffold (blank) was 
subtracted from the sample values. 
5.4.2.4 Cell imaging by Scanning Electron Microscopy 
Scaffolds seeded with cells were rinsed with 10 mM HEPES, pH 7.4, containing 10 mM CaCl2, 
100 mM NaCl, and 5 mM glucose and fixed with 10% glutaraldehyde in PBS for 1 h at room 
temperature. Samples were then washed three times with the same buffer described above, 
dehydrated by stepwise treatment with ethanol, and finally dried with a critical point dryer,  
sputter-coated with gold, and visualized by electron microscopy. 
5.4.2.5 Cell viability on microbeads 
UV-sterilized microbeads (nAg-MB and MB) were incubated in complete DMEM for 72 h. About 
10 microbeads were put in each well of a Microtest Plate 96-well (Sarstedt, non-treated for cell 
adhesion); 5000 cells were placed in each well and left for 24 h in a humidified atmosphere of 5 % 
CO2 at 37 °C. Cellular adhesion and growth were tested by means of Alamar Blue™ assay: 
microbeads were washed with PBS and incubated with 100 uL of 10% Alamar Blue™ in DMEM, 
for 5 hours in darkness, at 37°C. After the time indicated the medium was removed from each well 
and replaced with fresh medium; the fluorescence of the collected medium was measured  
(λexc= 544 nm; λem= 590 nm) with a spectrofluorimeter (FLUOstar Omega, BMG LABTECH, 
Germany). As a control, beads without cells were incubated at the same conditions and analyzed.  
5.4.2.6 Determination of alkaline phosphatase activity 
A suspension of MG63 cells (100000 cells) was seeded on the scaffolds and maintained in culture 
in complete medium at 37 °C in a 5% pCO2 atmosphere. At different days, scaffolds were washed 
at r.t. for 30 min in a buffer 10 mM HEPES, pH 7.4, containing 10 mM CaCl2, 100 mM NaCl, 5 
mM glucose, and finally dissolved in a sodium citrate solution (50 mM sodium citrate, 100 mM 
NaCl, 10 mM glucose, pH 7.4). Cells were collected by centrifugation at 800 rpm for 5 minutes 
and lysed in a TritonX-100 solution (0.2% w/w TritonX-100 in 100 mM Tris/HCl buffer, pH 9.8) 
keeping them for 30 minutes at -80 °C and transferring at 37 °C for two times. Enzymatic activity 
was measured in a solution of 6 mM para-nitro-phenyl-phosphate and 1 mM MgCl2 in  
Tris-HCl, 100 mM, pH 9.8, after 60 min of incubation at 37 °C. Absorbance was measured at 410 
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nm with a Tecan Nano Quant Infinite M200 Pro plate reader. The results were normalized to the 
amount of protein content in the cellular extract calculated by means of BCA method according to 
the manufacturer’s protocol (Sigma). All tests were performed in quadruplicate. 
5.4.2.7 Quantification of osteocalcin expression 
40000 cells suspended in 40 µL of culture medium were seeded on UV-sterilized scaffolds 
(CRIOsc and ISISAsc containing 0.5% w/V HAp) and incubated at 37 °C in a humidified air 
atmosphere of containing 5% CO2. At 1, 7, 14, 21 days culture medium was harvested and the 
osteocalcin was quantified using the Osteocalcin ELISA Kit, Human (Thermo Fisher Scientific, 
Milan, Italy), according to the protocol, and normalizing the values for the viability data, 
determined by MTS assay (as described in the previous paragraph). 
5.4.3 IN VITRO CHARACTERIZATION OF MATERIALS ON NEURAL CELLS 
5.4.3.1 Cell cultures and co-cultures on coated coverslips 
Primary cultures of hippocampal neurons were obtained from postnatal (P2-P3) rat pups (of either 
sex) as previously reported.99,238,347,348 Briefly, hippocampi were isolated from the rest of the brain 
and cells were dissociated enzymatically and mechanically. Cells were plated (150 μl of cell 
suspension) on three different substrates: Chitosan monolayer, chitlac monolayer and 
chitlac/alginate three-layers (see Material synthesis). Plating was carried out at a nominal density 
of 200000 ± 16000 cells/mL (n=4 different series of cultures) meaning that ~ 30000 cells were 
plated on each coverslip (12 x 24 mm2, 0.13-0.16 mm thick, Kindler, EU). Cultures were incubated 
at 37ºC, in a humidified atmosphere with 5% CO2 in culture medium, consisting of MEM (Gibco) 
supplemented with 35 mM glucose (CarloErba Reagents), 15 mM HEPES, 1 mM Apo-Transferrin, 
48 μM Insulin, 3 μM Biotin, 1 mM Vitamin B12 (Sigma-Aldrich) and 500 nM Gentamicin (Gibco) 
in the presence of 10% dialysed fetal bovine serum (FBS, Invitrogen). Culture medium 
(supplemented with the proliferation inhibitor cytosine arabinoside (Ara C) and with a lower 
concentration of serum (5%)) was renewed (~60%) after two days from seeding and hereafter 
changed every two days. Cultures were then used for experiments after 8-10 days in vitro. 
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D7 motor neuron (MN) progenitors were derived from embryonic spinal cord as described by Su 
et al.123 Cells were cultured as neurospheres in DMEM/F12 medium supplemented with B27 
(Invitrogen), EGF and bFGF (20 and 10 ng/ml, respectively; Peprotech) (growing medium) in a 
humidified incubator at 37°C in 5% CO2.  
To assess for differentiation, neurospheres were dissociated into single cells and transferred onto 
chitosan, chitlac or chitlac/alginate glass coverslips (12 mm diameter) in differentiating medium 
(growth medium without EGF and FGF) at 50000 cells density, in co-culture with control or 
neurotrophins producing MABs at the same cell density. Seven days after plating, cultures were 
fixed in 4% paraformaldehyde and processed for immunocytochemistry.   
GFP-expressing MABs D16 were grown in DMEM plus 10% FBS as described by Galvez et al.349 
NGF-expressing MABs (D16-NGF, clone F10) and BDNF-expressing MABs (D16-BDNF, clone 
A9) have been obtained upon stable transfection of D16 cells and single clone selection, as 
described in Su et al.123 F10 and A9 MABs produce 36 ng/ml/day/106 cells of NGF and  
30 ng/ml/day/106 cells of BDNF, respectively. 
In co-culture between primary neurons and control or neurotrophines producing MABs, 
hippocampal neurons were cultured as previously described. A 1:1 ratio between the two cell 
populations was maintained. Therefore, 30000 cells for each type of MABs were dissolved into the 
dissociated hippocampal neuron medium. These co-cultures were tested on the chitlac/alginate 
substrate. In this set of experiments control, D16-MABs, A9-MABs BDNF and F10-MABs NGF 
refer to dissociated hippocampal cultures alone, co-culture with control MABs, co-culture with 
BDNF-producing MABs and co-culture with NGF-producing MABs, respectively. 
All animal procedures were conducted in accordance with the National Institutes of Health, 
international and institutional standards for the care and use of animals in research, and after 
consulting with a veterinarian. All experiments were performed in accordance with the EU 
guidelines (2010/63/UE) and Italian law (decree 26/14) and were approved by the local authority 
veterinary service. All efforts were made to minimize animal suffering and to reduce the number 
of animal used. Animals use was approved by the Italian Ministry of Health, in agreement with the 
EU Recommendation 2007/526/CE. 
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5.4.3.2 Electrophysiological recordings 
For patch clamp recordings (whole-cell, voltage clamp mode), the samples were positioned in a 
recording chamber, mounted on an inverted microscope and continuously superfused with control 
Krebs solution containing (in mM): 150 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES and 10 glucose. 
The pH was adjusted to 7.4 with NaOH (osmolarity 300 mOsm). Cells were patched with pipettes 
(4-7 MΩ) filled with a solution of the following composition (in mM): 120 K gluconate, 20 KCl, 
2 MgCl2, 2 Na2ATP, 10 HEPES and 10 EGTA. The pH was adjusted to 7.3 with KOH (osmolarity 
295 mOsm). Voltage values indicated in the text and in figures are not corrected for the liquid 
junction potential, estimated to be ~ 14 mV. Electrophysiological responses were amplified (EPC-
7, HEKA; Multiclamp 700B, Axon Instruments), sampled and digitized at 10 kHz with the pClamp 
software (Axon Instruments) for offline analysis. Single spontaneous synaptic events were detected 
by the use of the AxoGraph X (Axograph Scientific) event detection program (Clements & 
Bekkers, 1997). On average, ≥ 400 events were analysed for each cell in order to obtain mean 
amplitude parameter. Neuronal passive properties were measured by repeated (80 times) 
stimulation of cells with a 100 ms lasting hyperpolarizing stimulus (5 mV). The area below 
capacitative transients was computed and normalized for voltage transient amplitude to calculate 
cell capacitance (Cm); input resistance (Rin) was obtained through Ohm’s law, by measuring the 
amplitude of steady state current generated by the voltage transient. 
5.4.3.3 Immunofluorescence: cell morphology analyses 
Immunolabelling on dissociated hippocampal neurons was performed after fixation with 4% 
paraformaldehyde (PFA) in PBS for 20 min at room temperature. Cells were permeabilized and 
blocked in 5% FBS and 0.3% Triton X-100 for at least 30 min at room temperature and incubated 
with the following primary antibodies for 30 min: rabbit polyclonal anti- β-Tubulin III  
(Sigma-Aldrich, T2200, 1:500) and mouse monoclonal anti-GFAP (Sigma-Aldrich, G3893, 
1:250). Upon washing, cells were then incubated for 30 min with the following secondary 
antibodies: goat anti-rabbit Alexa 594 (Invitrogen, A-11012, 1:500), goat anti-mouse Alexa 488 
(Invitrogen, A-11001, 1:500) and 4,6-diamidine-2-phenylindole dihydrochloride (DAPI, 
Invitrogen, D1306, 1:200) to label the nuclei. Finally, samples were washed in PBS and quickly 
rinsed with milliQ water to remove the PBS salt residual and mounted on glass microscope slides 
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using Vectashield hardset mounting medium (Vector Laboratories). Fluorescence images were 
acquired using a Leica DM6000 upright microscope with a 20X dry objective. Identical binning, 
gains and exposure times were used for all images of the same marker. Image analysis was 
performed using the professional image analysis software Volocity (PerkinElmer). For the 
quantification of the β-Tubulin positive area, a threshold was set for both intensity and object size, 
thus ensuring that the observed signal indicates the presence of genuine β-Tubulin positive 
labelling. Cell density counting analysis (number of cells/mm2) was obtained from at least three 
fields randomly selected from each sample per condition. 
Immunolabelling on MN progenitors was performed after fixation in 4% PFA for 10 min at RT. 
Upon fixation, cells were permeabilized in 0.1% Triton X-100 in PBS and then incubated with the 
following primary antibodies: rabbit polyclonal anti-GFAP (DakoCytomation, Z0334, 1:250), 
mouse monoclonal anti-Neuronal class III β-Tubulin (Covance; MMS-435P, 1:250), goat 
polyclonal anti-choline acethyltransferase (ChAT) (Merck Millipore, AB144P, 1:200) and then 
secondary antibodies: goat-anti rabbit antiserum conjugated to Alexa 488 (Invitrogen), goat-anti 
mouse antiserum conjugated to Alexa 594 (Invitrogen), donkey anti-goat conjugated to Alexa 647 
(Invitrogen). Immunolabelled cells were mounted in Aqua-Poly/Mount (Polysciences, Inc.) and 
analyzed at confocal microscopy, using a TCS SP5 microscope (Leica Microsystem). Z-stacks 
images were captured at 1 μm intervals with a 40X or 63X objectives and a pinhole of 1.0 Airy 
unit. Analyses were performed in sequential scanning mode to rule out cross-bleeding between 
channels. Fluorescence intensity quantification of β-tubulin was performed with ImageJ software. 
To quantify the percentage of differentiation, the number of β-tubulin (Tuj1) and glial fibrillary 
acid protein (GFAP) immunoreactive cells was counted in at least ten non-overlapping fields in 
each sample, for a total of >1000 cells per sample. The total number of cells in each field was 
determined by counterstaining cell nuclei with DAPI (Sigma-Aldrich, 50 mg/ml in PBS for 15 min 
at RT). The average percentage of differentiated cells for each sample was then calculated by 
dividing the number of Tuj1 and GFAP positive cells by the total number of cells for each field. 
For motor neuron differentiation, the average percentage of ChAT positive cells was calculated by 
dividing the number of ChAT immunoreactive cells a by the total number of Tuj1 positive cells for 
each field. Data are the mean ± standard error of the mean of three independent cultures, three 
independent experiments for each culture. 
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5.4.3.4 Statistical analyses 
Results are presented as mean ± standard deviation; n is the number of neurons, if not otherwise 
indicated. Statistically significant difference between groups was assessed by Student’s t test (after 
checking variances homogeneity by Levene’s test) for parametric data and by Mann-Whitney’s test 
for non-parametric ones. A p-value below 0.05 was accepted as indicative of a statistically 
significant difference. 
5.4.3.5 Galectin-1 quantification (ELISA) 
Galectin-1 quantification was performed by the enzyme-linked immunosorbent assay (ELISA). 
The quantification was performed on the culture medium, subtracted 2 times from the culture dish 
(the first one at the last medium change before the electrophysiological experiment and the second 
at the day of the experiment), to determine the amount of protein secreted by the cells. The ELISA 
kit Galectin 1 Mouse abcam® Company (Cambridge, UK) was used. 
5.4.3.6 Immunofluorescence: localization of Galectin-1 
Immunolabelling on dissociated hippocampal neurons was performed after fixation with 4% 
paraformaldehyde (PFA) in PBS for 20 min at room temperature. Cells were permeabilized and 
blocked in 5% FBS and 0.3% Triton X-100 for at least 30 min at room temperature and incubated 
with the following primary antibodies for 30 min: rabbit polyclonal anti-β-Tubulin III (Sigma-
Aldrich, T2200, 1:500) and mouse monoclonal anti-Galectin 1 Antibody (Invitrogen, 6C8.4-1, 
1:250). Upon washing, cells were then incubated for 30 min with the following secondary 
antibodies: goat anti-rabbit Alexa 568 (Invitrogen, A-11011, 1:400) and goat anti-mouse Alexa 
488 (Invitrogen, A-11001, 1:200). Finally, samples were washed in PBS and quickly rinsed with 
milliQ water to remove the PBS salt residual and mounted on glass microscope slides using Mowiol 
mounting medium (Sigma Aldrich). Images were taken with a Nikon Eclipse C1 microscope, with 
an objective Nikon 60X Plan using an argon laser (488 nm) and a diode laser (568 nm), an 
acquisition channel of 515/30 nm and of 590/50 nm. Identical binning, gains and exposure times 
were used for all images of the same marker. Image analysis was performed using the ImageJ 
software. For the quantification of the Galectin-1 and the β-Tubulin positive areas, a threshold was 
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set for both intensity and object size, thus ensuring that the observed signal indicates the presence 
of genuine positive labelling.  
5.5 IN VIVO CHARACTERIZATION OF INJECTABLE BONE FILLERS 
5.5.1 ANIMAL MODEL 
A total of 12 New Zealand white rabbits, body weight 3.9 ± 0.3 kg, age 6.9 ± 0.6 months, were 
used for this study. The selected animal model is well-established and recommended for use in 
biomaterial research.231 Two groups of animals (6 rabbits per group) were created; scaffolds were 
implanted in one group for 6 weeks and in the other for 12 weeks. 
5.5.2 MATERIALS PREPARATION 
Three types of materials have been tested: i) alginate microbeads containing chitlac/nAg, dispersed 
in alginate/hyaluronic acid; ii) alginate microbeads containing chitlac, dispersed in 
alginate/hyaluronic acid; iii) HydroSet™, Stryker, NJ, USA (LOT n. T45SB IC01996 and  
LOT n. T45SK IC02000), as positive control. 
The microbeads have been prepared as reported in the previous paragraphs using sterile 
instrumentation, autoclaved alginate, HAp and hyaluronic acid solutions and dispersions, and 
filtered chitac and chitlac/nAg solutions. Briefly, once the microbeads are formed, they are 
sterilized with UV irradiation and mixed with the autoclaved anionic polysaccharide (alginate 3% 
w/V; hyaluronic acid 1% w/V) solution. Autoclaved sterilized syringes have been loaded in sterile 
condition with the injectable formulation and sterile packaged. 
The positive control material was previously divided into one syringe per rabbit. The liquid and 
the powder were mixed together right before the drilling of the holes, and the resulting material 
was used right after. 
5.5.3 ANIMAL EXPERIMENTS 
The animal experiments have been carried out in the Central Animal Laboratory of the University 
of Turku which is managed according to the Act and Decrees on the Protection of Animals used 
for Scientific and Educational purposes in Finland (497/2013; 564/2013; 565/2013) and the EU 
Directive 2010/63/EU, the Decrees 1076/85 §3 and 1360/90. The Central Animal Laboratory has 
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the statement of GLP Compliance to OECD Principles, is included in the national GLP-Compliance 
Program and is inspected on a regular basis. The animal study protocols have been planned 
according to the 3Rs principles (Replacement, Reduction and Refinement). The Federation of 
Laboratory Animal Science Associations (FELASA) guidelines on pain and distress in laboratory 
rodents and lagomorphs and Recommendations for euthanasia of experimental animals as well as 
humane endpoint have been followed up in the procedures of the experiments. 
5.5.3.1 Implantations 
The procedure has been designed to simulate clinical filling of a non-critical bone defect. A well-
established rabbit bilateral femoral defect model has been applied. The animal model includes a 
creation of non-critical size medial longitudinal defects, 3 mm of diameter and 6 mm of depth, in 
both the left and right femoral condyles of the rabbit under general anesthesia. The anatomic 
location for the implantation (cancellous bone of the distal femur) provided similar structural and 
biomechanical conditions for the healing of multiple implants. 
Two scaffold formulations and injectable bone void filler have been randomly implanted. 
Randomization has been performed by drawings of the lots. The codes for the compositions has 
not been opened before the final data analysis (blinded analysis). In addition, one bone defect in 
each rabbit has been left unfilled to allow evaluation of a possible trend for osteoinduction of tested 
materials. After surgery, the functional activity of the animals is not restricted and the animals 
receive a post-operative pain medication. The animals have been euthanized 6 and 12 weeks after 
implantation in order to evaluate bone tissue healing and the replacement of materials. 
5.5.3.2 Micro-computed tomography (μ-CT) imaging 
The imaging was performed by SkyScan 1072 scanner (Skyscan N.V. Kontich, Belgium). One 
knee containing two implants was imaged in each imaging session. In the μ-CT imaging, the 
imaging step angle was 0.45 degrees, within a full angle of 180 degrees.  The source voltage was 
61 kV, the source current was 163 µA, and no filters were used. In image acquisition, a single  
16-bit grayscale shadow projection image was obtained for each step angle as an average of two 
consequent images. Image averaging resulted in the improved quality of the images. The acquired 
shadow projection images were reconstructed into an array of cross-sectional 8 bit grayscale 
MATERIALS AND METHODS 
 
147 
images using NRecon software (version v.1.4.3, Skyscan N.V. Kontich, Belgium). Automatic post-
alignment and beam hardening correction were used in the reconstruction. The resulting spatial 
resolution of the cross-sectional images was 18.9 µm per pixel. 
5.5.3.3 Analysis of the μ-CT data 
The arrays of the reconstructed cross-sectional images were loaded into DataViewer software 
(version v.1.4.4 64 bit, Skyscan N.V. Kontich, Belgium). For each of the two implants, the images 
were repositioned along the long axis of the implant (drilling direction) and cropped in a 
standardized way leaving sufficient amount of per-implant bone visible. This operation resulted in 
the creation of separate data arrays for each implant. These data arrays were characterized using 
CT analyzer software (CTAn version 1.5.0.0. Skyscan N.V. Kontich, Belgium). For each implant, 
a standard cylindrical volume of interest (VOI) with the diameter of 3 mm and the height of 3 mm 
was created within the implant volume.  
In the analysis, local thresholding procedure (adaptive mean) with pre-thresholding (50 - 255 
grayscale levels) was applied to segment the pixels containing bone and or implants from non-
mineralized tissues and voids. The selection was inverted to obtain dark grayscale pixels, which 
represented the non-mineralized tissues and voids. The total amount of dark grayscale pixels was 
counted within the VOI and expressed as percentage of the total area of the VOI. These dark 
grayscale pixels were expected to give an estimate of the volumes not occupied by the mineralized 
bone. 
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